##FILTER=off-target=Variant marked as 'off-target'.
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-421-ga6099d1
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Diseases of the nervous system,DiseaseStatus=affected>
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27682481	27682481	G	A	het	off-target	QUAL=2185;DP=168;AF=0.51;MQM=60;SAP=15;ABP=3	MAP3K6	intron	MAP3K6:ENST00000357582:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:ENST00000374040:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::,MAP3K6:ENST00000493901:intron_variant:MODIFIER:intron28/29:c.3711+36C>T::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::						rs12569127	0.1903	0.2679	1166,.	0.2161,0.2029,0.1156,0.3237,0.1645	-0.5000			0.06,0.19	4.58							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				%25%21new%20text%21%3C%3E%212%09%0Atext	SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27686063	27686063	G	C	hom	off-target	QUAL=6130;DP=198;AF=1.00;MQM=60;SAP=5;ABP=0	MAP3K6	intron	MAP3K6:ENST00000357582:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:ENST00000374040:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::,MAP3K6:ENST00000493901:intron_variant:MODIFIER:intron18/29:c.2320-50C>G::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::						rs7521552		0.9943	15305,.	0.9655,0.9966,1.0000,0.9953,0.9965	-0.3520			0.00,0.11	4.10							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				second2ddffd	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27687466	27687466	G	T	het		QUAL=9721;DP=729;AF=0.52;MQM=60;SAP=4;ABP=5	MAP3K6	missense	MAP3K6:ENST00000357582:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:,MAP3K6:ENST00000493901:missense_variant:MODERATE:exon15/30:c.1866C>A:p.Asn622Lys:	MAP3K6:NM_001297609.2:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:,MAP3K6:NM_004672.5:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:			403071 [benign DISEASE=not specified];			rs35659744	0.1220	0.2260	892,.	0.0497,0.1399,0.0936,0.3028,0.1508	0.0290	T(0.18),T(0.20),T(0.18)	B(0.00),B(0.00),B(0.00)	0.03,0.20	13.69	0.04			COSV62889375			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				1	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27690359	27690359	T	C	het	off-target	QUAL=1451;DP=111;AF=0.53;MQM=60;SAP=4;ABP=4	MAP3K6	intron	MAP3K6:ENST00000357582:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:ENST00000374040:intron_variant:MODIFIER:intron4/27:c.840+49A>G::,MAP3K6:ENST00000493901:intron_variant:MODIFIER:intron6/29:c.864+49A>G::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron4/27:c.840+49A>G::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron5/28:c.864+49A>G::					MIRb (SINE/MIR)	rs4307592	0.2196	0.3005	1452,.	0.3199,0.2199,0.1139,0.3232,0.1662	0.0910			0.01,0.14	3.87							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				4	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27690644	27690644	A	G	het	off-target	QUAL=639;DP=88;AF=0.35;MQM=60;SAP=4;ABP=20	MAP3K6	intron	MAP3K6:ENST00000357582:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:ENST00000374040:intron_variant:MODIFIER:intron3/27:c.671+51T>C::,MAP3K6:ENST00000493901:intron_variant:MODIFIER:intron5/29:c.695+51T>C::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron3/27:c.671+51T>C::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron4/28:c.695+51T>C::						rs12727507	0.3548	0.4173	3181,.	0.6804,0.2466,0.1147,0.3568,0.1999	-0.0660			0.01,0.20	3.64							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				5	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	45796269	45796269	G	C	hom	off-target	QUAL=264;DP=10;AF=1.00;MQM=60;SAP=25;ABP=0	MUTYH	intron	MUTYH:ENST00000354383:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:ENST00000355498:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000372098:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372100:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000372104:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:ENST00000372110:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:ENST00000372115:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000448481:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000450313:intron_variant:MODIFIER:intron14/15:c.1477-40C>G::,MUTYH:ENST00000456914:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000488731:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000528013:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000528332:intron_variant:MODIFIER:intron5/6:c.520-40C>G::,MUTYH:ENST00000529984:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000531105:intron_variant:MODIFIER:intron2/2:c.116-1160C>G::	MUTYH:NM_001048171.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:NM_001048172.1:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:NM_001048173.1:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001048174.1:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001128425.1:intron_variant:MODIFIER:intron14/15:c.1477-40C>G::,MUTYH:NM_001293190.1:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:NM_001293191.1:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:NM_001293192.1:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:NM_001293195.1:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:NM_001293196.1:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:NM_001350650.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:NM_001350651.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:NM_012222.2:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:NR_146882.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1651-40C>G::,MUTYH:NR_146883.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/15:n.1465-40C>G::		604933 [GENE=MUTYH PHENOS=Gastric cancer,somatic,613659/Adenomas,multiple colorectal,608456,Autosomal recessive];	439920 [benign DISEASE=not specified];			rs3219493	0.9353	0.9358	13754,.	0.9591,0.9512,0.8911,0.9120,0.9177	0.2580			0.00,0.06	4.23							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				fsdfsdf	HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45797505	45797505	C	G	het		QUAL=3110;DP=231;AF=0.51;MQM=60;SAP=5;ABP=3	MUTYH	missense,intron	MUTYH:ENST00000354383:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372098:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372100:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000372104:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000372110:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000372115:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000448481:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000450313:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:ENST00000456914:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000488731:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000528013:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000528332:intron_variant:MODIFIER:intron3/6:c.230-277G>C::,MUTYH:ENST00000529984:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000531105:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::	MUTYH:NM_001048171.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:NM_001048172.1:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:NM_001048173.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001048174.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001128425.1:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:NM_001293190.1:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:NM_001293191.1:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:NM_001293192.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001293195.1:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:NM_001293196.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001350650.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_001350651.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_012222.2:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:NR_146882.1:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.1188G>C::,MUTYH:NR_146883.1:non_coding_transcript_exon_variant:MODIFIER:exon11/16:n.1002G>C::		604933 [GENE=MUTYH PHENOS=Gastric cancer,somatic,613659/Adenomas,multiple colorectal,608456,Autosomal recessive];	41767 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,MYH-associated polyposis,not specified,not provided];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.3135	0.2900	1071,.	0.2630,0.4881,0.3974,0.2444,0.2371	0.0510	T(0.10),T(0.10),T(0.08),T(0.09),T(0.10),T(0.09),T(0.08),T(0.09),T(0.07),T(0.10), ,T(0.08), , , 	B(0.15),B(0.21),B(0.29),B(0.29),B(0.21),B(0.38),B(0.21),B(0.29),B(0.21),B(0.21), ,B(0.21), , , 	0.15,0.62	12.97	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				text edit	HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45798555	45798555	T	C	hom	off-target	QUAL=5838;DP=189;AF=1.00;MQM=60;SAP=3;ABP=0	MUTYH	intron	MUTYH:ENST00000354383:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:ENST00000355498:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000372098:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372100:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000372104:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:ENST00000372110:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:ENST00000372115:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000448481:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000450313:intron_variant:MODIFIER:intron6/15:c.504+35A>G::,MUTYH:ENST00000456914:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000488731:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000528013:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000528332:intron_variant:MODIFIER:intron2/6:c.158-49A>G::,MUTYH:ENST00000529984:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000531105:intron_variant:MODIFIER:intron2/2:c.115+1508A>G::	MUTYH:NM_001048171.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:NM_001048172.1:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:NM_001048173.1:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001048174.1:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001128425.1:intron_variant:MODIFIER:intron6/15:c.504+35A>G::,MUTYH:NM_001293190.1:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:NM_001293191.1:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:NM_001293192.1:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:NM_001293195.1:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:NM_001293196.1:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:NM_001350650.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:NM_001350651.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:NM_012222.2:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:NR_146882.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.678+35A>G::,MUTYH:NR_146883.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/15:n.492+35A>G::		604933 [GENE=MUTYH PHENOS=Gastric cancer,somatic,613659/Adenomas,multiple colorectal,608456,Autosomal recessive];	257529 [benign DISEASE=not specified];			rs3219487	0.9371	0.9392	13840,.	0.9677,0.9530,0.8902,0.9134,0.9190	-0.7130			0.03,0.17	1.45							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62713224	62713224	C	G	hom		QUAL=1165;DP=37;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	missense	KANK4:ENST00000317477:missense_variant:MODERATE:exon3/4:c.217G>C:p.Val73Leu:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150:missense_variant:MODERATE:exon6/7:c.871G>C:p.Val291Leu:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:,KANK4:NM_181712.5:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:						rs2941679		0.9750	14912,.	0.9936,0.9872,0.9993,0.9639,0.9725	0.6970	T(0.37),T(0.28),T(0.31),T(0.94)	B(0.00),B(0.00),B(0.00),B(0.00)	0.42,0.96	15.77	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62713246	62713246	G	A	het		QUAL=1311;DP=117;AF=0.44;MQM=60;SAP=3;ABP=7	KANK4	synonymous	KANK4:ENST00000317477:synonymous_variant:LOW:exon3/4:c.195C>T:p.His65=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150:synonymous_variant:LOW:exon6/7:c.849C>T:p.His283=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:						rs10889315	0.3189	0.3893	2423,.	0.3207,0.3324,0.1573,0.4246,0.4067	-0.5170			0.15,0.93	4.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728784	62728784	A	G	hom		QUAL=38141;DP=1196;AF=1.00;MQM=60;SAP=5;ABP=0	KANK4	5'UTR,missense	KANK4:ENST00000317477:5_prime_UTR_variant:MODIFIER:exon1/4:c.-68T>C::,KANK4:ENST00000354381:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150:missense_variant:MODERATE:exon4/7:c.587T>C:p.Val196Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:,KANK4:NM_181712.5:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:						rs2666472		0.7540	8118,.	0.5500,0.8594,0.8461,0.7369,0.7029	2.8410	 ,T(0.32),T(0.35),T(0.93)	 ,B(0.04),B(0.06),B(0.06)	0.78,0.95	11.20	0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728838	62728838	T	C	hom		QUAL=35318;DP=1135;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	5'UTR,missense	KANK4:ENST00000317477:5_prime_UTR_variant:MODIFIER:exon1/4:c.-122A>G::,KANK4:ENST00000354381:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150:missense_variant:MODERATE:exon4/7:c.533A>G:p.His178Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:,KANK4:NM_181712.5:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:	regulatory_region_variant:enhancer					rs2258470		0.7541	8086,.	0.5508,0.8597,0.8459,0.7369,0.7029	3.3080	 ,T(0.41),T(0.43),T(0.22)	 ,B(0.00),B(0.00),B(0.00)	0.14,0.94	14.79	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728861	62728861	T	C	hom		QUAL=35829;DP=1143;AF=1.00;MQM=60;SAP=5;ABP=0	KANK4	5'UTR,synonymous	KANK4:ENST00000317477:5_prime_UTR_variant:MODIFIER:exon1/4:c.-145A>G::,KANK4:ENST00000354381:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:,KANK4:ENST00000371150:synonymous_variant:LOW:exon4/7:c.510A>G:p.Lys170=:,KANK4:ENST00000371153:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:	KANK4:NM_001320269.2:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:	regulatory_region_variant:enhancer					rs2260581		0.7543	8089,.	0.5516,0.8598,0.8461,0.7373,0.7029	0.5670			0.03,0.94	10.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728918	62728918	G	A	hom		QUAL=5604;DP=187;AF=1.00;MQM=60;SAP=31;ABP=0	KANK4	5'UTR,synonymous	KANK4:ENST00000317477:5_prime_UTR_variant:MODIFIER:exon1/4:c.-202C>T::,KANK4:ENST00000354381:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:,KANK4:ENST00000371150:synonymous_variant:LOW:exon4/7:c.453C>T:p.Pro151=:,KANK4:ENST00000371153:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:	KANK4:NM_001320269.2:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:	regulatory_region_variant:enhancer					rs2262110	0.7161	0.7545	8119,.	0.5517,0.8595,0.8467,0.7377,0.7028	-1.7560			0.04,0.94	3.89							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62729015	62729015	G	A	hom	off-target	QUAL=7385;DP=225;AF=1.00;MQM=60;SAP=11;ABP=0	KANK4	5'UTR,intron	KANK4:ENST00000317477:5_prime_UTR_variant:MODIFIER:exon1/4:c.-299C>T::,KANK4:ENST00000354381:intron_variant:MODIFIER:intron5/8:c.436-32C>T::,KANK4:ENST00000371150:intron_variant:MODIFIER:intron3/6:c.388-32C>T::,KANK4:ENST00000371153:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron5/8:c.436-32C>T::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::	regulatory_region_variant:enhancer					rs2262106		0.7556	7975,.	0.5279,0.8585,0.8486,0.7400,0.7037	0.3490			0.22,0.20	10.04							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62732421	62732421	T	C	het		QUAL=11398;DP=885;AF=0.52;MQM=60;SAP=3;ABP=5	KANK4	missense	KANK4:ENST00000354381:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:ENST00000371150:missense_variant:MODERATE:exon3/7:c.370A>G:p.Thr124Ala:,KANK4:ENST00000371153:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:	KANK4:NM_001320269.2:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:NM_181712.5:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:						rs11207949	0.3055	0.2967	1353,.	0.2153,0.4784,0.5863,0.2438,0.1437	2.3800	T(0.55),T(0.54),T(0.12)	B(0.01),B(0.01),B(0.01)	0.76,0.33	14.21	0.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62733939	62733939	G	A	het	off-target	QUAL=1679;DP=151;AF=0.46;MQM=60;SAP=3;ABP=5	KANK4	intron	KANK4:ENST00000354381:intron_variant:MODIFIER:intron4/8:c.347+20C>T::,KANK4:ENST00000371150:intron_variant:MODIFIER:intron2/6:c.299+20C>T::,KANK4:ENST00000371153:intron_variant:MODIFIER:intron5/9:c.2231+20C>T::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron4/8:c.347+20C>T::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron5/9:c.2231+20C>T::						rs11207950	0.4669	0.4447	3203,.	0.5722,0.3458,0.2627,0.4150,0.5666	-0.4570			0.00,0.08	0.21							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62738904	62738904	T	C	hom		QUAL=1844;DP=63;AF=1.00;MQM=60;SAP=9;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:ENST00000371153:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:	regulatory_region_variant:promoter_flanking_region					rs7516290	0.8005	0.7709	9393,.	0.8562,0.8321,0.8485,0.6898,0.7526	-0.8540			0.05,0.20	1.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62739198	62739198	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60;SAP=10;ABP=3	KANK4	intron,synonymous	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:ENST00000371153:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:	regulatory_region_variant:promoter_flanking_region					rs17855078	0.2506	0.3037	1292,.	0.1791,0.2220,0.1264,0.3399,0.4044	-1.6330			0.07,0.11	0.04							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740065	62740065	A	G	het		QUAL=1454;DP=128;AF=0.48;MQM=60;SAP=3;ABP=4	KANK4	intron,synonymous	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:ENST00000371153:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:						rs12127930	0.4822	0.4851	3833,.	0.6174,0.3608,0.2619,0.4397,0.5676	-1.6810			0.05,0.15	0.58							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740446	62740446	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:ENST00000371153:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:						rs2666506	0.8045	0.7703	9309,.	0.8578,0.8402,0.8658,0.6865,0.7418	0.0250			0.00,0.20	2.54							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740449	62740449	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:ENST00000371153:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:						rs2666507	0.7809	0.7459	8702,.	0.7750,0.8364,0.8658,0.6862,0.7416	-1.5990			0.04,0.10	0.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740781	62740781	A	-	het	off-target	QUAL=270;DP=116;AF=0.20;MQM=60;SAP=3;ABP=95	KANK4	intron	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:ENST00000371153:intron_variant:MODIFIER:intron2/9:c.17-22del::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron2/9:c.17-22del::						rs761923018		0.1206	0,.	0.0807,0.1653,0.1052,0.1096,0.1776	0.6420				10.51							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	78578177	78578177	T	C	het		QUAL=4981;DP=413;AF=0.46;MQM=60;SAP=4;ABP=10	GIPC2	intron	GIPC2:ENST00000370759:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	GIPC2:NM_001304725.2:intron_variant:MODIFIER:intron3/5:c.386-6900T>C::,GIPC2:NM_017655.6:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::						rs6666954	0.4489	0.3754	2617,.	0.6112,0.2545,0.6166,0.2758,0.2698	-1.2050			0.00,0.05	1.07							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	120458004	120458004	A	T	het		QUAL=1766;DP=130;AF=0.55;MQM=60;SAP=3;ABP=6	NOTCH2	synonymous	NOTCH2:ENST00000256646:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:	NOTCH2:NM_024408.4:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];	261705 [benign DISEASE=not specified];			rs6685892	0.1925	0.1688	594,.	0.3365,0.0881,0.0295,0.1028,0.1890	-0.5740			0.09,0.21	5.88							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120465385	120465385	C	T	het		QUAL=268;DP=563;AF=0.33;MQM=60;SAP=403;ABP=150	NOTCH2	missense	NOTCH2:ENST00000256646:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:PF07684 [NOTCH protein]	NOTCH2:NM_024408.4:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs1447900658		0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	6.0740	D(0.00)	D(1.00)	1.00,1.00	32.00	0.48				-0.1306	0.9313	0	148	0 / 0					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120471857	120471857	C	T	het	off-target	QUAL=525;DP=29;AF=0.69;MQM=60;SAP=5;ABP=12	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::	NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2493392	0.1925	0.1688	595,.	0.3357,0.0880,0.0295,0.1022,0.1892	0.3380			0.04,0.24	3.84							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120477998	120477998	C	A	het	off-target	QUAL=286;DP=19;AF=0.63;MQM=60;SAP=3;ABP=6	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::	NOTCH2:NM_001200001.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*44G>T::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2453056	0.3013	0.2416	1354,.	0.5311,0.1816,0.1008,0.1229,0.3007	-0.0200			0.00,0.09	5.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120478285	120478285	T	C	het	off-target	QUAL=11655;DP=891;AF=0.51;MQM=60;SAP=3;ABP=4	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron21/21:c.3523-58A>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs5025718		0.6716	8503,.		-1.6160			0.02,0.13	5.18							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120484421	120484421	G	A	het	off-target	QUAL=762;DP=65;AF=0.49;MQM=60;SAP=3;ABP=3	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron17/21:c.2753-44C>T::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2493420	0.2714	0.2160	985,.	0.4422,0.1784,0.1021,0.1236,0.3014	0.0360			0.00,0.10	7.83							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120496119	120496119	A	T	het	off-target	QUAL=7157;DP=638;AF=0.45;MQM=60;SAP=3;ABP=17	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron14/21:c.2365+47T>A::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs7534585	0.1923	0.1674	568,.	0.3358,0.0882,0.0296,0.1022,0.1879	0.2040			0.06,0.22	5.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120496127	120496127	A	C	het	off-target	QUAL=7123;DP=638;AF=0.45;MQM=60;SAP=3;ABP=17	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron14/21:c.2365+39T>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs7534586	0.1923	0.1672	566,.	0.3358,0.0882,0.0296,0.1022,0.1879	-0.0920			0.08,0.23	5.63							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120512104	120512104	T	C	hom	off-target	QUAL=18002;DP=571;AF=1.00;MQM=60;SAP=4;ABP=0	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron6/21:c.1108+30A>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::		600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2493409		0.9942	15026,.	0.9220,0.9966,1.0000,0.9995,0.9997	-2.1020			0.02,0.11	0.18							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120529750	120529750	A	C	het	off-target	QUAL=11312;DP=921;AF=0.48;MQM=60;SAP=4;ABP=6	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron4/21:c.752-45T>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2453040	0.1907	0.1664	576,.	0.3302,0.0871,0.0299,0.1014,0.1877	-0.0020			0.09,0.41	7.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120539331	120539331	C	T	het		QUAL=25003;DP=1918;AF=0.52;MQM=49;SAP=4;ABP=7	NOTCH2	intron,missense	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron4/33:c.751+289G>A::,NOTCH2:ENST00000602566:missense_variant:MODERATE:exon6/6:c.673G>A:p.Gly225Arg:	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron4/21:c.751+289G>A::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron4/33:c.751+289G>A::	regulatory_region_variant:promoter_flanking_region	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2124109		0.4374	0,.	0.2349,0.4172,0.4612,0.4569,0.4527	-0.7660	 ,T(0.93)	 ,P(0.55)	0.02,0.14	7.74							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120611496	120611496	C	A	het		QUAL=276;DP=41;AF=0.49;MQM=47;SAP=46;ABP=3	NOTCH2	intron	NOTCH2:ENST00000256646:intron_variant:MODIFIER:intron1/33:c.73+452G>T::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron1/21:c.73+452G>T::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron1/33:c.73+452G>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2794164		0.4987	876,.	0.5084,0.2885,0.4209,0.2317,0.2388	0.1850			0.00,0.10	8.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120611960	120611960	C	T	het		QUAL=4716;DP=1928;AF=0.21;MQM=47;SAP=3;ABP=1406	NOTCH2	missense	NOTCH2:ENST00000256646:missense_variant:MODERATE:exon1/34:c.61G>A:p.Ala21Thr:	NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.61G>A:p.Ala21Thr:,NOTCH2:NM_024408.4:missense_variant:MODERATE:exon1/34:c.61G>A:p.Ala21Thr:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs2603926		0.1154	0,.	0.1924,0.0615,0.0501,0.1505,0.0930	0.4330	T(0.57)	B(0.01)	0.26,0.89	16.28	0.05			COSV56681399			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120611964	120611964	G	C	het		QUAL=16670;DP=1962;AF=0.38;MQM=59;SAP=8;ABP=229	NOTCH2	missense	NOTCH2:ENST00000256646:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp:	NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.57C>G:p.Cys19Trp:,NOTCH2:NM_024408.4:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];	801540 [benign DISEASE=Hajdu-Cheney syndrome];			rs11810554		0.4434	0,.	0.2583,0.4276,0.4668,0.4595,0.4561	0.7670	T(0.18)	B(0.00)	0.33,0.90	21.30	0.10			COSV56680365			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120612006	120612006	G	A	het		QUAL=19826;DP=2005;AF=0.39;MQM=58;SAP=4;ABP=217	NOTCH2	synonymous	NOTCH2:ENST00000256646:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5=:	NOTCH2:NM_001200001.1:synonymous_variant:LOW:exon1/22:c.15C>T:p.Arg5=:,NOTCH2:NM_024408.4:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];				rs4021006	0.3940	0.4509	92,.	0.2970,0.4472,0.4622,0.4601,0.4676	1.0740			0.19,0.89	13.37				COSV56680229,COSV56680371			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120612034	120612034	T	G	het		QUAL=3626;DP=2011;AF=0.20;MQM=47;SAP=3;ABP=1566	NOTCH2	5'UTR	NOTCH2:ENST00000256646:5_prime_UTR_variant:MODIFIER:exon1/34:c.-14A>C::	NOTCH2:NM_001200001.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-14A>C::,NOTCH2:NM_024408.4:5_prime_UTR_variant:MODIFIER:exon1/34:c.-14A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];			(CGC)n (Simple_repeat)	rs201668322		0.0593	0,.	0.0749,0.0289,0.0310,0.0881,0.0341	0.2430			0.16,0.88	15.76							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17941423	17941423	T	G	hom	off-target	QUAL=1007;DP=33;AF=1.00;MQM=60;SAP=38;ABP=0	GEN1,SMC6	intron	GEN1:ENST00000317402:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:ENST00000381254:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,SMC6:ENST00000402989:intron_variant:MODIFIER:intron4/29:c.-5-14205A>C::	GEN1:NM_001130009.3:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:NM_182625.5:intron_variant:MODIFIER:intron2/13:c.161+52T>G::						rs2555072		0.6825	5814,.	0.4720,0.8154,0.9574,0.6213,0.8616	-0.6670			0.14,0.18	0.50							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17942775	17942775	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60;SAP=14;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],SMC6:ENST00000402989:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:NM_182625.5:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:						rs1812152		0.7177	7473,.	0.7654,0.8383,0.9844,0.6243,0.8734	0.5660	T(0.36),T(0.36), 	B(0.00),B(0.00), 	0.02,0.90	12.41	0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17954027	17954027	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60;SAP=22;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,SMC6:ENST00000402989:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:NM_182625.5:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:						rs300175	0.9770	0.9944	15324,.	0.9515,0.9973,0.9998,0.9999,0.9842	-2.1940	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.01,0.10	0.00	0.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17954421	17954421	C	G	hom	off-target	QUAL=3002;DP=93;AF=1.00;MQM=60;SAP=4;ABP=0	GEN1,SMC6	intron	GEN1:ENST00000317402:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:ENST00000381254:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,SMC6:ENST00000402989:intron_variant:MODIFIER:intron4/29:c.-6+14661G>C::	GEN1:NM_001130009.3:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:NM_182625.5:intron_variant:MODIFIER:intron9/13:c.990+22C>G::						rs300177		0.7167	7404,.	0.7561,0.8376,0.9847,0.6241,0.8732	-1.9120			0.00,0.09	0.48							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17962450	17962450	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60;SAP=84;ABP=0	GEN1,SMC6	synonymous,intron	GEN1:ENST00000317402:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,SMC6:ENST00000402989:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::	GEN1:NM_001130009.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:NM_182625.5:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:						rs300168	0.5739	0.5891	3679,.	0.2165,0.7466,0.9232,0.5153,0.7680	0.4800			0.72,0.96	10.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17962518	17962518	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60;SAP=3;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,SMC6:ENST00000402989:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:NM_182625.5:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:						rs300169		0.7049	6505,.	0.5958,0.8273,0.9846,0.6234,0.8730	0.1800	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.00,0.16	8.92	0.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47601106	47601106	T	C	het		QUAL=747;DP=42;AF=0.71;MQM=60;SAP=3;ABP=20	EPCAM	missense	EPCAM:ENST00000263735:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000405271:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat]	EPCAM:NM_002354.3:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	185535 [GENE=EPCAM PHENOS=Colorectal cancer,hereditary nonpolyposis,type 8,613244/Diarrhea 5,with tufting enteropathy,congenital,613217,Autosomal recessive];	183700 [benign/likely benign DISEASE=Hereditary nonpolyposis colon cancer,Hereditary cancer-predisposing syndrome,Lynch syndrome,Lynch syndrome I,not specified];			rs1126497	0.6661	0.6003	6090,.	0.8418,0.4720,0.8320,0.4359,0.4807	0.0410	T(1.00),T(1.00)	B(0.00),B(0.00)	0.08,0.17	11.56	0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47635523	47635523	-	T	het	off-target	QUAL=53;DP=18;AF=0.33;MQM=60;SAP=16;ABP=7	MSH2	intron	MSH2:ENST00000233146:intron_variant:MODIFIER:intron1/15:c.212-4dup::,MSH2:ENST00000406134:intron_variant:MODIFIER:intron1/15:c.212-4dup::,MSH2:ENST00000543555:intron_variant:MODIFIER:intron2/16:c.14-4dup::	MSH2:NM_000251.3:intron_variant:MODIFIER:intron1/15:c.212-4dup::,MSH2:NM_001258281.1:intron_variant:MODIFIER:intron2/16:c.14-4dup::		609309 [GENE=MSH2 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Muir-Torre syndrome,158320,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 1,120435,Autosomal dominant];	491795 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs746333570		0.2036	0,.	0.1599,0.2545,0.2199,0.1769,0.2580					4.55							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	48010488	48010488	G	A	het		QUAL=143;DP=14;AF=0.50;MQM=60;SAP=3;ABP=3	MSH6	missense	MSH6:ENST00000234420:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000540021:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:	MSH6:NM_000179.2:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:NM_001281492.1:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,MSH6:NM_001281493.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-621G>A::	regulatory_region_variant:promoter	600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant];	36581 [benign DISEASE=Hereditary nonpolyposis colon cancer,Hereditary cancer-predisposing syndrome,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,Lynch syndrome I,not specified,not provided];	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6];		rs1042821	0.2009	0.1893	556,.	0.2215,0.1042,0.2531,0.1809,0.2120	1.7020	T(1.00),T(0.62)	B(0.00),B(0.00)	0.05,0.69	12.17	0.16			COSV52274018			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34)
chr2	48018030	48018030	A	G	het	off-target	QUAL=10791;DP=927;AF=0.46;MQM=60;SAP=3;ABP=14	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.170-1451T>C::,MSH6:ENST00000538136:intron_variant:MODIFIER:intron1/9:c.-642-36A>G::,MSH6:ENST00000540021:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::	MSH6:NM_000179.2:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:NM_001281492.1:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::,MSH6:NM_001281493.1:intron_variant:MODIFIER:intron1/8:c.-476-36A>G::,MSH6:NM_001281494.1:intron_variant:MODIFIER:intron1/9:c.-642-36A>G::		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	89301 [benign DISEASE=Lynch syndrome,not specified];			rs1800931	0.0220	0.0386	31,.	0.0091,0.0338,0.0190,0.0542,0.0167	0.8590			0.23,0.27	6.39							32	1375	10 / 250					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	48022981	48022981	G	T	het	off-target	QUAL=281;DP=26;AF=0.46;MQM=60;SAP=15;ABP=3	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.170-6402C>A::,MSH6:ENST00000538136:intron_variant:MODIFIER:intron2/9:c.-445-52G>T::,MSH6:ENST00000540021:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::	MSH6:NM_000179.2:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:NM_001281492.1:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::,MSH6:NM_001281493.1:intron_variant:MODIFIER:intron2/8:c.-279-2769G>T::,MSH6:NM_001281494.1:intron_variant:MODIFIER:intron2/9:c.-445-52G>T::		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	89532 [benign DISEASE=Lynch syndrome];		FLAM_C (SINE/Alu)	rs1800934	0.2244	0.2078	709,.		0.3750			0.03,0.14	2.46				COSV52273967			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	48030692	48030692	T	A	het		QUAL=247;DP=17;AF=0.65;MQM=60;SAP=27;ABP=6	MSH6,FBXO11	synonymous,intron	MSH6:ENST00000234420:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:PF00488 [MutS domain V],FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.169+4642A>T::,MSH6:ENST00000538136:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800=:PF00488 [MutS domain V],MSH6:ENST00000540021:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:PF00488 [MutS domain V]	MSH6:NM_000179.2:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,MSH6:NM_001281492.1:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,MSH6:NM_001281493.1:synonymous_variant:LOW:exon4/9:c.2400T>A:p.Thr800=:,MSH6:NM_001281494.1:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800=:		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	36589 [benign DISEASE=Hereditary nonpolyposis colon cancer,Hereditary cancer-predisposing syndrome,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified];			rs2020910	0.0493	0.0203	22,.	0.0080,0.0137,0.2030,0.0017,0.0080	-2.3650			0.11,0.41	1.81							5	191	0 / 16	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	48030838	48030838	A	T	het	off-target	QUAL=2490;DP=238;AF=0.49;MQM=60;SAP=208;ABP=3	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron_variant:MODIFIER:intron5/9:c.3438+14A>T::,FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.169+4496T>A::,MSH6:ENST00000538136:intron_variant:MODIFIER:intron5/9:c.2532+14A>T::,MSH6:ENST00000540021:intron_variant:MODIFIER:intron3/7:c.3048+14A>T::	MSH6:NM_000179.2:intron_variant:MODIFIER:intron5/9:c.3438+14A>T::,MSH6:NM_001281492.1:intron_variant:MODIFIER:intron3/7:c.3048+14A>T::,MSH6:NM_001281493.1:intron_variant:MODIFIER:intron4/8:c.2532+14A>T::,MSH6:NM_001281494.1:intron_variant:MODIFIER:intron5/9:c.2532+14A>T::		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	42471 [benign DISEASE=Hereditary cancer-predisposing syndrome,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified];			rs2020911	0.4010	0.4118	1844,.	0.1685,0.5075,0.6240,0.3819,0.4764	-0.1210			0.04,0.24	1.78				COSV52273834			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	48032875	48032878	CTAT	-	het	off-target	QUAL=603;DP=44;AF=0.59;MQM=60;SAP=8;ABP=6	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.169+2456_169+2459del::,MSH6:ENST00000538136:intron_variant:MODIFIER:intron7/9:c.2740+35_2740+38del::,MSH6:ENST00000540021:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::	MSH6:NM_000179.2:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,MSH6:NM_001281492.1:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::,MSH6:NM_001281493.1:intron_variant:MODIFIER:intron6/8:c.2740+35_2740+38del::,MSH6:NM_001281494.1:intron_variant:MODIFIER:intron7/9:c.2740+35_2740+38del::		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	89429 [benign DISEASE=Lynch syndrome,not specified];			rs1805181		0.7047	7836,.	0.8012,0.5297,0.8703,0.6763,0.7258	0.4270				1.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	48033551	48033551	C	G	hom	off-target	QUAL=1514;DP=48;AF=1.00;MQM=60;SAP=5;ABP=0	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.169+1783G>C::,MSH6:ENST00000538136:intron_variant:MODIFIER:intron8/9:c.2896-40C>G::,MSH6:ENST00000540021:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::	MSH6:NM_000179.2:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,MSH6:NM_001281492.1:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::,MSH6:NM_001281493.1:intron_variant:MODIFIER:intron7/8:c.2896-40C>G::,MSH6:NM_001281494.1:intron_variant:MODIFIER:intron8/9:c.2896-40C>G::		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	36594 [benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified];			rs3136367		0.7710	9530,.	0.9186,0.6161,0.8828,0.7298,0.7398	-0.1120			0.08,0.21	1.08				COSV52273637			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	48033891	48033891	T	-	het	off-target	QUAL=285;DP=31;AF=0.48;MQM=60;SAP=7;ABP=3	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron_variant:MODIFIER:intron9/9:c.4002-10del::,FBXO11:ENST00000405808:intron_variant:MODIFIER:intron3/3:c.169+1443del::,MSH6:ENST00000538136:intron_variant:MODIFIER:intron9/9:c.3096-10del::,MSH6:ENST00000540021:intron_variant:MODIFIER:intron7/7:c.3612-10del::	MSH6:NM_000179.2:intron_variant:MODIFIER:intron9/9:c.4002-10del::,MSH6:NM_001281492.1:intron_variant:MODIFIER:intron7/7:c.3612-10del::,MSH6:NM_001281493.1:intron_variant:MODIFIER:intron8/8:c.3096-10del::,MSH6:NM_001281494.1:intron_variant:MODIFIER:intron9/9:c.3096-10del::		600678 [GENE=MSH6 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Endometrial cancer,familial,608089,Somatic mutation,Autosomal dominant/Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	89508 [likely benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified];		(T)n (Simple_repeat)	rs59056100		0.2911	768,.		-1.0950				0.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	147596973	147596973	A	G	het		QUAL=10818;DP=817;AF=0.51;MQM=60;SAP=3;ABP=4	AC103881.1	intron&non_coding_transcript	AC103881.1:ENST00000450667:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/5:n.229+1200A>G::	::intergenic_variant:MODIFIER::::						rs4411641	0.5090	0.4872	3884,.	0.6458,0.6144,0.4402,0.3990,0.4075	0.2240			0.00,0.04	5.08							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr2	190670539	190670539	-	A	het	off-target	QUAL=41;DP=44;AF=0.18;MQM=60;SAP=20;ABP=42	PMS1	intron,frameshift	PMS1:ENST00000374826:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:ENST00000409823:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:ENST00000409985:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:ENST00000418224:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:ENST00000432292:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:ENST00000441310:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:ENST00000447232:intron_variant:MODIFIER:intron4/11:c.418+70dup::	PMS1:NM_000534.4:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:NM_001128143.2:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:NM_001128144.2:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:NM_001289408.1:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:NM_001289409.1:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:NM_001321044.2:intron_variant:MODIFIER:intron4/10:c.418+70dup::,PMS1:NM_001321045.2:intron_variant:MODIFIER:intron5/13:c.418+70dup::,PMS1:NM_001321046.2:intron_variant:MODIFIER:intron3/11:c.235+70dup::,PMS1:NM_001321047.2:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:NM_001321048.2:intron_variant:MODIFIER:intron5/13:c.418+70dup::,PMS1:NM_001321049.2:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:NM_001321051.1:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:NR_110332.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/12:n.679+70dup::						rs3214425		0.2784	728,.	0.3364,0.3245,0.3048,0.2639,0.2164					5.63							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	215595164	215595164	G	A	het		QUAL=261;DP=27;AF=0.44;MQM=60;SAP=4;ABP=4	BARD1	missense	BARD1:ENST00000260947:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:ENST00000432456:missense_variant:MODERATE:exon2/3:c.85C>T:p.Arg29Cys:,BARD1:ENST00000449967:missense_variant:MODERATE:exon9/10:c.1540C>T:p.Arg514Cys:	BARD1:NM_000465.4:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:NM_001282545.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:NM_001282548.2:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:NM_001282549.2:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.1937C>T::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon8/9:n.1880C>T::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.1136C>T::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	136500 [likely benign(replaced by megSAP based on classifications:6x1,5x2,1x3) DISEASE=Neoplasm of the breast,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Triple-Negative Breast Cancer Finding,not specified,not provided];	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1];		rs3738888	0.0054	0.0084	1,.	0.0020,0.0125,0.0115,0.0087,0.0041	5.1660	D(0.00),D(0.00),D(0.00)	B(0.36),B(0.37),B(0.29)	0.98,0.99	26.40	0.10				-0.1567	0.8792	1	213	0 / 30	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215610638	215610638	A	G	het	off-target	QUAL=3825;DP=272;AF=0.51;MQM=60;SAP=3;ABP=4	BARD1	intron	BARD1:ENST00000260947:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:ENST00000449967:intron_variant:MODIFIER:intron6/9:c.1246-60T>C::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron6/9:c.1621-60T>C::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron3/6:c.325-60T>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron2/5:c.268-60T>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.365-15406T>C::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1643-60T>C::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1586-60T>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.842-60T>C::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	676478 [likely benign DISEASE=not provided];			rs4986842	0.0030	0.0059	1,.		-0.7960			0.06,0.18	5.12					-0.0329	0.9359	1	199	0 / 30					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215632155	215632155	T	C	het	off-target	QUAL=1555;DP=109;AF=0.57;MQM=60;SAP=5;ABP=7	BARD1	intron	BARD1:ENST00000260947:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:ENST00000449967:intron_variant:MODIFIER:intron5/9:c.1136+51A>G::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron5/9:c.1511+51A>G::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14876A>G::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14876A>G::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24866A>G::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.1533+51A>G::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.1476+51A>G::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.732+51A>G::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];				rs5031009	0.3662	0.3848	2357,.	0.3713,0.2925,0.3633,0.3675,0.4021	-2.0190			0.01,0.14	1.89							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215632192	215632192	G	A	het	off-target	QUAL=1787;DP=114;AF=0.57;MQM=60;SAP=4;ABP=8	BARD1	intron	BARD1:ENST00000260947:intron_variant:MODIFIER:intron6/10:c.1568+14C>T::,BARD1:ENST00000449967:intron_variant:MODIFIER:intron5/9:c.1136+14C>T::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron6/10:c.1568+14C>T::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron5/9:c.1511+14C>T::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14913C>T::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14913C>T::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24829C>T::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.1533+14C>T::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.1476+14C>T::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.732+14C>T::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	256214 [benign/likely benign DISEASE=Neoplasm of the breast,Hereditary cancer-predisposing syndrome,not specified];			rs5031011	0.3522	0.3647	2111,.	0.3471,0.2866,0.3664,0.3480,0.3938	-0.8300			0.02,0.20	4.54							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215632255	215632255	C	T	het		QUAL=3056;DP=110;AF=0.55;MQM=60;SAP=29;ABP=6	BARD1	missense	BARD1:ENST00000260947:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:PF00023 [Ankyrin repeat],BARD1:ENST00000449967:missense_variant:MODERATE:exon5/10:c.1087G>A:p.Val363Met:PF00023 [Ankyrin repeat]	BARD1:NM_000465.4:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1484G>A::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon4/9:n.1427G>A::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.683G>A::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	140757 [benign/likely benign DISEASE=Neoplasm of the breast,Hereditary cancer-predisposing syndrome,not specified];	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1];		rs2070094	0.3662	0.3840	2331,.	0.3752,0.2940,0.3662,0.3707,0.4030	-5.2630	T(0.12),T(0.13)	B(0.03),B(0.01)	0.02,0.15	0.10	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215632256	215632256	A	G	hom		QUAL=3056;DP=110;AF=0.55;MQM=60;SAP=18;ABP=9	BARD1	synonymous	BARD1:ENST00000260947:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:PF00023 [Ankyrin repeat],BARD1:ENST00000449967:synonymous_variant:LOW:exon5/10:c.1086T>C:p.His362=:PF00023 [Ankyrin repeat]	BARD1:NM_000465.4:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:,BARD1:NM_001282543.2:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1483T>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon4/9:n.1426T>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.682T>C::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	183704 [benign/likely benign DISEASE=Neoplasm of the breast,Familial cancer of breast,Hereditary cancer-predisposing syndrome,not specified];			rs2070093	0.7706	0.8169	9351,.	0.5970,0.8158,0.9535,0.8062,0.8408	-0.3720			0.01,0.18	4.57							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215634055	215634055	C	T	het	off-target	QUAL=2564;DP=270;AF=0.47;MQM=60;SAP=262;ABP=5	BARD1	intron	BARD1:ENST00000260947:intron_variant:MODIFIER:intron4/10:c.1315-19G>A::,BARD1:ENST00000449967:intron_variant:MODIFIER:intron3/9:c.883-19G>A::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron4/10:c.1315-19G>A::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron3/9:c.1258-19G>A::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-16776G>A::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-16776G>A::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+22966G>A::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.1280-19G>A::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.1223-19G>A::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.479-19G>A::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	256213 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs6704780	0.3652	0.3851	2351,.	0.3747,0.2939,0.3659,0.3702,0.4006	-2.4810			0.01,0.31	1.71		10.09>9.72					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215645464	215645464	C	G	het		QUAL=1090;DP=79;AF=0.53;MQM=60;SAP=8;ABP=4	BARD1	missense	BARD1:ENST00000260947:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:ENST00000449967:missense_variant:MODERATE:exon3/10:c.702G>C:p.Arg234Ser:	BARD1:NM_000465.4:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon3/10:n.1099G>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon2/9:n.1042G>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.479-11428G>C::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	142769 [benign/likely benign DISEASE=Neoplasm of the breast,Familial cancer of breast,Hereditary cancer-predisposing syndrome,not specified];	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs2229571	0.4593	0.5522	4972,.	0.3976,0.4125,0.3645,0.6166,0.4846	-0.6010	T(0.24),T(0.19)	B(0.02),B(0.01)	0.12,0.22	9.28	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215674090	215674090	T	G	hom	off-target	QUAL=3869;DP=120;AF=1.00;MQM=60;SAP=3;ABP=0	BARD1	intron	BARD1:ENST00000260947:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000449967:intron_variant:MODIFIER:intron1/9:c.-126+46A>C::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron1/6:c.158+46A>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.158+46A>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron1/4:c.158+46A>C::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/9:n.272+46A>C::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.272+46A>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/9:n.272+46A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];				rs35933323		0.7477	8789,.	0.7659,0.8196,0.8124,0.7135,0.6646	0.1840			0.00,0.07	9.13							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215674224	215674224	G	A	het		QUAL=8447;DP=788;AF=0.48;MQM=60;SAP=3;ABP=5	BARD1	missense,5'UTR	BARD1:ENST00000260947:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000449967:5_prime_UTR_variant:MODIFIER:exon1/10:c.-214C>T::	BARD1:NM_000465.4:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:NM_001282545.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:NM_001282548.2:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:NM_001282549.2:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.184C>T::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.184C>T::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.184C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	183698 [benign/likely benign DISEASE=Neoplasm of the breast,Familial cancer of breast,Hereditary cancer-predisposing syndrome,not specified];	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs1048108	0.3313	0.3836	1968,.	0.2213,0.4318,0.3576,0.3775,0.4088	0.9680	T(0.13), 	B(0.01), 	0.26,0.91	17.50	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215674323	215674323	C	G	hom	off-target	QUAL=3244;DP=106;AF=1.00;MQM=60;SAP=13;ABP=0	BARD1	5'UTR	BARD1:ENST00000260947:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000449967:5_prime_UTR_variant:MODIFIER:exon1/10:c.-313G>C::	BARD1:NM_000465.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:NM_001282543.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:NM_001282545.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-30G>C::,BARD1:NM_001282548.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-30G>C::,BARD1:NM_001282549.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-30G>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.85G>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.85G>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.85G>C::	regulatory_region_variant:promoter	601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	334199 [likely benign DISEASE=Neoplasm of the breast];			rs1129804	0.7446	0.7467	8747,.	0.7644,0.8147,0.8037,0.7082,0.6635	-0.5760			0.00,0.15	5.86							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215674341	215674341	A	G	hom	off-target	QUAL=3155;DP=105;AF=1.00;MQM=60;SAP=14;ABP=0	BARD1	5'UTR	BARD1:ENST00000260947:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000449967:5_prime_UTR_variant:MODIFIER:exon1/10:c.-331T>C::	BARD1:NM_000465.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:NM_001282543.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:NM_001282545.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-48T>C::,BARD1:NM_001282548.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-48T>C::,BARD1:NM_001282549.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-48T>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.67T>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.67T>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.67T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	334200 [likely benign DISEASE=Neoplasm of the breast];			rs17489363	0.7450	0.7470	8755,.	0.7646,0.8147,0.8047,0.7071,0.6627	-2.4040			0.00,0.10	8.77							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	220415596	220415597	GA	-	hom	off-target	QUAL=4860;DP=157;AF=0.99;MQM=60;SAP=3;ABP=0	OBSL1	intron	OBSL1:ENST00000265318:intron_variant:MODIFIER:intron19/19:c.*1078-33_*1078-32del::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron19/19:c.5408-33_5408-32del::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs146790993		0.4495	3192,.	0.3849,0.5338,0.4071,0.4448,0.2437	1.3400				14.11							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220416570	220416570	C	T	hom	off-target	QUAL=341;DP=13;AF=1.00;MQM=60;SAP=31;ABP=0	OBSL1	intron	OBSL1:ENST00000265318:intron_variant:MODIFIER:intron18/19:c.*808-50G>A::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs4672931	0.9287	0.9774	13761,.	0.7691,0.9818,0.9999,0.9937,0.9993	-2.3550			0.05,0.17	9.18							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220416803	220416803	A	T	hom	off-target	QUAL=37753;DP=1163;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	intron	OBSL1:ENST00000265318:intron_variant:MODIFIER:intron18/19:c.*807+31T>A::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs4672933		0.9954	15146,.	0.9350,0.9953,0.9999,0.9996,0.9998	-0.5070			0.02,0.21	4.83							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220416942	220416942	G	C	hom		QUAL=1045;DP=34;AF=1.00;MQM=60;SAP=34;ABP=0	OBSL1	splice_region&intron	OBSL1:ENST00000265318:splice_region_variant&intron_variant:LOW:intron17/19:c.*703-4C>G::,OBSL1:ENST00000373876:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,OBSL1:ENST00000404537:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::	OBSL1:NM_015311.3:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	194972 [benign DISEASE=Three M syndrome,not specified];			rs34490902	0.3876	0.4595	3370,.	0.4019,0.5464,0.4234,0.4682,0.2587	-0.7820			0.04,0.27	12.01		6.86>7.91	0.000/0.104				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220417228	220417228	G	T	hom	off-target	QUAL=2373;DP=79;AF=1.00;MQM=60;SAP=166;ABP=0	OBSL1	intron	OBSL1:ENST00000265318:intron_variant:MODIFIER:intron17/19:c.*702+30C>A::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::	regulatory_region_variant:promoter	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs60549465	0.3391	0.4213	2917,.	0.2341,0.5338,0.4153,0.4572,0.2546	0.6750			0.25,0.20	9.07							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220417266	220417266	C	T	hom		QUAL=4420;DP=146;AF=1.00;MQM=60;SAP=93;ABP=0	OBSL1	3'UTR,missense	OBSL1:ENST00000265318:3_prime_UTR_variant:MODIFIER:exon17/20:c.*694G>A::,OBSL1:ENST00000373876:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_015311.3:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:	regulatory_region_variant:promoter,TF_binding_site_variant	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	288014 [benign DISEASE=Three M syndrome 2,Three M syndrome,not specified];			rs59332477	0.3766	0.4435	3127,.	0.3735,0.5443,0.4201,0.4570,0.2527	3.5870	 ,T(0.81),T(0.33)	 ,D(1.00),D(1.00)	0.40,0.96	27.80	0.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220419236	220419236	T	C	hom		QUAL=14216;DP=466;AF=1.00;MQM=60;SAP=515;ABP=0	OBSL1	3'UTR,synonymous	OBSL1:ENST00000265318:3_prime_UTR_variant:MODIFIER:exon14/20:c.*230A>G::,OBSL1:ENST00000373876:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:ENST00000404537:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:	OBSL1:NM_015311.3:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334466 [benign DISEASE=Three M syndrome];			rs10932813		0.9967	15332,.	0.9595,0.9964,1.0000,0.9997,0.9998	-3.9420			0.04,0.36	8.87							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220419339	220419339	T	C	hom		QUAL=21571;DP=692;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	3'UTR,missense	OBSL1:ENST00000265318:3_prime_UTR_variant:MODIFIER:exon14/20:c.*127A>G::,OBSL1:ENST00000373876:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:ENST00000404537:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:	OBSL1:NM_015311.3:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334469 [benign DISEASE=Three M syndrome];			rs10932814	0.9611	0.9873	14629,.	0.8802,0.9883,1.0000,0.9941,0.9995	0.1950	 ,T(0.61),T(0.51)	 ,B(0.00),B(0.00)	0.02,0.88	19.73	0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220420956	220420956	A	G	hom		QUAL=1388;DP=52;AF=1.00;MQM=60;SAP=91;ABP=0	OBSL1	synonymous,missense	OBSL1:ENST00000265317:synonymous_variant:LOW:exon5/5:c.1092T>C:p.Asp364=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318:missense_variant:MODERATE:exon13/20:c.3995T>C:p.Met1332Thr:,OBSL1:ENST00000373876:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334475 [benign DISEASE=Three M syndrome];			rs10932816		0.9917	14831,.	0.8885,0.9929,0.9999,0.9996,0.9996	-3.7740	 ,D(0.02), , , 	 , (0.00), , , 	0.02,0.17	1.30	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220421417	220421417	C	G	hom		QUAL=23402;DP=732;AF=1.00;MQM=60;SAP=10;ABP=0	OBSL1	missense	OBSL1:ENST00000265317:missense_variant:MODERATE:exon4/5:c.792G>C:p.Glu264Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF13895 [Immunoglobulin domain],OBSL1:ENST00000373876:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334483 [benign DISEASE=Three M syndrome];			rs1983210	0.7246	0.7384	7807,.	0.6130,0.6707,0.7101,0.7404,0.8941	0.9030	T(0.48),T(0.27),T(0.27),T(0.23),T(0.13)	B(0.08),P(0.77),P(0.77),P(0.76),D(0.95)	0.86,0.93	20.20	0.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220421456	220421456	C	A	hom	off-target	QUAL=22586;DP=677;AF=1.00;MQM=60;SAP=40;ABP=0	OBSL1	intron	OBSL1:ENST00000265317:intron_variant:MODIFIER:intron3/4:c.764-11G>T::,OBSL1:ENST00000265318:intron_variant:MODIFIER:intron11/19:c.3791-11G>T::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron11/19:c.3791-11G>T::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::,OBSL1:ENST00000603926:intron_variant:MODIFIER:intron12/13:c.4067-11G>T::	OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron12/13:c.4067-11G>T::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334484 [benign DISEASE=Three M syndrome];			rs1983211	0.1170	0.1685	432,.	0.0309,0.2186,0.1316,0.1826,0.1521	-0.5030			0.06,0.21	0.33		7.34>8.35	0.000/0.040				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220422029	220422029	G	A	hom	off-target	QUAL=4744;DP=163;AF=1.00;MQM=60;SAP=5;ABP=0	OBSL1	intron	OBSL1:ENST00000265317:intron_variant:MODIFIER:intron3/4:c.763+516C>T::,OBSL1:ENST00000265318:intron_variant:MODIFIER:intron11/19:c.3790+36C>T::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron11/19:c.3790+516C>T::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:ENST00000603926:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::	OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs55873563	0.1188	0.1582	432,.	0.0308,0.2150,0.1281,0.1751,0.1460	-0.4430			0.06,0.58	14.10							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220422400	220422400	C	G	hom	off-target	QUAL=10367;DP=381;AF=1.00;MQM=60;SAP=472;ABP=0	OBSL1	intron	OBSL1:ENST00000265317:intron_variant:MODIFIER:intron3/4:c.763+145G>C::,OBSL1:ENST00000265318:intron_variant:MODIFIER:intron10/19:c.3515-60G>C::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron11/19:c.3790+145G>C::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:ENST00000603926:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::	OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs2278200	0.4087	0.4671	3435,.		-0.7230			0.00,0.08	4.67				COSV54704992			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220422686	220422686	C	T	het		QUAL=529;DP=61;AF=0.44;MQM=60;SAP=38;ABP=5	OBSL1	missense	OBSL1:ENST00000265317:missense_variant:MODERATE:exon3/5:c.622G>A:p.Glu208Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318:missense_variant:MODERATE:exon10/20:c.3373G>A:p.Glu1125Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	193901 [likely benign(replaced by megSAP based on classifications:2x1,1x2,1x3) DISEASE=Three M syndrome,not specified,not provided];			rs72957510	0.0070	0.0079	1,.	0.0162,0.0019,0.0000,0.0072,0.0023	0.5010	T(0.15),T(0.23),T(0.22),T(0.50),T(0.41)	B(0.05),B(0.12),P(0.79),P(0.77),B(0.01)	0.10,0.52	18.90	0.03				-0.0453	0.0913	4	218	0 / 46					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220422774	220422774	A	G	hom		QUAL=23993;DP=753;AF=1.00;MQM=60;SAP=9;ABP=0	OBSL1	synonymous	OBSL1:ENST00000265317:synonymous_variant:LOW:exon3/5:c.534T>C:p.Pro178=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318:synonymous_variant:LOW:exon10/20:c.3285T>C:p.Pro1095=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334496 [benign DISEASE=Three M syndrome];			rs2278201	0.4191	0.4751	3573,.	0.5183,0.5484,0.4187,0.4398,0.2543	-4.6180			0.01,0.16	0.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220428381	220428381	A	T	het	off-target	QUAL=3399;DP=280;AF=0.45;MQM=60;SAP=15;ABP=9	OBSL1	intron	OBSL1:ENST00000265318:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:ENST00000289656:intron_variant:MODIFIER:intron6/8:c.1169-32T>A::,OBSL1:ENST00000373873:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:ENST00000603926:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::	OBSL1:NM_001173408.2:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs2303543		0.6444	5739,.	0.2967,0.5308,0.6842,0.6796,0.7502	0.7970			0.14,0.36	10.32							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220430203	220430203	C	T	hom		QUAL=23710;DP=741;AF=1.00;MQM=60;SAP=15;ABP=0	OBSL1	missense	OBSL1:ENST00000265318:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000289656:missense_variant:MODERATE:exon6/9:c.929G>A:p.Arg310Lys:,OBSL1:ENST00000373873:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373876:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000404537:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000603926:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:	OBSL1:NM_001173408.2:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:NM_001173431.2:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:	regulatory_region_variant:promoter_flanking_region	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334508 [benign DISEASE=Three M syndrome];			rs1039898	0.7927	0.8673	11006,.	0.6290,0.8312,0.9160,0.9036,0.8350	-0.1210	T(0.67),T(0.80),T(0.80),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.03,0.65	11.32	0.05			COSV54731761			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220432709	220432709	A	T	het	off-target	QUAL=9163;DP=724;AF=0.48;MQM=60;SAP=3;ABP=5	OBSL1	intron	OBSL1:ENST00000265318:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:ENST00000289656:intron_variant:MODIFIER:intron2/8:c.44-18T>A::,OBSL1:ENST00000373873:intron_variant:MODIFIER:intron2/8:c.1283-18T>A::,OBSL1:ENST00000373876:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:ENST00000404537:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:ENST00000603926:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::	OBSL1:NM_001173408.2:intron_variant:MODIFIER:intron2/8:c.1283-18T>A::,OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];				rs2292360	0.3678	0.4229	2634,.	0.1795,0.3641,0.4921,0.4523,0.4414	-0.7300			0.05,0.20	5.30		6.52>5.43					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	220435034	220435034	A	G	hom		QUAL=20371;DP=649;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	synonymous,intron	OBSL1:ENST00000265318:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656:intron_variant:MODIFIER:intron1/8:c.-228+1082T>C::,OBSL1:ENST00000373873:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	193382 [benign DISEASE=Three M syndrome,not specified];			rs10180675	0.7833	0.8651	10869,.	0.6051,0.8299,0.9153,0.9035,0.8331	-0.6420			0.06,0.75	13.44							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	220435375	220435375	G	A	het		QUAL=384;DP=19;AF=0.84;MQM=60;SAP=4;ABP=22	OBSL1	synonymous,intron	OBSL1:ENST00000265318:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::,OBSL1:ENST00000373873:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	290129 [benign DISEASE=Three M syndrome,not specified];			rs1061399	0.3588	0.4289	2536,.	0.1596,0.3684,0.4918,0.4562,0.4435	2.9300			0.71,0.94	12.95							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10076843	10076844	TT	-	het	off-target	QUAL=1941;DP=168;AF=0.45;MQM=60;SAP=10;ABP=7	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000431693:intron_variant:MODIFIER:intron4/7:c.378-6_378-5del::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	342255 [benign/likely benign DISEASE=Fanconi anemia,not provided];			rs55973240		0.2363	994,.	0.4744,0.2346,0.0966,0.2132,0.2534	1.0130				8.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10076975	10076975	A	C	het	off-target	QUAL=1279;DP=99;AF=0.48;MQM=60;SAP=12;ABP=3	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000431693:intron_variant:MODIFIER:intron5/7:c.438+58A>C::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron6/42:c.438+58A>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];				rs17032276	0.1811	0.1965	677,.		2.6730			0.36,0.31	8.12							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10077955	10077955	A	G	het	off-target	QUAL=553;DP=46;AF=0.63;MQM=60;SAP=66;ABP=10	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron6/42:c.439-16A>G::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron6/42:c.439-16A>G::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:ENST00000431693:intron_variant:MODIFIER:intron5/7:c.439-16A>G::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron6/42:c.439-16A>G::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257083 [benign DISEASE=not specified];			rs17032278	0.1821	0.1947	652,.	0.3358,0.1545,0.0657,0.1590,0.1770	-1.0280			0.01,0.10	2.80		10.11>10.91					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10081545	10081545	G	C	het	off-target	QUAL=5185;DP=484;AF=0.47;MQM=60;SAP=3;ABP=6	FANCD2	intron,synonymous	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron9/42:c.695+16G>C::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron9/42:c.695+16G>C::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:ENST00000431693:synonymous_variant:LOW:exon8/8:c.711G>C:p.Leu237=:	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron9/42:c.695+16G>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257086 [benign DISEASE=not specified];			rs17032283	0.1821	0.1969	679,.	0.3332,0.1546,0.0657,0.1586,0.1767	0.0530			0.05,0.20	1.47							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10084224	10084224	C	T	het	off-target	QUAL=14508;DP=1027;AF=0.54;MQM=60;SAP=3;ABP=14	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron10/42:c.784-19C>T::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron10/42:c.784-19C>T::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron10/43:c.784-19C>T::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron10/42:c.784-19C>T::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257087 [benign DISEASE=not specified];			rs9879080	0.2107	0.2258	999,.	0.4323,0.1579,0.0654,0.1593,0.1753	0.8890			0.00,0.16	8.18		12.10>11.70					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10085130	10085130	C	G	het	off-target	QUAL=62;DP=10;AF=0.40;MQM=60;SAP=12;ABP=4	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron12/43:c.990-38C>G::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron12/42:c.990-38C>G::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257088 [benign DISEASE=not specified];			rs9809061	0.2117	0.2259	998,.	0.4320,0.1572,0.0653,0.1583,0.1770	-0.3390			0.01,0.10	5.40							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10085536	10085536	A	G	het		QUAL=2140;DP=295;AF=0.43;MQM=60;SAP=182;ABP=17	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383806:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383807:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.2:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_033084.5:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257065 [benign DISEASE=Fanconi anemia,Fanconi anemia, complementation group A,not specified];			rs34046352		0.1936	45,.	0.2875,0.0988,0.0387,0.0796,0.0881	-0.0020			0.00,0.07	1.01							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10089773	10089773	A	C	het	off-target	QUAL=1155;DP=92;AF=0.52;MQM=60;SAP=25;ABP=3	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257067 [benign DISEASE=not specified];			rs7615646	0.1791	0.2203	102,.	0.3487,0.2143,0.1183,0.2236,0.2492	0.3960			0.08,0.24	4.42				COSV55031871			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10094206	10094206	-	T	het	off-target	QUAL=110;DP=25;AF=0.36;MQM=60;SAP=23;ABP=7	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron18/42:c.1656+38dup::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron18/42:c.1656+38dup::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron18/43:c.1656+38dup::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron18/42:c.1656+38dup::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];			AluSx (SINE/Alu)	rs544799101		0.2114	539,.	0.3753,0.2432,0.0424,0.2038,0.1953					9.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10106532	10106532	C	T	het		QUAL=1275;DP=75;AF=0.64;MQM=60;SAP=4;ABP=16	FANCD2	missense	FANCD2:ENST00000287647:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383806:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383807:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.2:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:,FANCD2:NM_001319984.2:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:,FANCD2:NM_033084.5:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	134315 [benign DISEASE=Fanconi anemia,Fanconi anemia, complementation group A,not specified];	CM1814115 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCD2];		rs3864017		0.1875	361,.	0.2614,0.1393,0.0524,0.1409,0.1622	-0.1820	T(0.31),T(0.32),T(0.31),T(0.31)	B(0.00),B(0.00),B(0.00),B(0.00)	0.05,0.21	0.24	0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10107520	10107520	G	T	het	off-target	QUAL=12204;DP=1013;AF=0.48;MQM=60;SAP=3;ABP=7	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257074 [benign DISEASE=not specified];			rs34608006	0.1753	0.1935	642,.	0.3185,0.1537,0.0650,0.1587,0.1780	0.3780			0.29,0.34	7.71							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10119917	10119917	T	C	het	off-target	QUAL=741;DP=72;AF=0.46;MQM=60;SAP=4;ABP=4	FANCD2	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257077 [benign DISEASE=not specified];			rs6805869	0.2115	0.2255	996,.	0.4329,0.1583,0.0657,0.1591,0.1806	0.0370			0.03,0.18	1.39							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10128965	10128965	-	T	het	off-target	QUAL=92;DP=33;AF=0.18;MQM=60;SAP=16;ABP=32	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2OS:ENST00000524279:intron_variant:MODIFIER:intron2/2:c.*44-5751dup::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*44-5751dup::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];			(T)n (Simple_repeat)	rs371321981		0.0514	12,.	0.0784,0.0395,0.0279,0.0499,0.0774					1.46							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10132127	10132127	A	T	het	off-target	QUAL=48;DP=25;AF=0.20;MQM=60;SAP=14;ABP=23	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron37/42:c.3777+58A>T::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron36/42:c.3683+1493A>T::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2OS:ENST00000524279:intron_variant:MODIFIER:intron2/2:c.*44-8912T>A::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron37/42:c.3777+58A>T::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*44-8912T>A::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];				rs1276937447					-0.1950			0.02,0.14	7.23					0.0465	0.1785	16	35	1 / 5					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10133949	10133949	A	G	het	off-target	QUAL=2563;DP=176;AF=0.55;MQM=60;SAP=5;ABP=6	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron38/42:c.3849+13A>G::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron37/42:c.*5+13A>G::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2OS:ENST00000524279:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron38/42:c.3849+13A>G::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257079 [benign DISEASE=Fanconi anemia,not specified];			rs9811771	0.2542	0.2456	1278,.	0.5004,0.1825,0.0893,0.1598,0.2263	0.5050			0.00,0.13	13.08							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10138069	10138069	T	G	het		QUAL=9105;DP=785;AF=0.47;MQM=60;SAP=3;ABP=9	FANCD2,FANCD2OS	synonymous,3'UTR,intron	FANCD2:ENST00000287647:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383806:3_prime_UTR_variant:MODIFIER:exon41/43:c.*254T>G::,FANCD2:ENST00000383807:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2OS:ENST00000524279:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::	FANCD2:NM_001018115.2:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:,FANCD2:NM_033084.5:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257081 [benign DISEASE=Fanconi anemia,not specified];	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2];		rs2272125	0.2422	0.2400	1189,.	0.4778,0.1816,0.0893,0.1593,0.2085	2.5830			0.21,0.96	10.97							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10138189	10138189	T	C	het	off-target	QUAL=2791;DP=206;AF=0.52;MQM=60;SAP=4;ABP=4	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron41/42:c.*341+33T>C::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2OS:ENST00000524279:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:NM_033084.5:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257082 [benign DISEASE=not specified];			rs2272124	0.2418	0.2402	1192,.	0.4778,0.1815,0.0894,0.1593,0.2084	0.0530			0.00,0.11	6.24							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10140671	10140671	G	A	het	off-target	QUAL=10311;DP=680;AF=0.54;MQM=60;SAP=3;ABP=15	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2:ENST00000383806:intron_variant:MODIFIER:intron42/42:c.*437+172G>A::,FANCD2:ENST00000383807:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:ENST00000419585:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2OS:ENST00000524279:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::	FANCD2:NM_001018115.2:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:NM_033084.5:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	342381 [benign DISEASE=Fanconi anemia];			rs7626117	0.3452	0.3354	2770,.	0.7649,0.2070,0.0894,0.1795,0.2321	-0.0060			0.00,0.05	5.84							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	37067097	37067097	A	T	het	off-target	QUAL=1193;DP=247;AF=0.25;MQM=60;SAP=33;ABP=140	MLH1	intron	MLH1:ENST00000231790:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:ENST00000435176:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:ENST00000455445:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:ENST00000458205:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000536378:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:ENST00000539477:intron_variant:MODIFIER:intron10/17:c.316-31A>T::	MLH1:NM_000249.3:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:NM_001167617.2:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:NM_001167618.2:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:NM_001167619.2:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001258271.1:intron_variant:MODIFIER:intron11/16:c.1039-31A>T::,MLH1:NM_001258273.1:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001258274.2:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:NM_001354615.1:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001354616.1:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001354617.1:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:NM_001354618.1:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:NM_001354619.1:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:NM_001354620.1:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:NM_001354621.1:intron_variant:MODIFIER:intron9/16:c.16-31A>T::,MLH1:NM_001354622.1:intron_variant:MODIFIER:intron10/17:c.16-31A>T::,MLH1:NM_001354623.1:intron_variant:MODIFIER:intron9/16:c.16-31A>T::,MLH1:NM_001354624.1:intron_variant:MODIFIER:intron9/16:c.-36-31A>T::,MLH1:NM_001354625.1:intron_variant:MODIFIER:intron8/15:c.-36-31A>T::,MLH1:NM_001354626.1:intron_variant:MODIFIER:intron9/16:c.-36-31A>T::,MLH1:NM_001354627.1:intron_variant:MODIFIER:intron9/16:c.-36-31A>T::,MLH1:NM_001354628.1:intron_variant:MODIFIER:intron11/17:c.1039-31A>T::,MLH1:NM_001354629.1:intron_variant:MODIFIER:intron10/17:c.940-31A>T::,MLH1:NM_001354630.1:intron_variant:MODIFIER:intron11/17:c.1039-31A>T::	regulatory_region_variant:promoter_flanking_region	120436 [GENE=MLH1 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Colorectal cancer,hereditary nonpolyposis,type 2,609310/Muir-Torre syndrome,158320,Autosomal dominant];	629888 [likely benign DISEASE=Hereditary cancer-predisposing syndrome];		(TA)n (Simple_repeat)	rs59684491		0.2237	287,.	0.0391,0.0449,0.0412,0.0274,0.0401	-1.5490			0.03,0.17	0.15				COSV51624244			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37067099	37067099	A	T	het	off-target	QUAL=1193;DP=247;AF=0.25;MQM=60;SAP=33;ABP=140	MLH1	intron	MLH1:ENST00000231790:intron_variant:MODIFIER:intron11/18:c.1039-29A>T::,MLH1:ENST00000435176:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:ENST00000455445:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:ENST00000458205:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:ENST00000536378:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:ENST00000539477:intron_variant:MODIFIER:intron10/17:c.316-29A>T::	MLH1:NM_000249.3:intron_variant:MODIFIER:intron11/18:c.1039-29A>T::,MLH1:NM_001167617.2:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:NM_001167618.2:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:NM_001167619.2:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001258271.1:intron_variant:MODIFIER:intron11/16:c.1039-29A>T::,MLH1:NM_001258273.1:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001258274.2:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:NM_001354615.1:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001354616.1:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001354617.1:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:NM_001354618.1:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:NM_001354619.1:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:NM_001354620.1:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:NM_001354621.1:intron_variant:MODIFIER:intron9/16:c.16-29A>T::,MLH1:NM_001354622.1:intron_variant:MODIFIER:intron10/17:c.16-29A>T::,MLH1:NM_001354623.1:intron_variant:MODIFIER:intron9/16:c.16-29A>T::,MLH1:NM_001354624.1:intron_variant:MODIFIER:intron9/16:c.-36-29A>T::,MLH1:NM_001354625.1:intron_variant:MODIFIER:intron8/15:c.-36-29A>T::,MLH1:NM_001354626.1:intron_variant:MODIFIER:intron9/16:c.-36-29A>T::,MLH1:NM_001354627.1:intron_variant:MODIFIER:intron9/16:c.-36-29A>T::,MLH1:NM_001354628.1:intron_variant:MODIFIER:intron11/17:c.1039-29A>T::,MLH1:NM_001354629.1:intron_variant:MODIFIER:intron10/17:c.940-29A>T::,MLH1:NM_001354630.1:intron_variant:MODIFIER:intron11/17:c.1039-29A>T::	regulatory_region_variant:promoter_flanking_region	120436 [GENE=MLH1 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Colorectal cancer,hereditary nonpolyposis,type 2,609310/Muir-Torre syndrome,158320,Autosomal dominant];	629889 [benign DISEASE=Hereditary cancer-predisposing syndrome];		(TA)n (Simple_repeat)	rs6771325		0.0366		0.0448,0.0302,0.1222,0.0359,0.0505	-1.5590			0.01,0.11	1.87				COSV51617601			821	4149	115 / 640	2	"[2] auto-classification 24.10.2017%0A%0A"			MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	142168331	142168331	C	T	hom		QUAL=1594;DP=49;AF=1.00;MQM=60;SAP=4;ABP=0	ATR	synonymous	ATR:ENST00000350721:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000383101:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	93669 [benign/likely benign DISEASE=Seckel syndrome,not specified,not provided];			rs1802904	0.9163	0.8883	12419,.	0.9733,0.7565,0.9333,0.8561,0.9373	1.2260			0.38,0.96	8.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142178144	142178144	C	T	het		QUAL=1052;DP=77;AF=0.55;MQM=60;SAP=8;ABP=4	ATR	missense	ATR:ENST00000350721:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000383101:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]	ATR:NM_001184.4:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:,ATR:NM_001354579.2:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	136470 [benign/likely benign DISEASE=Seckel syndrome,not specified,not provided];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.1022	0.1337	310,.	0.0795,0.0994,0.0982,0.1599,0.0957	0.0440	T(0.23),T(0.23)	B(0.00),B(0.00)	0.23,0.63	7.66	0.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142188337	142188337	A	C	het		QUAL=9936;DP=681;AF=0.56;MQM=60;SAP=4;ABP=26	ATR,RP11-383G6.3	missense,intron&non_coding_transcript	ATR:ENST00000350721:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:ENST00000383101:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:,RP11-383G6.3:ENST00000460977:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.268+2575T>G::	ATR:NM_001184.4:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:NM_001354579.2:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	158000 [likely benign(replaced by megSAP based on classifications:1x1,3x2,1x3) DISEASE=not specified,not provided];			rs28910273	0.0020	0.0032	0,.	0.0016,0.0016,0.0000,0.0056,0.0014	2.3490	T(0.06),T(0.07), 	B(0.01),B(0.01), 	0.83,0.98	15.88	0.05				0.1884	0.1512	0	159	0 / 22	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142215171	142215171	T	C	het	off-target	QUAL=124;DP=8;AF=0.75;MQM=60;SAP=16;ABP=7	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:ENST00000383101:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	157998 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs11719960		0.0283	54,.	0.0000,0.0001,0.0003,0.0002,0.0002	-1.3110			0.01,0.14	1.09							269	2847	49 / 532					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142215178	142215178	A	C	het	off-target	QUAL=124;DP=8;AF=0.75;MQM=60;SAP=16;ABP=7	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:ENST00000383101:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	157997 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs7620648		0.6668	2395,.	0.8447,0.4206,0.4360,0.5578,0.3542	-0.3320			0.03,0.14	1.67							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142217537	142217537	A	G	het		QUAL=3564;DP=350;AF=0.51;MQM=60;SAP=345;ABP=3	ATR	synonymous	ATR:ENST00000350721:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:PF02259 [FAT domain],ATR:ENST00000383101:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:PF02259 [FAT domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	136471 [benign/likely benign DISEASE=Seckel syndrome,not specified];			rs2227932	0.0669	0.0922	136,.	0.0161,0.0401,0.0014,0.1098,0.1610	1.5160			0.87,0.98	10.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142231062	142231062	-	A	het	off-target	QUAL=20;DP=21;AF=0.19;MQM=60;SAP=12;ABP=20	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:ENST00000383101:intron_variant:MODIFIER:intron26/45:c.4660+39dup::	ATR:NM_001184.4:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron26/45:c.4660+39dup::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];			(A)n (Simple_repeat)	rs74269486		0.4606	1984,.	0.1935,0.1566,0.1714,0.1151,0.0902					1.71							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142255090	142255090	T	C	het	off-target	QUAL=1313;DP=111;AF=0.46;MQM=60;SAP=6;ABP=5	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:ENST00000383101:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	157979 [benign DISEASE=not specified,not provided];			rs73240314	0.1172	0.1431	336,.	0.1166,0.1051,0.0996,0.1624,0.0990	-0.1880			0.02,0.14	4.41							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142259707	142259707	A	-	het	off-target	QUAL=9092;DP=875;AF=0.43;MQM=60;SAP=4;ABP=46	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:ENST00000383101:intron_variant:MODIFIER:intron17/45:c.3389+39del::	ATR:NM_001184.4:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron17/45:c.3389+39del::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];				rs201551475		0.4587	307,.	0.4479,0.4599,0.4625,0.4623,0.4558	6.4460				0.53							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142277427	142277427	A	G	het	off-target	QUAL=6988;DP=587;AF=0.48;MQM=60;SAP=5;ABP=6	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:ENST00000383101:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::	ATR:NM_001184.4:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	157967 [likely benign DISEASE=not specified];		(TAGA)n (Simple_repeat)	rs73240318	0.1122	0.1043	189,.	0.0197,0.0408,0.0637,0.0969,0.0639	0.0520			0.07,0.40	8.51							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142277575	142277575	A	T	het		QUAL=3159;DP=274;AF=0.47;MQM=60;SAP=13;ABP=6	ATR	synonymous	ATR:ENST00000350721:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:ENST00000383101:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:	ATR:NM_001184.4:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	157965 [benign/likely benign DISEASE=Seckel syndrome,not specified,not provided];			rs2227930	0.5980	0.6304	6380,.	0.8003,0.4534,0.4689,0.5786,0.4321	-0.0710			0.13,0.94	9.89							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142281612	142281612	A	G	het		QUAL=6583;DP=530;AF=0.49;MQM=60;SAP=3;ABP=4	ATR	missense	ATR:ENST00000350721:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:ENST00000383101:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:	ATR:NM_001184.4:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:NM_001354579.2:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	93668 [benign/likely benign DISEASE=Seckel syndrome,not specified];			rs2227928	0.5974	0.6296	6369,.	0.7970,0.4558,0.4701,0.5796,0.4362	1.2740	T(0.63),T(0.58)	B(0.00),B(0.00)	0.11,0.55	14.36	0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	156421525	156421525	G	T	het	off-target	QUAL=6009;DP=474;AF=0.52;MQM=60;SAP=3;ABP=4	TIPARP	intron	TIPARP:ENST00000295924:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000461166:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000486483:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000542783:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::	TIPARP:NM_001184717.1:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:NM_001184718.1:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:NM_015508.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::					AluYm1 (SINE/Alu)	rs34277251	0.3832	0.4411	2169,.	0.0786,0.5687,0.7189,0.4184,0.3793	-0.1840			0.02,0.46	6.97							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	178917005	178917005	A	G	het	off-target	QUAL=850;DP=54;AF=0.63;MQM=60;SAP=3;ABP=11	PIK3CA	intron	PIK3CA:ENST00000263967:intron_variant:MODIFIER:intron2/20:c.352+40A>G::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::		171834 [GENE=PIK3CA PHENOS=Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500/CLAPO syndrome,somatic,613089/Cowden syndrome 5,615108/Hepatocellular carcinoma,somatic,114550/Breast cancer,somatic,114480/Macrodactyly,somatic,155500/Keratosis,seborrheic,somatic,182000/Gastric cancer,somatic,613659/Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501/Nevus,epidermal,somatic,162900/CLOVE syndrome,somatic,612918/Nonsmall cell lung cancer,somatic,211980];				rs3729674	0.2734	0.2444	1153,.	0.4297,0.2068,0.1035,0.1964,0.2430	0.7790			0.01,0.45	10.02				COSV55876899			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	178922274	178922274	C	A	hom	off-target	QUAL=13699;DP=480;AF=1.00;MQM=60;SAP=643;ABP=0	PIK3CA	intron	PIK3CA:ENST00000263967:intron_variant:MODIFIER:intron5/20:c.1060-17C>A::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron5/20:c.1060-17C>A::		171834 [GENE=PIK3CA PHENOS=Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500/CLAPO syndrome,somatic,613089/Cowden syndrome 5,615108/Hepatocellular carcinoma,somatic,114550/Breast cancer,somatic,114480/Macrodactyly,somatic,155500/Keratosis,seborrheic,somatic,182000/Gastric cancer,somatic,613659/Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501/Nevus,epidermal,somatic,162900/CLOVE syndrome,somatic,612918/Nonsmall cell lung cancer,somatic,211980];	259957 [benign DISEASE=not specified];			rs2699896		0.6194	6383,.	0.8648,0.4871,0.2627,0.5840,0.5599	-0.8190			0.01,0.18	4.16		11.00>10.43		COSV55874930			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	178922430	178922430	A	G	hom	off-target	QUAL=1931;DP=64;AF=1.00;MQM=60;SAP=8;ABP=0	PIK3CA	intron	PIK3CA:ENST00000263967:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::		171834 [GENE=PIK3CA PHENOS=Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500/CLAPO syndrome,somatic,613089/Cowden syndrome 5,615108/Hepatocellular carcinoma,somatic,114550/Breast cancer,somatic,114480/Macrodactyly,somatic,155500/Keratosis,seborrheic,somatic,182000/Gastric cancer,somatic,613659/Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501/Nevus,epidermal,somatic,162900/CLOVE syndrome,somatic,612918/Nonsmall cell lung cancer,somatic,211980];				rs3729679	0.5180	0.5572	5112,.		-1.0930			0.00,0.11	6.20				COSV55874940			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	178938747	178938747	A	T	het	off-target	QUAL=4429;DP=375;AF=0.47;MQM=55;SAP=10;ABP=6	PIK3CA	intron	PIK3CA:ENST00000263967:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::		171834 [GENE=PIK3CA PHENOS=Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500/CLAPO syndrome,somatic,613089/Cowden syndrome 5,615108/Hepatocellular carcinoma,somatic,114550/Breast cancer,somatic,114480/Macrodactyly,somatic,155500/Keratosis,seborrheic,somatic,182000/Gastric cancer,somatic,613659/Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501/Nevus,epidermal,somatic,162900/CLOVE syndrome,somatic,612918/Nonsmall cell lung cancer,somatic,211980];				rs6443625	0.2730	0.2441	1144,.	0.4394,0.2084,0.1105,0.1987,0.2440	-0.7290			0.01,0.08	0.03							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	178942431	178942431	C	G	hom	off-target	QUAL=183;DP=7;AF=1.00;MQM=60;SAP=18;ABP=0	PIK3CA	intron	PIK3CA:ENST00000263967:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::		171834 [GENE=PIK3CA PHENOS=Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500/CLAPO syndrome,somatic,613089/Cowden syndrome 5,615108/Hepatocellular carcinoma,somatic,114550/Breast cancer,somatic,114480/Macrodactyly,somatic,155500/Keratosis,seborrheic,somatic,182000/Gastric cancer,somatic,613659/Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501/Nevus,epidermal,somatic,162900/CLOVE syndrome,somatic,612918/Nonsmall cell lung cancer,somatic,211980];				rs2699889		0.6500	7076,.		0.1320			0.00,0.09	5.26				COSV55874955			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr4	185999587	185999587	T	A	het	off-target	QUAL=686;DP=71;AF=0.46;MQM=60;SAP=75;ABP=4	RP11-386B13.3	intron&non_coding_transcript	RP11-386B13.3:ENST00000509017:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1340+6360T>A::	LINC02436:NR_147059.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1340+6360T>A::	regulatory_region_variant:enhancer					rs6818170	0.6675	0.6819	7483,.	0.8328,0.5467,0.4189,0.6699,0.6606	0.4470			0.00,0.11	9.82							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr5	57617403	57617403	G	C	het		QUAL=11940;DP=940;AF=0.50;MQM=60;SAP=3;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					MLT1E1A (LTR/ERVL-MaLR)	rs37535		0.5798	5303,.		0.8490			0.01,0.11	1.27							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr5	79950508	79950508	C	T	hom	off-target	QUAL=3032;DP=109;AF=1.00;MQM=60;SAP=5;ABP=0	MSH3,DHFR	5'UTR	MSH3:ENST00000265081:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::,DHFR:ENST00000439211:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-306G>A::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-200G>A::,MSH3:NM_002439.5:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.295G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	126060 [GENE=DHFR PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency,613839,Autosomal recessive],600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];				rs1105525	0.1230	0.1561	368,.	0.0442,0.0786,0.0686,0.1763,0.2386	-0.4220			0.02,0.33	9.32				COSV54143671			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	79950512	79950512	A	G	hom	off-target	QUAL=3032;DP=109;AF=1.00;MQM=60;SAP=5;ABP=0	MSH3,DHFR	5'UTR	MSH3:ENST00000265081:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::,DHFR:ENST00000439211:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-310T>C::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-204T>C::,MSH3:NM_002439.5:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.291T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	126060 [GENE=DHFR PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency,613839,Autosomal recessive],600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];				rs1105524		0.7128	8054,.	0.9248,0.4874,0.3586,0.6609,0.7608	-3.6080			0.00,0.29	11.43				COSV54143681			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	79950781	79950781	A	G	het		QUAL=420;DP=38;AF=0.47;MQM=60;SAP=27;ABP=3	MSH3,DHFR	missense&splice_region,5'UTR	MSH3:ENST00000265081:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,DHFR:ENST00000439211:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-579T>C::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-473T>C::,MSH3:NM_002439.5:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.22T>C::	regulatory_region_variant:promoter	126060 [GENE=DHFR PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency,613839,Autosomal recessive],600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];	402591 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs1650697		0.8570	9631,.	0.9671,0.9134,0.8262,0.8662,0.8358	-0.4930	T(1.00), 	B(0.00), 	0.00,0.28	0.26	0.24	4.07>2.71	0.002/0.082	COSV54144023			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	79966178	79966178	G	A	het	off-target	QUAL=5454;DP=416;AF=0.50;MQM=60;SAP=3;ABP=3	MSH3	intron	MSH3:ENST00000265081:intron_variant:MODIFIER:intron4/23:c.792+50G>A::	MSH3:NM_002439.5:intron_variant:MODIFIER:intron4/23:c.792+50G>A::		600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];				rs6151630	0.0232	0.0417	28,.	0.0109,0.0170,0.0001,0.0546,0.0352	0.3950			0.03,0.22	11.37				COSV54144136			45	1472	6 / 259					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80149981	80149981	A	G	hom		QUAL=28040;DP=903;AF=1.00;MQM=60;SAP=3;ABP=0	MSH3	missense	MSH3:ENST00000265081:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:PF00488 [MutS domain V]	MSH3:NM_002439.5:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:		600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];	821892 [benign DISEASE=Hereditary cancer-predisposing syndrome];			rs184967		0.8735	11896,.	0.8933,0.9129,0.9994,0.8404,0.8820	0.4030	T(1.00)	B(0.00)	0.18,0.95	14.82	0.28			COSV54143790			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80160597	80160600	AATG	-	het	off-target	QUAL=58;DP=16;AF=0.38;MQM=60;SAP=16;ABP=5	MSH3	intron	MSH3:ENST00000265081:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::	MSH3:NM_002439.5:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::		600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];				rs3991216		0.4851	3498,.	0.2306,0.3526,0.3830,0.5513,0.5265	3.2410				12.44							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80168937	80168937	G	A	hom		QUAL=3771;DP=114;AF=1.00;MQM=60;SAP=16;ABP=0	MSH3	missense&splice_region	MSH3:ENST00000265081:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:PF00488 [MutS domain V]	MSH3:NM_002439.5:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:		600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];	822964 [benign DISEASE=Hereditary cancer-predisposing syndrome];			rs26279	0.7202	0.7294	7872,.	0.6635,0.7560,0.7469,0.7137,0.7934	1.0140	T(0.54)	B(0.04)	0.55,0.20	4.63	0.11	10.88>10.94		COSV54143807			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	112162854	112162854	T	C	het		QUAL=1667;DP=183;AF=0.42;MQM=60;SAP=58;ABP=14	APC	synonymous	APC:ENST00000257430:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000457016:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000508376:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:	APC:NM_000038.6:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:NM_001127510.3:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:,APC:NM_001127511.3:synonymous_variant:LOW:exon10/14:c.1404T>C:p.Tyr468=:,APC:NM_001354895.2:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:NM_001354896.2:synonymous_variant:LOW:exon13/17:c.1512T>C:p.Tyr504=:,APC:NM_001354897.2:synonymous_variant:LOW:exon11/15:c.1488T>C:p.Tyr496=:,APC:NM_001354898.2:synonymous_variant:LOW:exon12/16:c.1383T>C:p.Tyr461=:,APC:NM_001354899.2:synonymous_variant:LOW:exon11/15:c.1374T>C:p.Tyr458=:,APC:NM_001354900.2:synonymous_variant:LOW:exon12/16:c.1335T>C:p.Tyr445=:,APC:NM_001354901.2:synonymous_variant:LOW:exon11/15:c.1281T>C:p.Tyr427=:,APC:NM_001354902.2:synonymous_variant:LOW:exon11/15:c.1185T>C:p.Tyr395=:,APC:NM_001354903.2:synonymous_variant:LOW:exon12/16:c.1155T>C:p.Tyr385=:,APC:NM_001354904.2:synonymous_variant:LOW:exon12/16:c.1080T>C:p.Tyr360=:,APC:NM_001354905.2:synonymous_variant:LOW:exon11/15:c.978T>C:p.Tyr326=:,APC:NM_001354906.2:synonymous_variant:LOW:exon13/17:c.609T>C:p.Tyr203=:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	42238 [benign DISEASE=Hepatocellular carcinoma,Neoplasm of stomach,Carcinoma of colon,Hereditary cancer-predisposing syndrome,Desmoid disease, hereditary,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];	CS1822474 [CLASS=DFP MUT=ALT PHEN="Adenomatous polyposis coli predisposition to" GENE=APC];		rs2229992		0.5844	3887,.	0.1960,0.6976,0.6734,0.5922,0.6386	1.3010			0.83,0.97	10.04				COSV57321592			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112164561	112164561	G	A	het		QUAL=2531;DP=179;AF=0.51;MQM=60;SAP=3;ABP=3	APC,CTC-554D6.1	synonymous,synonymous&NMD_transcript	APC:ENST00000257430:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000457016:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000508376:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],CTC-554D6.1:ENST00000520401:synonymous_variant&NMD_transcript_variant:LOW:exon3/8:c.123G>A:p.Ala41=:PF00514 [Armadillo/beta-catenin-like repeat]	APC:NM_000038.6:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:,APC:NM_001127510.3:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:,APC:NM_001127511.3:synonymous_variant:LOW:exon12/14:c.1581G>A:p.Ala527=:,APC:NM_001354895.2:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:,APC:NM_001354896.2:synonymous_variant:LOW:exon15/17:c.1689G>A:p.Ala563=:,APC:NM_001354897.2:synonymous_variant:LOW:exon13/15:c.1665G>A:p.Ala555=:,APC:NM_001354898.2:synonymous_variant:LOW:exon14/16:c.1560G>A:p.Ala520=:,APC:NM_001354899.2:synonymous_variant:LOW:exon13/15:c.1551G>A:p.Ala517=:,APC:NM_001354900.2:synonymous_variant:LOW:exon14/16:c.1512G>A:p.Ala504=:,APC:NM_001354901.2:synonymous_variant:LOW:exon13/15:c.1458G>A:p.Ala486=:,APC:NM_001354902.2:synonymous_variant:LOW:exon13/15:c.1362G>A:p.Ala454=:,APC:NM_001354903.2:synonymous_variant:LOW:exon14/16:c.1332G>A:p.Ala444=:,APC:NM_001354904.2:synonymous_variant:LOW:exon14/16:c.1257G>A:p.Ala419=:,APC:NM_001354905.2:synonymous_variant:LOW:exon13/15:c.1155G>A:p.Ala385=:,APC:NM_001354906.2:synonymous_variant:LOW:exon15/17:c.786G>A:p.Ala262=:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	42239 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs351771	0.6661	0.6492	5541,.	0.5317,0.7330,0.8218,0.6187,0.7136	1.6080			0.26,0.97	12.40				COSV57321606			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112175770	112175770	G	A	het		QUAL=5170;DP=423;AF=0.49;MQM=60;SAP=3;ABP=3	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000457016:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000508376:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],CTC-554D6.1:ENST00000520401:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11101G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.4425G>A:p.Thr1475=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.4533G>A:p.Thr1511=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.4509G>A:p.Thr1503=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.4404G>A:p.Thr1468=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.4395G>A:p.Thr1465=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.4356G>A:p.Thr1452=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.4302G>A:p.Thr1434=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4206G>A:p.Thr1402=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4176G>A:p.Thr1392=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4101G>A:p.Thr1367=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.3999G>A:p.Thr1333=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.3630G>A:p.Thr1210=:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	42242 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs41115	0.6655	0.6497	5534,.	0.5328,0.7339,0.8216,0.6188,0.7128	0.0930			0.46,0.90	8.19				COSV57321403,COSV57381675			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112176325	112176325	G	A	het		QUAL=233;DP=26;AF=0.50;MQM=60;SAP=31;ABP=3	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:ENST00000457016:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:ENST00000508376:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:,CTC-554D6.1:ENST00000520401:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11656G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.4980G>A:p.Gly1660=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5088G>A:p.Gly1696=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5064G>A:p.Gly1688=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.4959G>A:p.Gly1653=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.4950G>A:p.Gly1650=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.4911G>A:p.Gly1637=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.4857G>A:p.Gly1619=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4761G>A:p.Gly1587=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4731G>A:p.Gly1577=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4656G>A:p.Gly1552=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.4554G>A:p.Gly1518=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.4185G>A:p.Gly1395=:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	42243 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs42427	0.6667	0.6524	5580,.	0.5353,0.7363,0.8218,0.6235,0.7127	0.3110			0.21,0.40	4.52				COSV57321627			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112176559	112176559	T	G	het		QUAL=3249;DP=261;AF=0.49;MQM=60;SAP=4;ABP=3	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:ENST00000457016:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:ENST00000508376:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:,CTC-554D6.1:ENST00000520401:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11890T>G::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.5214T>G:p.Ser1738=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5322T>G:p.Ser1774=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5298T>G:p.Ser1766=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.5193T>G:p.Ser1731=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.5184T>G:p.Ser1728=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.5145T>G:p.Ser1715=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.5091T>G:p.Ser1697=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4995T>G:p.Ser1665=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4965T>G:p.Ser1655=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4890T>G:p.Ser1630=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.4788T>G:p.Ser1596=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.4419T>G:p.Ser1473=:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	42245 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs866006		0.6513	5567,.	0.5340,0.7343,0.8213,0.6209,0.7135	0.9850			0.72,0.25	0.05				COSV57321636,COSV57325918			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112176756	112176756	T	A	het		QUAL=4290;DP=381;AF=0.45;MQM=60;SAP=8;ABP=11	APC,CTC-554D6.1	missense,intron&NMD_transcript	APC:ENST00000257430:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:ENST00000457016:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:ENST00000508376:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:,CTC-554D6.1:ENST00000520401:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+12087T>A::	APC:NM_000038.6:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:NM_001127510.3:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:,APC:NM_001127511.3:missense_variant:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp:,APC:NM_001354895.2:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:NM_001354896.2:missense_variant:MODERATE:exon17/17:c.5519T>A:p.Val1840Asp:,APC:NM_001354897.2:missense_variant:MODERATE:exon15/15:c.5495T>A:p.Val1832Asp:,APC:NM_001354898.2:missense_variant:MODERATE:exon16/16:c.5390T>A:p.Val1797Asp:,APC:NM_001354899.2:missense_variant:MODERATE:exon15/15:c.5381T>A:p.Val1794Asp:,APC:NM_001354900.2:missense_variant:MODERATE:exon16/16:c.5342T>A:p.Val1781Asp:,APC:NM_001354901.2:missense_variant:MODERATE:exon15/15:c.5288T>A:p.Val1763Asp:,APC:NM_001354902.2:missense_variant:MODERATE:exon15/15:c.5192T>A:p.Val1731Asp:,APC:NM_001354903.2:missense_variant:MODERATE:exon16/16:c.5162T>A:p.Val1721Asp:,APC:NM_001354904.2:missense_variant:MODERATE:exon16/16:c.5087T>A:p.Val1696Asp:,APC:NM_001354905.2:missense_variant:MODERATE:exon15/15:c.4985T>A:p.Val1662Asp:,APC:NM_001354906.2:missense_variant:MODERATE:exon17/17:c.4616T>A:p.Val1539Asp:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	21030 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs459552		0.8094	10459,.	0.9587,0.8269,0.9029,0.7706,0.7820	3.6530	T(0.50),T(0.50),T(0.50), 	B(0.00),B(0.00),B(0.00), 	0.05,0.95	18.00	0.19			COSV57321643			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112177171	112177171	G	A	het		QUAL=9917;DP=812;AF=0.49;MQM=60;SAP=4;ABP=5	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000457016:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000508376:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],CTC-554D6.1:ENST00000520401:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+12502G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.5826G>A:p.Pro1942=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5934G>A:p.Pro1978=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5910G>A:p.Pro1970=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.5805G>A:p.Pro1935=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.5796G>A:p.Pro1932=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.5757G>A:p.Pro1919=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.5703G>A:p.Pro1901=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.5607G>A:p.Pro1869=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.5577G>A:p.Pro1859=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.5502G>A:p.Pro1834=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.5400G>A:p.Pro1800=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.5031G>A:p.Pro1677=:		611731 [GENE=APC PHENOS=Adenoma,periampullary,somatic/Desmoid disease,hereditary,135290,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Hepatoblastoma,somatic,114550/Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Gastric cancer,somatic,613659];	42247 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs465899	0.6665	0.6497	5574,.	0.5367,0.7336,0.8217,0.6188,0.7122	-0.1780			0.23,0.91	8.95				COSV57321652			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	131892979	131892979	G	A	hom	off-target	QUAL=1592;DP=66;AF=0.98;MQM=60;SAP=144;ABP=0	RAD50	5'UTR	RAD50:ENST00000265335:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::,RAD50:ENST00000378823:5_prime_UTR_variant:MODIFIER:exon1/25:c.-455G>A::	RAD50:NM_005732.4:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::	regulatory_region_variant:promoter	604040 [GENE=RAD50 PHENOS=Nijmegen breakage syndrome-like disorder,613078];				rs4526098		0.9791	13754,.	0.7535,0.9847,0.9999,0.9967,0.9918	2.2380			0.22,0.54	12.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	131915213	131915213	G	A	het	off-target	QUAL=1499;DP=145;AF=0.46;MQM=60;SAP=69;ABP=5	RAD50	intron	RAD50:ENST00000265335:intron_variant:MODIFIER:intron4/24:c.551+19G>A::,RAD50:ENST00000378823:intron_variant:MODIFIER:intron4/24:c.134+19G>A::	RAD50:NM_005732.4:intron_variant:MODIFIER:intron4/24:c.551+19G>A::		604040 [GENE=RAD50 PHENOS=Nijmegen breakage syndrome-like disorder,613078];	259870 [benign DISEASE=Nijmegen breakage syndrome-like disorder,not specified,not provided];	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50];		rs17166050	0.1677	0.1997	686,.	0.1125,0.1442,0.1684,0.2076,0.2282	-0.1970			0.01,0.13	1.32							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	131925483	131925483	G	C	het		QUAL=814;DP=67;AF=0.49;MQM=60;SAP=3;ABP=3	RAD50	missense	RAD50:ENST00000265335:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:,RAD50:ENST00000378823:missense_variant:MODERATE:exon9/25:c.989G>C:p.Gly330Ala:	RAD50:NM_005732.4:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040 [GENE=RAD50 PHENOS=Nijmegen breakage syndrome-like disorder,613078];	216618 [uncertain significance DISEASE=Hereditary cancer-predisposing syndrome];			rs55653181	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	6.3330	T(0.20),T(0.21)	B(0.19),B(0.19)	0.98,0.99	22.60	0.26				-0.0234	0.5698	0	8	0 / 0					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	176334195	176334195	C	T	het	off-target	QUAL=11593;DP=625;AF=0.69;MQM=60;SAP=3;ABP=205	UIMC1	intron	UIMC1:ENST00000377219:intron_variant:MODIFIER:intron12/14:c.1852-17G>A::,UIMC1:ENST00000377227:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:ENST00000506128:intron_variant:MODIFIER:intron12/14:c.1351-17G>A::,UIMC1:ENST00000511320:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::	UIMC1:NM_001199297.2:intron_variant:MODIFIER:intron13/15:c.1849-17G>A::,UIMC1:NM_001199298.2:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:NM_001317961.1:intron_variant:MODIFIER:intron12/14:c.1351-17G>A::,UIMC1:NM_016290.4:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:NR_146149.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/15:n.2084-17G>A::,UIMC1:NR_146150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/14:n.2010-17G>A::						rs2292255		0.5900	5842,.	0.8281,0.3515,0.4827,0.5003,0.4703	-3.9050			0.01,0.05	0.02		12.99>12.00					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176338288	176338288	C	T	het	off-target	QUAL=3694;DP=318;AF=0.49;MQM=60;SAP=111;ABP=3	UIMC1	intron	UIMC1:ENST00000377219:intron_variant:MODIFIER:intron11/14:c.1679+24G>A::,UIMC1:ENST00000377227:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000506128:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:ENST00000511320:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::	UIMC1:NM_001199297.2:intron_variant:MODIFIER:intron12/15:c.1676+24G>A::,UIMC1:NM_001199298.2:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:NM_001317961.1:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:NM_016290.4:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:NR_146149.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/15:n.1911+24G>A::,UIMC1:NR_146150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/14:n.1837+16G>A::	regulatory_region_variant:promoter_flanking_region					rs17078630	0.0092	0.0249	10,.	0.0058,0.0125,0.0001,0.0364,0.0056	-2.9760			0.01,0.13	0.30							22	793	9 / 172					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr6	35420628	35420628	A	C	het	off-target	QUAL=67;DP=8;AF=0.50;MQM=60;SAP=3;ABP=3	FANCE	intron	FANCE:ENST00000229769:intron_variant:MODIFIER:intron1/9:c.248+58A>C::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron1/9:c.248+58A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	613976 [GENE=FANCE PHENOS=Fanconi anemia,complementation group E,600901,Autosomal recessive];				rs9470029	0.6172	0.6324	6278,.		-1.9940			0.00,0.04	4.65							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MKRN6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35423489	35423489	A	G	het	off-target	QUAL=7908;DP=635;AF=0.49;MQM=60;SAP=3;ABP=4	FANCE	intron	FANCE:ENST00000229769:intron_variant:MODIFIER:intron1/9:c.249-35A>G::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron1/9:c.249-35A>G::		613976 [GENE=FANCE PHENOS=Fanconi anemia,complementation group E,600901,Autosomal recessive];	261434 [benign DISEASE=not specified];			rs7757405		0.7427	8733,.	0.8668,0.8195,0.6817,0.6734,0.7467	1.3540			0.00,0.07	11.72							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35423662	35423662	A	C	het		QUAL=871;DP=98;AF=0.40;MQM=60;SAP=3;ABP=12	FANCE	synonymous	FANCE:ENST00000229769:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:	FANCE:NM_021922.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:		613976 [GENE=FANCE PHENOS=Fanconi anemia,complementation group E,600901,Autosomal recessive];	261435 [benign DISEASE=Fanconi anemia,Fanconi anemia, complementation group E,not specified];			rs4713867		0.7433	8772,.	0.8720,0.8209,0.6819,0.6734,0.7478	-1.1480			0.00,0.14	1.72							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35424188	35424188	A	G	het	off-target	QUAL=1441;DP=106;AF=0.53;MQM=60;SAP=7;ABP=4	FANCE	intron	FANCE:ENST00000229769:intron_variant:MODIFIER:intron2/9:c.855+58A>G::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron2/9:c.855+58A>G::		613976 [GENE=FANCE PHENOS=Fanconi anemia,complementation group E,600901,Autosomal recessive];				rs3800377		0.7158	8174,.		-1.5140			0.00,0.05	0.06							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35425416	35425416	A	G	het	off-target	QUAL=10898;DP=830;AF=0.50;MQM=60;SAP=3;ABP=3	FANCE	intron	FANCE:ENST00000229769:intron_variant:MODIFIER:intron3/9:c.900+39A>G::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron3/9:c.900+39A>G::		613976 [GENE=FANCE PHENOS=Fanconi anemia,complementation group E,600901,Autosomal recessive];	261436 [benign DISEASE=not specified];			rs13214239	0.3596	0.5019	3763,.	0.1291,0.6321,0.3569,0.5547,0.4297	-1.0880			0.02,0.15	5.98							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	131148863	131148863	A	T	het		QUAL=4396;DP=373;AF=0.52;MQM=60;SAP=222;ABP=4	SMLR1	intron	SMLR1:ENST00000541421:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	SMLR1:NM_001195597.1:intron_variant:MODIFIER:intron1/1:c.238+72A>T::						rs9388856	0.4794	0.3781	2349,.		0.0190			0.08,0.21	0.50							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	131148891	131148891	-	AT	het	off-target	QUAL=6746;DP=703;AF=0.41;MQM=60;SAP=6;ABP=53	SMLR1	intron	SMLR1:ENST00000541421:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	SMLR1:NM_001195597.1:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::						rs113795427		0.3951	2416,.						1.76							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr7	6026775	6026775	T	C	hom		QUAL=524;DP=21;AF=1.00;MQM=60;SAP=49;ABP=0	PMS2	missense,intron	PMS2:ENST00000265849:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000382321:intron_variant:MODIFIER:intron7/10:c.804-4153A>G::,PMS2:ENST00000406569:missense_variant:MODERATE:exon11/12:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000441476:missense_variant:MODERATE:exon8/12:c.1303A>G:p.Lys435Glu:	PMS2:NM_000535.7:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:NM_001322003.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322004.2:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322005.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322006.2:missense_variant:MODERATE:exon10/14:c.1465A>G:p.Lys489Glu:,PMS2:NM_001322007.1:missense_variant:MODERATE:exon10/14:c.1303A>G:p.Lys435Glu:,PMS2:NM_001322008.2:missense_variant:MODERATE:exon9/13:c.1303A>G:p.Lys435Glu:,PMS2:NM_001322009.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322010.2:missense_variant:MODERATE:exon9/13:c.1060A>G:p.Lys354Glu:,PMS2:NM_001322011.2:missense_variant:MODERATE:exon11/15:c.688A>G:p.Lys230Glu:,PMS2:NM_001322012.2:missense_variant:MODERATE:exon11/15:c.688A>G:p.Lys230Glu:,PMS2:NM_001322013.2:missense_variant:MODERATE:exon10/14:c.1048A>G:p.Lys350Glu:,PMS2:NM_001322014.2:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:NM_001322015.2:missense_variant:MODERATE:exon11/15:c.1312A>G:p.Lys438Glu:,PMS2:NR_136154.1:non_coding_transcript_exon_variant:MODIFIER:exon11/15:n.1708A>G::		600259 [GENE=PMS2 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Colorectal cancer,hereditary nonpolyposis,type 4,614337];	135065 [benign DISEASE=Hereditary nonpolyposis colon cancer,Hereditary nonpolyposis colorectal cancer type 4,not specified];			rs2228006	0.8832	0.8724	11970,.	0.9247,0.6690,0.9212,0.8498,0.8953	1.4430	T(1.00), ,T(1.00),T(1.00)	B(0.00), ,B(0.00),B(0.00)	0.00,0.13	10.11	0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6036980	6036980	G	C	hom		QUAL=748;DP=24;AF=1.00;MQM=60;SAP=3;ABP=0	PMS2	synonymous	PMS2:ENST00000265849:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000382321:synonymous_variant:LOW:exon7/11:c.780C>G:p.Ser260=:,PMS2:ENST00000406569:synonymous_variant:LOW:exon7/12:c.780C>G:p.Ser260=:,PMS2:ENST00000441476:synonymous_variant:LOW:exon4/12:c.462C>G:p.Ser154=:	PMS2:NM_000535.7:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:NM_001322003.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322004.2:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:NM_001322005.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322006.2:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:NM_001322007.1:synonymous_variant:LOW:exon6/14:c.462C>G:p.Ser154=:,PMS2:NM_001322008.2:synonymous_variant:LOW:exon5/13:c.462C>G:p.Ser154=:,PMS2:NM_001322009.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322010.2:synonymous_variant:LOW:exon6/13:c.375C>G:p.Ser125=:,PMS2:NM_001322011.2:5_prime_UTR_variant:MODIFIER:exon7/15:c.-154C>G::,PMS2:NM_001322012.2:5_prime_UTR_variant:MODIFIER:exon7/15:c.-154C>G::,PMS2:NM_001322013.2:synonymous_variant:LOW:exon6/14:c.207C>G:p.Ser69=:,PMS2:NM_001322014.2:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:NM_001322015.2:synonymous_variant:LOW:exon7/15:c.471C>G:p.Ser157=:,PMS2:NR_136154.1:non_coding_transcript_exon_variant:MODIFIER:exon7/15:n.867C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	600259 [GENE=PMS2 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Colorectal cancer,hereditary nonpolyposis,type 4,614337];	36693 [benign DISEASE=Hereditary nonpolyposis colon cancer,Hereditary cancer-predisposing syndrome,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 4,not specified];			rs1805319		0.8206	10471,.	0.8425,0.6511,0.9207,0.8166,0.8173	-2.6950			0.03,0.07	0.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6037057	6037057	-	A	het		QUAL=230;DP=27;AF=0.44;MQM=60;SAP=6;ABP=4	PMS2	splice_region&intron	PMS2:ENST00000265849:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000382321:splice_region_variant&intron_variant:LOW:intron6/10:c.706-4dup::,PMS2:ENST00000406569:splice_region_variant&intron_variant:LOW:intron6/11:c.706-4dup::,PMS2:ENST00000441476:splice_region_variant&intron_variant:LOW:intron3/11:c.388-4dup::	PMS2:NM_000535.7:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:NM_001322003.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322004.2:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:NM_001322005.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322006.2:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:NM_001322007.1:splice_region_variant&intron_variant:LOW:intron5/13:c.388-4dup::,PMS2:NM_001322008.2:splice_region_variant&intron_variant:LOW:intron4/12:c.388-4dup::,PMS2:NM_001322009.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322010.2:splice_region_variant&intron_variant:LOW:intron5/12:c.301-4dup::,PMS2:NM_001322011.2:splice_region_variant&intron_variant:LOW:intron6/14:c.-228-4dup::,PMS2:NM_001322012.2:splice_region_variant&intron_variant:LOW:intron6/14:c.-228-4dup::,PMS2:NM_001322013.2:splice_region_variant&intron_variant:LOW:intron5/13:c.133-4dup::,PMS2:NM_001322014.2:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:NM_001322015.2:splice_region_variant&intron_variant:LOW:intron6/14:c.397-4dup::,PMS2:NR_136154.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron6/14:n.793-4dup::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	600259 [GENE=PMS2 PHENOS=Mismatch repair cancer syndrome,276300,Autosomal recessive/Colorectal cancer,hereditary nonpolyposis,type 4,614337];	198429 [benign(replaced by megSAP based on classifications:6x1,2x2,1x3) DISEASE=Hereditary nonpolyposis colon cancer,Hereditary cancer-predisposing syndrome,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 4,not specified];		(A)n (Simple_repeat)	rs60794673		0.0962	71,.	0.0783,0.0866,0.0270,0.0766,0.0460					10.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	128843169	128843169	C	T	hom	off-target	QUAL=315;DP=12;AF=1.00;MQM=60;SAP=29;ABP=0	SMO	intron	SMO:ENST00000249373:intron_variant:MODIFIER:intron1/11:c.332-56C>T::	SMO:NM_005631.5:intron_variant:MODIFIER:intron1/11:c.332-56C>T::		601500 [GENE=SMO PHENOS=Curry-Jones syndrome,somatic mosaic,601707/Basal cell carcinoma,somatic,605462];				rs2566871	0.4615	0.4971	3883,.		-1.5800			0.00,0.08	4.90							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	128845018	128845018	C	T	hom	off-target	QUAL=6757;DP=205;AF=1.00;MQM=60;SAP=24;ABP=0	SMO	intron	SMO:ENST00000249373:intron_variant:MODIFIER:intron2/11:c.538-26C>T::	SMO:NM_005631.5:intron_variant:MODIFIER:intron2/11:c.538-26C>T::		601500 [GENE=SMO PHENOS=Curry-Jones syndrome,somatic mosaic,601707/Basal cell carcinoma,somatic,605462];				rs2703091	0.7524	0.7965	9905,.	0.6834,0.7157,0.7553,0.8411,0.7655	-0.1140			0.05,0.20	3.18							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	128845277	128845277	G	C	hom	off-target	QUAL=1590;DP=55;AF=1.00;MQM=60;SAP=83;ABP=0	SMO	intron	SMO:ENST00000249373:intron_variant:MODIFIER:intron3/11:c.747+24G>C::	SMO:NM_005631.5:intron_variant:MODIFIER:intron3/11:c.747+24G>C::		601500 [GENE=SMO PHENOS=Curry-Jones syndrome,somatic mosaic,601707/Basal cell carcinoma,somatic,605462];				rs2075777		0.7966	9900,.	0.6836,0.7166,0.7563,0.8417,0.7633	-0.0960			0.10,0.13	0.16							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	128846328	128846328	G	C	hom		QUAL=28443;DP=908;AF=1.00;MQM=60;SAP=3;ABP=0	SMO	synonymous	SMO:ENST00000249373:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:PF01534 [Frizzled/Smoothened family membrane region]	SMO:NM_005631.5:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:		601500 [GENE=SMO PHENOS=Curry-Jones syndrome,somatic mosaic,601707/Basal cell carcinoma,somatic,605462];	403462 [benign DISEASE=not specified];			rs2228617		0.7981	9942,.	0.6878,0.7170,0.7677,0.8413,0.7658	1.1300			0.42,0.97	11.65							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	128846469	128846469	A	G	hom	off-target	QUAL=27683;DP=857;AF=1.00;MQM=60;SAP=3;ABP=0	SMO	intron	SMO:ENST00000249373:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::	SMO:NM_005631.5:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::		601500 [GENE=SMO PHENOS=Curry-Jones syndrome,somatic mosaic,601707/Basal cell carcinoma,somatic,605462];				rs2735842	0.7532	0.7969	9931,.	0.6878,0.7171,0.7558,0.8411,0.7659	0.2160			0.00,0.07	4.36							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	142460261	142460261	T	A	hom	off-target	QUAL=2060;DP=69;AF=1.00;MQM=60;SAP=17;ABP=0	PRSS1	intron	PRSS1:ENST00000311737:intron_variant:MODIFIER:intron3/4:c.455-21T>A::,PRSS1:ENST00000486171:intron_variant:MODIFIER:intron4/5:c.497-21T>A::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron3/4:c.455-21T>A::		276000 [GENE=PRSS1 PHENOS=Pancreatitis,hereditary,167800,Autosomal dominant];				rs201825825		0.7843	7017,.	0.6700,0.6628,0.7457,0.6157,0.6183	-0.8960			0.00,0.08	5.21							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142460313	142460313	T	C	hom		QUAL=4964;DP=164;AF=1.00;MQM=60;SAP=13;ABP=0	PRSS1	synonymous	PRSS1:ENST00000311737:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin],PRSS1:ENST00000486171:synonymous_variant:LOW:exon5/6:c.528T>C:p.Asp176=:PF00089 [Trypsin]	PRSS1:NM_002769.5:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:		276000 [GENE=PRSS1 PHENOS=Pancreatitis,hereditary,167800,Autosomal dominant];	239391 [benign/likely benign DISEASE=Inborn genetic diseases,Hereditary pancreatitis,not specified];			rs6666	0.3966	0.4105	995,.	0.3600,0.4294,0.2078,0.4259,0.2607	-4.3320			0.02,0.08	0.11							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142460865	142460865	T	C	hom		QUAL=10156;DP=357;AF=1.00;MQM=60;SAP=411;ABP=0	PRSS1	synonymous	PRSS1:ENST00000311737:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:,PRSS1:ENST00000486171:synonymous_variant:LOW:exon6/6:c.780T>C:p.Asn260=:	PRSS1:NM_002769.5:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:		276000 [GENE=PRSS1 PHENOS=Pancreatitis,hereditary,167800,Autosomal dominant];	258803 [benign/likely benign DISEASE=Inborn genetic diseases,not specified];			rs6667	0.3938	0.5221	4349,.	0.4323,0.5609,0.2287,0.5783,0.3051	0.2230			0.01,0.80	5.12							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr8	90955624	90955624	T	A	het	off-target	QUAL=411;DP=31;AF=0.55;MQM=60;SAP=18;ABP=4	NBN	intron	NBN:ENST00000265433:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::,NBN:ENST00000409330:intron_variant:MODIFIER:intron13/15:c.1825-30A>T::	NBN:NM_001024688.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:NM_002485.4:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	258769 [benign DISEASE=not specified];			rs3736639	0.3792	0.3539	1809,.	0.3207,0.3539,0.4561,0.3254,0.4290	-0.2360			0.00,0.07	3.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90958422	90958422	T	C	het		QUAL=584;DP=47;AF=0.55;MQM=60;SAP=11;ABP=4	NBN	synonymous	NBN:ENST00000265433:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:ENST00000409330:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:	NBN:NM_001024688.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:NM_002485.4:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	183696 [benign DISEASE=Hereditary cancer-predisposing syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified];			rs1061302	0.3528	0.3467	1606,.	0.2298,0.3492,0.4561,0.3250,0.4285	-0.8170			0.06,0.19	0.63							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90958530	90958530	T	C	het		QUAL=380;DP=35;AF=0.46;MQM=60;SAP=12;ABP=4	NBN	splice_region&intron	NBN:ENST00000265433:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:ENST00000409330:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::	NBN:NM_001024688.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:NM_002485.4:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	258768 [benign DISEASE=Hereditary cancer-predisposing syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified];			rs2308962	0.3790	0.3535	1805,.	0.3186,0.3539,0.4561,0.3253,0.4278	-1.8420			0.02,0.10	0.08		3.91>3.28	0.000/0.036				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90967711	90967711	A	G	het		QUAL=349;DP=37;AF=0.43;MQM=60;SAP=4;ABP=4	NBN	synonymous	NBN:ENST00000265433:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:ENST00000409330:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:	NBN:NM_001024688.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:NM_002485.4:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	183701 [benign DISEASE=Hereditary cancer-predisposing syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified];			rs709816	0.6086	0.5112	4568,.	0.7781,0.5773,0.6480,0.3625,0.5115	0.0420			0.03,0.15	0.42							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90970935	90970935	G	A	het	off-target	QUAL=463;DP=48;AF=0.42;MQM=60;SAP=19;ABP=6	NBN	intron	NBN:ENST00000265433:intron_variant:MODIFIER:intron9/15:c.1124+18C>T::,NBN:ENST00000409330:intron_variant:MODIFIER:intron9/15:c.878+18C>T::	NBN:NM_001024688.2:intron_variant:MODIFIER:intron10/16:c.878+18C>T::,NBN:NM_002485.4:intron_variant:MODIFIER:intron9/15:c.1124+18C>T::		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	199080 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs2234744	0.3530	0.3465	1619,.	0.2297,0.3489,0.4559,0.3250,0.4279	-0.4390			0.01,0.14	0.21							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90990479	90990479	C	G	het		QUAL=10738;DP=828;AF=0.50;MQM=60;SAP=3;ABP=3	NBN	missense	NBN:ENST00000265433:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:ENST00000409330:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:	NBN:NM_001024688.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:NM_002485.4:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	134876 [benign DISEASE=Hereditary cancer-predisposing syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified];	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN];		rs1805794	0.3570	0.3470	1628,.	0.2363,0.3494,0.4562,0.3246,0.4281	2.1330	T(1.00),T(1.00)	B(0.00),B(0.00)	0.09,0.94	14.87	0.10			COSV55372457,COSV55375647			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90995019	90995019	C	T	het		QUAL=99;DP=19;AF=0.37;MQM=60;SAP=18;ABP=6	NBN	synonymous,5'UTR	NBN:ENST00000265433:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000409330:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::	NBN:NM_001024688.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:NM_002485.4:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:	regulatory_region_variant:promoter	602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Nijmegen breakage syndrome,251260,Autosomal recessive/Aplastic anemia,609135];	183697 [benign DISEASE=Hereditary cancer-predisposing syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified];			rs1063045	0.3792	0.3535	1792,.	0.3184,0.3540,0.4563,0.3253,0.4283	-0.2470			0.10,0.85	12.20							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	107236280	107236280	G	T	hom		QUAL=20602;DP=650;AF=1.00;MQM=60;SAP=4;ABP=0		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.6096	0.5562	5348,.		-0.5990			0.00,0.05	0.10							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	5921881	5921881	G	A	het		QUAL=15232;DP=1060;AF=0.54;MQM=60;SAP=5;ABP=15	KIAA2026	missense	KIAA2026:ENST00000381461:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:ENST00000399933:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:	KIAA2026:NM_001017969.3:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:						rs72697396	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0001	1.9050	D(0.02),D(0.02)	B(0.08),B(0.08)	0.39,0.53	15.18	0.03				-0.0005	0.9431	0	20	0 / 3					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	17235643	17235643	T	-	het	off-target	QUAL=521;DP=40;AF=0.60;MQM=60;SAP=16;ABP=6	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron3/25:c.535-7del::,CNTLN:ENST00000380641:intron_variant:MODIFIER:intron3/6:c.535-7del::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron3/25:c.535-7del::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron3/25:c.535-7del::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron3/6:c.535-7del::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron3/25:c.535-7del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron3/25:c.535-7del::						rs67017076		0.7976	10144,.	0.9558,0.9055,0.9998,0.7338,0.9304	1.7450				4.10							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273878	17273878	A	G	het		QUAL=1145;DP=64;AF=0.72;MQM=60;SAP=4;ABP=30	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron6/25:c.987+10A>G::,CNTLN:ENST00000380641:intron_variant:MODIFIER:intron6/6:c.983+14A>G::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron6/25:c.987+10A>G::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron6/6:c.983+14A>G::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron6/25:c.983+14A>G::						rs12376938	0.2258	0.2498	897,.	0.1713,0.1941,0.0717,0.2631,0.3574	-1.6410			0.00,0.08	5.76							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273926	17273926	C	G	het	off-target	QUAL=173;DP=16;AF=0.50;MQM=60;SAP=3;ABP=3	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron6/25:c.987+58C>G::,CNTLN:ENST00000380641:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron6/25:c.983+62C>G::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron6/25:c.987+58C>G::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron6/25:c.983+62C>G::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron6/25:c.983+62C>G::						rs12379655	0.3343	0.2873	1314,.		-1.7500			0.00,0.08	3.59				COSV52097738			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17342383	17342383	C	T	hom		QUAL=983;DP=30;AF=1.00;MQM=60;SAP=13;ABP=0	CNTLN	synonymous	CNTLN:ENST00000262360:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:ENST00000380647:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:ENST00000425824:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:						rs1442527	0.9495	0.9887	14455,.	0.8435,0.9919,1.0000,0.9995,0.9998	2.3280			0.13,0.94	8.10							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394536	17394536	C	T	hom		QUAL=1783;DP=56;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	missense	CNTLN:ENST00000262360:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:ENST00000380647:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:ENST00000425824:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:	CNTLN:NM_001365029.1:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:NM_017738.4:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:						rs7035276		0.8300	10710,.	0.6917,0.7734,0.8094,0.8725,0.7405	0.3250	T(0.27),T(0.27),T(0.27)	B(0.00),B(0.00),B(0.00)	0.11,0.67	13.60	0.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394996	17394996	T	C	hom		QUAL=3143;DP=98;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	synonymous	CNTLN:ENST00000262360:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:ENST00000380647:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:ENST00000425824:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	regulatory_region_variant:promoter_flanking_region					rs3739489	0.8411	0.8779	12081,.	0.7731,0.7920,0.8121,0.9165,0.8706	0.6140			0.30,0.96	8.33							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17395108	17395108	C	T	hom	off-target	QUAL=6825;DP=215;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::	regulatory_region_variant:promoter_flanking_region					rs3739488	0.7819	0.8306	10732,.	0.6973,0.7766,0.8106,0.8739,0.7485	3.8330			0.21,0.97	19.15							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409366	17409366	G	A	hom		QUAL=12154;DP=384;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	synonymous	CNTLN:ENST00000262360:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:,CNTLN:ENST00000380647:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:,CNTLN:ENST00000425824:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon16/26:c.2688G>A:p.Thr896=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:						rs2780211		0.8742	12056,.	0.7732,0.7924,0.8113,0.9133,0.8500	0.9030			0.01,0.65	8.89							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457513	17457513	A	-	hom		QUAL=104;DP=4;AF=1.00;MQM=60;SAP=12;ABP=0	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron18/25:c.3115-2del::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron18/25:c.3115-2del::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron18/25:c.3115-2del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron18/25:c.3112-2del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron18/25:c.3115-2del::					(TATATT)n (Simple_repeat)	rs35399020		0.8540	10171,.	0.5934,0.7533,0.6981,0.9105,0.7931	0.1540				0.67				COSV52086669			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494875	17494875	T	-	het	off-target	QUAL=222;DP=30;AF=0.20;MQM=60;SAP=9;ABP=26	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron25/25:c.4120-9del::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron25/25:c.4120-7653del::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron25/25:c.4120-7653del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron25/25:c.4117-7653del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron25/25:c.4120-7653del::					AluSx (SINE/Alu)	rs35224903		0.4816	652,.	0.2348,0.2082,0.2046,0.0996,0.0997	0.1780				1.02							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494875	17494877	TTT	-	het	off-target	QUAL=222;DP=30;AF=0.17;MQM=60;SAP=14;ABP=32	CNTLN	intron	CNTLN:ENST00000262360:intron_variant:MODIFIER:intron25/25:c.4120-11_4120-9del::,CNTLN:ENST00000380647:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::,CNTLN:ENST00000425824:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron25/25:c.4117-7655_4117-7653del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::					AluSx (SINE/Alu)	rs35224903		0.0485	0,.	0.0642,0.0742,0.0702,0.0441,0.0279	0.1780				0.82							164	50	50 / 2	2	"[2] auto-classification 15.09.2017%0A%0A"			CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	21971137	21971137	T	G	het		QUAL=264;DP=53;AF=0.45;MQM=60;SAP=55;ABP=4	CDKN2A,RP11-145E5.5	missense,synonymous,intron&NMD_transcript	CDKN2A:ENST00000304494:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000361570:synonymous_variant:LOW:exon2/3:c.387A>C:p.Arg129=:,RP11-145E5.5:ENST00000404796:intron_variant&NMD_transcript_variant:MODIFIER:intron4/5:c.348-58295T>G::,CDKN2A:ENST00000446177:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000479692:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000494262:missense_variant:MODERATE:exon3/4:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000497750:missense_variant:MODERATE:exon2/2:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000498124:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000498628:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000530628:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000578845:missense_variant:MODERATE:exon1/2:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000579122:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000579755:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:	CDKN2A:NM_000077.4:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:NM_001195132.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:,CDKN2A:NM_001363763.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:NM_058195.3:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:NM_058197.4:3_prime_UTR_variant:MODIFIER:exon2/3:c.*144A>C::		600160 [GENE=CDKN2A PHENOS=Melanoma and neural system tumor syndrome,155755,Autosomal dominant/Melanoma,cutaneous malignant,2,155601,Autosomal dominant/Melanoma-pancreatic cancer syndrome,606719,Autosomal dominant];	802463 [uncertain significance DISEASE=Melanoma-pancreatic cancer syndrome];	CM165602 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=CDKN2A];		rs200429615		0.0013		0.0007,0.0005,0.0000,0.0019,0.0007	5.3760	D(0.00), , ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), ,D(0.00),D(0.00), 	D(1.00), , ,D(1.00),D(1.00),D(1.00),D(1.00),D(1.00),D(1.00), ,D(1.00),P(0.87), 	0.97,0.98	29.20	0.88			COSV58684939,COSV58689077	-0.0702	0.8399	4	214	0 / 0	1	"[1] old entry - no details available"			CDKN2A-DT (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=n/a), CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974671	21974671	A	C	het		QUAL=122;DP=20;AF=0.70;MQM=60;SAP=33;ABP=10	CDKN2A,RP11-145E5.5	splice_region&intron,intron,intron&NMD_transcript	CDKN2A:ENST00000304494:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000361570:intron_variant:MODIFIER:intron1/2:c.317-3464T>G::,RP11-145E5.5:ENST00000404796:intron_variant&NMD_transcript_variant:MODIFIER:intron4/5:c.348-54761A>C::,CDKN2A:ENST00000446177:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000494262:intron_variant:MODIFIER:intron2/3:c.-3-3464T>G::,CDKN2A:ENST00000498124:splice_region_variant&intron_variant:LOW:intron1/3:c.150+6T>G::,CDKN2A:ENST00000498628:intron_variant:MODIFIER:intron1/2:c.-3-3464T>G::,CDKN2A:ENST00000530628:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:ENST00000579122:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000579755:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::	CDKN2A:NM_000077.4:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:NM_001195132.1:splice_region_variant&intron_variant:LOW:intron1/3:c.150+6T>G::,CDKN2A:NM_001363763.2:intron_variant:MODIFIER:intron1/2:c.-3-3464T>G::,CDKN2A:NM_058195.3:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:NM_058197.4:synonymous_variant:LOW:exon1/3:c.156T>G:p.Gly52=:	regulatory_region_variant:promoter,TF_binding_site_variant	600160 [GENE=CDKN2A PHENOS=Melanoma and neural system tumor syndrome,155755,Autosomal dominant/Melanoma,cutaneous malignant,2,155601,Autosomal dominant/Melanoma-pancreatic cancer syndrome,606719,Autosomal dominant];									0.5660			0.10,0.30	9.58		8.56>6.92			-1.2625	0.9626	31	19	0 / 0	2	"[2] auto-classification 15.09.2017%0A%0A[3] ahsepai1 2016-07-13%0A%0A"			CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974675	21974675	A	C	het		QUAL=122;DP=20;AF=0.70;MQM=60;SAP=33;ABP=10	CDKN2A,RP11-145E5.5	splice_donor,intron,intron&NMD_transcript	CDKN2A:ENST00000304494:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:ENST00000361570:intron_variant:MODIFIER:intron1/2:c.317-3468T>G::,RP11-145E5.5:ENST00000404796:intron_variant&NMD_transcript_variant:MODIFIER:intron4/5:c.348-54757A>C::,CDKN2A:ENST00000446177:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:ENST00000494262:intron_variant:MODIFIER:intron2/3:c.-3-3468T>G::,CDKN2A:ENST00000498124:splice_donor_variant:HIGH:intron1/3:c.150+2T>G::,CDKN2A:ENST00000498628:intron_variant:MODIFIER:intron1/2:c.-3-3468T>G::,CDKN2A:ENST00000530628:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:ENST00000579122:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:ENST00000579755:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::	CDKN2A:NM_000077.4:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:NM_001195132.1:splice_donor_variant:HIGH:intron1/3:c.150+2T>G::,CDKN2A:NM_001363763.2:intron_variant:MODIFIER:intron1/2:c.-3-3468T>G::,CDKN2A:NM_058195.3:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:NM_058197.4:missense_variant:MODERATE:exon1/3:c.152T>G:p.Val51Gly:	regulatory_region_variant:promoter,TF_binding_site_variant	600160 [GENE=CDKN2A PHENOS=Melanoma and neural system tumor syndrome,155755,Autosomal dominant/Melanoma,cutaneous malignant,2,155601,Autosomal dominant/Melanoma-pancreatic cancer syndrome,606719,Autosomal dominant];									3.7700			0.93,0.95	32.00		8.56>0.92		COSV58686447,COSV58697953	-3.7329	1.0	31	19	0 / 0	4	"[4] ahsepai1 2016-07-13%0A%0A"			CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	35074917	35074917	T	C	hom		QUAL=3127;DP=99;AF=1.00;MQM=60;SAP=6;ABP=0	FANCG	splice_region&intron	FANCG:ENST00000378643:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::	FANCG:NM_004629.1:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::		602956 [GENE=FANCG PHENOS=Fanconi anemia,complementation group G,614082];	259477 [benign DISEASE=Fanconi anemia,not specified,Amyotrophic Lateral Sclerosis, Dominant,Inclusion Body Myopathy, Dominant];			rs587118	0.2202	0.4017	2719,.	0.0803,0.5007,0.0032,0.4999,0.2614	0.2340			0.13,0.60	13.19			0.000/0.002				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35077441	35077441	T	C	hom	off-target	QUAL=6869;DP=207;AF=1.00;MQM=60;SAP=3;ABP=0	FANCG	intron	FANCG:ENST00000378643:intron_variant:MODIFIER:intron4/13:c.511-45A>G::	FANCG:NM_004629.1:intron_variant:MODIFIER:intron4/13:c.511-45A>G::		602956 [GENE=FANCG PHENOS=Fanconi anemia,complementation group G,614082];	259478 [benign DISEASE=not specified];			rs554098		0.7509	8906,.	0.7437,0.8445,0.4522,0.7779,0.7088	-1.4140			0.00,0.06	5.41							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	90062823	90062823	A	G	hom		QUAL=14935;DP=527;AF=1.00;MQM=60;SAP=740;ABP=0		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs12682834	0.6368	0.6507	5562,.	0.4721,0.6890,0.6846,0.6292,0.7402	-0.5480			0.00,0.26	0.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	98209594	98209594	G	A	het		QUAL=1180;DP=71;AF=0.66;MQM=60;SAP=4;ABP=19	PTCH1	missense	PTCH1:ENST00000331920:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:ENST00000375274:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:ENST00000418258:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000421141:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000429896:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000430669:missense_variant:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000437951:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu:	PTCH1:NM_000264.5:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:NM_001083602.2:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu:,PTCH1:NM_001083603.2:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:NM_001083604.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083605.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083606.3:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083607.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001354918.2:missense_variant:MODERATE:exon22/23:c.3788C>T:p.Pro1263Leu:,PTCH1:NR_149061.2:non_coding_transcript_exon_variant:MODIFIER:exon23/24:n.4683C>T::		601309 [GENE=PTCH1 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Holoprosencephaly 7,610828,Autosomal dominant];	41663 [benign DISEASE=Holoprosencephaly sequence,Gorlin syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs357564	0.3968	0.3892	1900,.	0.2327,0.4872,0.5627,0.3388,0.4468	9.4090	D(0.01),D(0.01),D(0.01),D(0.01),D(0.01),D(0.01),D(0.01)	B(0.44),P(0.71),B(0.44),B(0.44),B(0.44),P(0.65),P(0.65)	1.00,0.99	24.60	0.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	98232224	98232224	A	-	het		QUAL=546;DP=59;AF=0.54;MQM=60;SAP=72;ABP=4	PTCH1	intron	PTCH1:ENST00000331920:intron_variant:MODIFIER:intron12/23:c.1729-11del::,PTCH1:ENST00000375274:intron_variant:MODIFIER:intron12/23:c.1726-11del::,PTCH1:ENST00000418258:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000421141:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000429896:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000430669:intron_variant:MODIFIER:intron12/22:c.1531-11del::,PTCH1:ENST00000437951:intron_variant:MODIFIER:intron12/23:c.1531-11del::	PTCH1:NM_000264.5:intron_variant:MODIFIER:intron12/23:c.1729-11del::,PTCH1:NM_001083602.2:intron_variant:MODIFIER:intron12/23:c.1531-11del::,PTCH1:NM_001083603.2:intron_variant:MODIFIER:intron12/23:c.1726-11del::,PTCH1:NM_001083604.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083605.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083606.3:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083607.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001354918.2:intron_variant:MODIFIER:intron11/22:c.1573-11del::,LOC100507346:NR_038982.1:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.1887del::,PTCH1:NR_149061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/23:n.2634-11del::		601309 [GENE=PTCH1 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Holoprosencephaly 7,610828,Autosomal dominant];				rs779000277		0.0011	0,.	0.0001,0.0007,0.0000,0.0020,0.0000	0.6250				0.46				COSV59495096	-0.2837	0.3034	0	41	0 / 7					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	98239190	98239190	G	C	hom	off-target	QUAL=1285;DP=42;AF=1.00;MQM=60;SAP=16;ABP=0	PTCH1	intron	PTCH1:ENST00000331920:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:ENST00000375274:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::,PTCH1:ENST00000418258:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:ENST00000421141:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:ENST00000429896:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:ENST00000430669:intron_variant:MODIFIER:intron10/22:c.1306-51C>G::,PTCH1:ENST00000437951:intron_variant:MODIFIER:intron10/23:c.1306-51C>G::	PTCH1:NM_000264.5:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:NM_001083602.2:intron_variant:MODIFIER:intron10/23:c.1306-51C>G::,PTCH1:NM_001083603.2:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::,PTCH1:NM_001083604.2:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001083605.2:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001083606.3:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001083607.2:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001354918.2:intron_variant:MODIFIER:intron9/22:c.1348-51C>G::,PTCH1:NR_149061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/23:n.2409-51C>G::		601309 [GENE=PTCH1 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Holoprosencephaly 7,610828,Autosomal dominant];				rs574688	0.1627	0.2280	683,.	0.0485,0.2153,0.0600,0.2671,0.2760	0.6610			0.11,0.23	3.57							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr10	43595968	43595968	A	G	hom		QUAL=16186;DP=520;AF=1.00;MQM=60;SAP=4;ABP=0	RET	synonymous	RET:ENST00000340058:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:,RET:ENST00000355710:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:	RET:NM_020630.5:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:,RET:NM_020975.6:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:		164761 [GENE=RET PHENOS=Multiple endocrine neoplasia IIB,162300,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Central hypoventilation syndrome,congenital,209880,Autosomal dominant/Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant];	167589 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified];			rs1800858		0.7725	9544,.	0.9530,0.7589,0.5513,0.7401,0.7290	-2.5110			0.01,0.17	1.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43612226	43612226	C	T	het	off-target	QUAL=2397;DP=316;AF=0.46;MQM=60;SAP=213;ABP=8	RET	intron	RET:ENST00000340058:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:ENST00000355710:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::	RET:NM_001355216.1:intron_variant:MODIFIER:intron9/15:c.1522+47C>T::,RET:NM_020630.5:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:NM_020975.6:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::		164761 [GENE=RET PHENOS=Multiple endocrine neoplasia IIB,162300,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Central hypoventilation syndrome,congenital,209880,Autosomal dominant/Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant];	261396 [benign DISEASE=not specified];			rs760466	0.1206	0.2074	634,.	0.0519,0.1823,0.0586,0.2781,0.1330	-0.9710			0.02,0.13	0.54							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43613843	43613843	G	T	hom		QUAL=37763;DP=1156;AF=1.00;MQM=60;SAP=3;ABP=0	RET	synonymous	RET:ENST00000340058:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine kinase],RET:ENST00000355710:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine kinase]	RET:NM_001355216.1:synonymous_variant:LOW:exon10/16:c.1545G>T:p.Leu515=:,RET:NM_020630.5:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:,RET:NM_020975.6:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:		164761 [GENE=RET PHENOS=Multiple endocrine neoplasia IIB,162300,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Central hypoventilation syndrome,congenital,209880,Autosomal dominant/Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant];	167590 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified];			rs1800861		0.7798	9644,.	0.8846,0.7707,0.5057,0.7688,0.6426	1.2300			0.79,0.94	10.76							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43615505	43615505	G	A	het	off-target	QUAL=9252;DP=734;AF=0.51;MQM=60;SAP=3;ABP=3	RET	intron	RET:ENST00000340058:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:ENST00000355710:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::	RET:NM_001355216.1:intron_variant:MODIFIER:intron11/15:c.1846-24G>A::,RET:NM_020630.5:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:NM_020975.6:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::	regulatory_region_variant:promoter_flanking_region	164761 [GENE=RET PHENOS=Multiple endocrine neoplasia IIB,162300,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Central hypoventilation syndrome,congenital,209880,Autosomal dominant/Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant];	24956 [benign DISEASE=not specified];	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2472737	0.1731	0.2079	743,.	0.1498,0.1531,0.2331,0.2261,0.1595	-0.0220			0.01,0.30	8.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43622217	43622217	T	C	hom	off-target	QUAL=1163;DP=42;AF=1.00;MQM=60;SAP=86;ABP=0	RET	3'UTR,intron	RET:ENST00000340058:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:ENST00000355710:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::	RET:NM_001355216.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*15T>C::,RET:NM_020630.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:NM_020975.6:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::	regulatory_region_variant:promoter_flanking_region	164761 [GENE=RET PHENOS=Multiple endocrine neoplasia IIB,162300,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Central hypoventilation syndrome,congenital,209880,Autosomal dominant/Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant];	165056 [benign DISEASE=not specified];	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2075912	0.7550	0.8235	10749,.	0.9172,0.7973,0.5115,0.8266,0.7399	1.3820			0.08,0.78	15.79							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	88635779	88635779	C	A	het		QUAL=850;DP=71;AF=0.56;MQM=52;SAP=4;ABP=5	BMPR1A	missense	BMPR1A:ENST00000372037:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:	BMPR1A:NM_004329.2:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:		601299 [GENE=BMPR1A PHENOS=Polyposis syndrome,hereditary mixed,2,610069/Polyposis,juvenile intestinal,174900,Autosomal dominant/Juvenile polyposis syndrome,infantile form,174900,Autosomal dominant];	41782 [benign DISEASE=Hereditary cancer-predisposing syndrome,Juvenile polyposis syndrome,not specified,Juvenile Polyposis,not provided];			rs11528010	0.4998	0.4123	3213,.	0.6679,0.3900,0.7182,0.2583,0.3004	3.7690	T(1.00)	B(0.00)	0.02,0.92	14.41	0.21			COSV64406247			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	88649763	88649763	C	T	het	off-target	QUAL=672;DP=53;AF=0.49;MQM=60;SAP=15;ABP=3	BMPR1A	intron	BMPR1A:ENST00000372037:intron_variant:MODIFIER:intron3/12:c.68-56C>T::	BMPR1A:NM_004329.2:intron_variant:MODIFIER:intron3/12:c.68-56C>T::	regulatory_region_variant:CTCF_binding_site	601299 [GENE=BMPR1A PHENOS=Polyposis syndrome,hereditary mixed,2,610069/Polyposis,juvenile intestinal,174900,Autosomal dominant/Juvenile polyposis syndrome,infantile form,174900,Autosomal dominant];				rs7087358	0.5312	0.4586	3760,.		-0.3980			0.00,0.12	5.11							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17), RNU1-19P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	88683122	88683122	T	C	het	off-target	QUAL=5533;DP=615;AF=0.44;MQM=60;SAP=431;ABP=22	BMPR1A	intron	BMPR1A:ENST00000372037:intron_variant:MODIFIER:intron11/12:c.1343-11T>C::	BMPR1A:NM_004329.2:intron_variant:MODIFIER:intron11/12:c.1343-11T>C::		601299 [GENE=BMPR1A PHENOS=Polyposis syndrome,hereditary mixed,2,610069/Polyposis,juvenile intestinal,174900,Autosomal dominant/Juvenile polyposis syndrome,infantile form,174900,Autosomal dominant];	259286 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,Juvenile Polyposis];			rs7074064	0.4966	0.4118	3197,.	0.6705,0.3665,0.7177,0.2576,0.3035	-0.4350			0.00,0.21	5.81		10.64>9.92	0.000/0.004				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	89720907	89720907	T	G	het	off-target	QUAL=251;DP=29;AF=0.52;MQM=60;SAP=36;ABP=3	PTEN	intron	PTEN:ENST00000371953:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::	PTEN:NM_000314.8:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::,PTEN:NM_001304717.5:intron_variant:MODIFIER:intron9/9:c.1545+32T>G::,PTEN:NM_001304718.2:intron_variant:MODIFIER:intron8/8:c.436+32T>G::		601728 [GENE=PTEN PHENOS=Prostate cancer,somatic,176807/Glioma susceptibility 2,613028/Cowden syndrome 1,158350,Autosomal dominant/Lhermitte-Duclos syndrome,158350,Autosomal dominant/Macrocephaly/autism syndrome,605309,Autosomal dominant/Meningioma,607174,Autosomal dominant];	92810 [benign DISEASE=PTEN hamartoma tumor syndrome,not specified];	CS1815672 [CLASS=R MUT=ALT PHEN="Cowden disease" GENE=PTEN];		rs555895	0.4325	0.3859	2350,.	0.4981,0.4574,0.4887,0.3352,0.3088	-0.8620			0.00,0.10	0.42							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AR+AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	104264107	104264107	C	T	hom		QUAL=9982;DP=411;AF=1.00;MQM=60;SAP=895;ABP=0	SUFU	intron	SUFU:ENST00000369899:intron_variant:MODIFIER:intron1/10:c.182+16C>T::,SUFU:ENST00000369902:intron_variant:MODIFIER:intron1/11:c.182+16C>T::,SUFU:ENST00000423559:intron_variant:MODIFIER:intron1/9:c.182+16C>T::	SUFU:NM_001178133.2:intron_variant:MODIFIER:intron1/10:c.182+16C>T::,SUFU:NM_016169.3:intron_variant:MODIFIER:intron1/11:c.182+16C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607035 [GENE=SUFU PHENOS=Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,desmoplastic,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive];	260689 [benign DISEASE=not specified,not provided];			rs2274351	0.3962	0.4757	3507,.	0.3131,0.2994,0.3222,0.5481,0.4885	-0.2610			0.10,0.79	16.75							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTR1A (inh=n/a oe_syn=0.79 oe_mis=0.44 oe_lof=0.13), SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	104356822	104356822	A	G	hom	off-target	QUAL=2286;DP=74;AF=1.00;MQM=60;SAP=3;ABP=0	SUFU	intron	SUFU:ENST00000369899:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:ENST00000369902:intron_variant:MODIFIER:intron6/11:c.757-75A>G::,SUFU:ENST00000423559:intron_variant:MODIFIER:intron6/9:c.757-75A>G::	SUFU:NM_001178133.2:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:NM_016169.3:intron_variant:MODIFIER:intron6/11:c.757-75A>G::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	607035 [GENE=SUFU PHENOS=Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,desmoplastic,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive];				rs10786690		0.9932	15471,.		-0.0750			0.01,0.16	5.88							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	104387019	104387019	T	C	het		QUAL=14824;DP=1197;AF=0.49;MQM=60;SAP=4;ABP=5	SUFU	intron	SUFU:ENST00000369902:intron_variant:MODIFIER:intron11/11:c.1365+19T>C::	SUFU:NM_016169.3:intron_variant:MODIFIER:intron11/11:c.1365+19T>C::		607035 [GENE=SUFU PHENOS=Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,desmoplastic,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive];	260688 [benign DISEASE=not specified,not provided];			rs12414407	0.7196	0.6877	7422,.	0.7545,0.5777,0.7448,0.6474,0.7144	0.2210			0.01,0.32	11.26							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	104389932	104389932	T	G	hom		QUAL=59563;DP=1886;AF=1.00;MQM=60;SAP=4;ABP=0	SUFU	3'UTR	SUFU:ENST00000369902:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::	SUFU:NM_016169.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::		607035 [GENE=SUFU PHENOS=Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,desmoplastic,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive];				rs4917980		0.9995	15632,.	0.9934,0.9994,1.0000,0.9999,1.0000	1.3870			0.07,0.81	16.29							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr11	13102890	13102890	C	A	het	off-target	QUAL=22540;DP=1762;AF=0.50;MQM=60;SAP=3;ABP=3	CTC-497E21.5	intron&non_coding_transcript	CTC-497E21.5:ENST00000531136:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.48-26309G>T::	::intergenic_variant:MODIFIER::::						rs2727397	0.5050	0.5693	5247,.		0.0460			0.06,0.20	5.99							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	13102924	13102924	G	A	het		QUAL=297;DP=26;AF=0.54;MQM=60;SAP=19;ABP=3	CTC-497E21.5	intron&non_coding_transcript	CTC-497E21.5:ENST00000531136:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.48-26343C>T::	::intergenic_variant:MODIFIER::::						rs2583136		0.5695	5253,.		-0.4930			0.00,0.07	2.76							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	64572018	64572018	T	C	hom		QUAL=8197;DP=256;AF=1.00;MQM=60;SAP=23;ABP=0	MEN1	missense	MEN1:ENST00000312049:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:PF05053 [Menin],MEN1:ENST00000315422:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:PF05053 [Menin],MEN1:ENST00000337652:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000377313:missense_variant:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000377316:missense_variant:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala:PF05053 [Menin],MEN1:ENST00000377321:missense_variant:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala:PF05053 [Menin],MEN1:ENST00000377326:missense_variant:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala:PF05053 [Menin],MEN1:ENST00000394374:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000394376:missense_variant:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000443283:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:PF05053 [Menin]	MEN1:NM_000244.3:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_001370251.1:synonymous_variant:LOW:exon11/11:c.1747A>G:p.Ala583=:,MEN1:NM_001370259.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370260.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370261.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370262.1:synonymous_variant:LOW:exon10/10:c.1516A>G:p.Ala506=:,MEN1:NM_001370263.1:synonymous_variant:LOW:exon10/10:c.1516A>G:p.Ala506=:,MEN1:NM_130799.2:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_130800.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130801.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130802.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130803.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130804.2:synonymous_variant:LOW:exon11/11:c.1636A>G:p.Ala546=:	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	613733 [GENE=MEN1 PHENOS=Angiofibroma,somatic/Adrenal adenoma,somatic/Parathyroid adenoma,somatic/Lipoma,somatic/Carcinoid tumor of lung/Multiple endocrine neoplasia 1,131100,Autosomal dominant];	134640 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs2959656	0.8345	0.9374	12830,.	0.7063,0.8813,0.6972,0.9960,0.9949	0.1310	T(0.77),T(0.77),T(0.76),T(0.76),T(0.76),T(0.75),T(0.77),T(0.76),T(0.76),T(0.76)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.01,0.39	11.00	0.30			COSV53639974			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64572557	64572557	A	G	hom		QUAL=6551;DP=203;AF=1.00;MQM=60;SAP=38;ABP=0	MEN1	synonymous,intron	MEN1:ENST00000312049:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000315422:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000337652:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000377313:synonymous_variant:LOW:exon8/9:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000377316:intron_variant:MODIFIER:intron7/7:c.1186-269T>C::,MEN1:ENST00000377321:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:PF05053 [Menin],MEN1:ENST00000377326:synonymous_variant:LOW:exon8/9:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000394374:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000394376:synonymous_variant:LOW:exon10/11:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000443283:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin]	MEN1:NM_000244.3:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_001370251.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:,MEN1:NM_001370259.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370260.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370261.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370262.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:,MEN1:NM_001370263.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:,MEN1:NM_130799.2:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_130800.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130801.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130802.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130803.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130804.2:synonymous_variant:LOW:exon10/11:c.1314T>C:p.His438=:	regulatory_region_variant:CTCF_binding_site	613733 [GENE=MEN1 PHENOS=Angiofibroma,somatic/Adrenal adenoma,somatic/Parathyroid adenoma,somatic/Lipoma,somatic/Carcinoid tumor of lung/Multiple endocrine neoplasia 1,131100,Autosomal dominant];	167288 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs540012		0.9942	15012,.	0.9189,0.9969,0.9999,0.9999,0.9999	-0.3000			0.07,0.89	8.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64577620	64577620	G	C	het	off-target	QUAL=195;DP=33;AF=0.45;MQM=60;SAP=36;ABP=4	MEN1	intron,5'UTR	MEN1:ENST00000312049:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000315422:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000337652:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000377316:5_prime_UTR_variant:MODIFIER:exon1/8:c.-39C>G::,MEN1:ENST00000377321:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000377326:5_prime_UTR_variant:MODIFIER:exon1/9:c.-39C>G::,MEN1:ENST00000394374:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000394376:intron_variant:MODIFIER:intron2/10:c.-23-16C>G::,MEN1:ENST00000443283:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::	MEN1:NM_000244.3:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370251.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:NM_001370259.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370260.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370261.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370262.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370263.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130799.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130800.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130801.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130802.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130803.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130804.2:intron_variant:MODIFIER:intron2/10:c.-23-16C>G::	regulatory_region_variant:promoter	613733 [GENE=MEN1 PHENOS=Angiofibroma,somatic/Adrenal adenoma,somatic/Parathyroid adenoma,somatic/Lipoma,somatic/Carcinoid tumor of lung/Multiple endocrine neoplasia 1,131100,Autosomal dominant];	439889 [benign DISEASE=Multiple endocrine neoplasia, type 1];			rs509606	0.1749	0.1792	259,.	0.1019,0.3013,0.2891,0.1070,0.1944	0.1970			0.06,0.13	2.01		11.39>10.32					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	108100105	108100105	-	T	het	off-target	QUAL=408;DP=47;AF=0.45;MQM=60;SAP=6;ABP=4	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:ENST00000452508:intron_variant:MODIFIER:intron5/63:c.331+69dup::	ATM:NM_000051.3:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron5/63:c.331+69dup::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs11390378		0.4749	2734,.	0.4275,0.4742,0.4678,0.4530,0.4781					1.87							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108100105	108100105	-	TT	het	off-target	QUAL=408;DP=47;AF=0.19;MQM=60;SAP=9;ABP=42	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:ENST00000452508:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::	ATM:NM_000051.3:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs11390378		0.1506	10,.	0.0684,0.1806,0.0881,0.1492,0.1866					1.82							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108114662	108114662	T	-	het	off-target	QUAL=63;DP=137;AF=0.15;MQM=60;SAP=19;ABP=152	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron5/62:c.497-4del::,ATM:ENST00000452508:intron_variant:MODIFIER:intron6/63:c.497-4del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron5/62:c.497-4del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron6/63:c.497-4del::	regulatory_region_variant:promoter_flanking_region	607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	183775 [likely benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs768748099		0.2789	0,.	0.2426,0.2590,0.2417,0.2865,0.3066	-0.2420				0.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108119616	108119616	A	-	het	off-target	QUAL=11;DP=32;AF=0.16;MQM=60;SAP=3;ABP=36	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:ENST00000452508:intron_variant:MODIFIER:intron9/63:c.1066-31del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron9/63:c.1066-31del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			AluSp (SINE/Alu)	rs35813860		0.3562	0,.	0.3045,0.3572,0.3687,0.3577,0.3752	1.5680				1.26							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108129657	108129657	A	G	het	off-target	QUAL=38;DP=16;AF=0.25;MQM=60;SAP=3;ABP=12	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:ENST00000452508:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::	ATM:NM_000051.3:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs672655	0.4764	0.4879	3966,.		1.4540			0.42,0.91	17.36							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108141956	108141957	TT	-	het	off-target	QUAL=340;DP=164;AF=0.17;MQM=60;SAP=3;ABP=157	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::,ATM:ENST00000452508:intron_variant:MODIFIER:intron20/63:c.2922-9_2922-8del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron20/63:c.2922-9_2922-8del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs373881770		0.0153	0,.	0.0103,0.0117,0.0133,0.0156,0.0193	0.1370				3.03							0	40	0 / 20					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108150208	108150208	T	-	het		QUAL=889;DP=98;AF=0.39;MQM=60;SAP=3;ABP=14	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:ENST00000452508:intron_variant:MODIFIER:intron23/63:c.3285-9del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron23/63:c.3285-9del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	181857 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];		(TTTG)n (Simple_repeat)	rs1799757		0.1130	283,.	0.0227,0.0614,0.0063,0.1426,0.0768	0.5990				6.99							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108151707	108151707	-	A	het	off-target	QUAL=1037;DP=76;AF=0.53;MQM=60;SAP=29;ABP=3	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:ENST00000452508:intron_variant:MODIFIER:intron24/63:c.3403-13dup::	ATM:NM_000051.3:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron24/63:c.3403-13dup::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];			rs3218681		0.5603	4494,.	0.4510,0.6113,0.3791,0.5616,0.6142					0.84							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108175394	108175394	T	C	het		QUAL=161;DP=14;AF=0.57;MQM=60;SAP=13;ABP=4	ATM	splice_region&intron	ATM:ENST00000278616:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:ENST00000452508:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::	ATM:NM_000051.3:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:NM_001351834.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	132706 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];			rs3092829	0.0132	0.0225	7,.	0.0057,0.0186,0.0003,0.0333,0.0061	1.1230			0.19,0.32	5.92		10.05>8.69	0.000/0.004				25	1274	5 / 265	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108175462	108175462	G	A	het		QUAL=388;DP=30;AF=0.53;MQM=60;SAP=3;ABP=3	ATM	missense	ATM:ENST00000278616:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:	ATM:NM_000051.3:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:NM_001351834.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	128458 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.0669	0.1136	286,.	0.0227,0.0613,0.0063,0.1435,0.0772	6.3420	T(0.08),T(0.08)	B(0.02),B(0.02)	0.98,0.99	23.40	0.12			COSV53728020			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108183167	108183167	A	G	hom		QUAL=14140;DP=443;AF=1.00;MQM=60;SAP=5;ABP=0	ATM,C11orf65	missense,intron	ATM:ENST00000278616:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser:,ATM:ENST00000452508:missense_variant:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser:,C11orf65:ENST00000525729:intron_variant:MODIFIER:intron6/6:c.641-3369T>C::	ATM:NM_000051.3:synonymous_variant:LOW:exon40/63:c.5948A>G:p.Ser1983=:,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.641-3369T>C::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron8/8:c.*39-3369T>C::,ATM:NM_001351834.2:synonymous_variant:LOW:exon41/64:c.5948A>G:p.Ser1983=:		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	133627 [benign DISEASE=Ataxia-telangiectasia syndrome,not specified];			rs659243	1.0000	1.0000	15702,.	1.0000,1.0000,1.0000,1.0000,1.0000	-1.0580	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.01,0.17	7.88	0.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108225483	108225483	C	T	het	off-target	QUAL=1990;DP=159;AF=0.48;MQM=60;SAP=6;ABP=4	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:ENST00000452508:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:ENST00000525729:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::	ATM:NM_000051.3:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-19464G>A::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:NR_147053.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.2301+159G>A::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs664982		0.5293	4432,.		-1.2540			0.00,0.06	0.82							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108225661	108225661	A	G	het	off-target	QUAL=4410;DP=275;AF=0.58;MQM=60;SAP=3;ABP=19	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:ENST00000452508:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:ENST00000525729:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::	ATM:NM_000051.3:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-19642T>C::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:NR_147053.2:non_coding_transcript_exon_variant:MODIFIER:exon11/13:n.2282T>C::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs664143		0.6053	5780,.		-0.7070			0.00,0.06	0.18							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	125497466	125497466	G	T	het	off-target	QUAL=1071;DP=108;AF=0.49;MQM=60;SAP=118;ABP=3	CHEK1	intron	CHEK1:ENST00000278916:intron_variant:MODIFIER:intron1/10:c.66-36G>T::,CHEK1:ENST00000427383:intron_variant:MODIFIER:intron2/11:c.337+738G>T::,CHEK1:ENST00000428830:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:ENST00000438015:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000524737:intron_variant:MODIFIER:intron1/12:c.66-36G>T::,CHEK1:ENST00000534070:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000544373:intron_variant:MODIFIER:intron2/11:c.66-36G>T::	CHEK1:NM_001114121.2:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:NM_001114122.2:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:NM_001244846.1:intron_variant:MODIFIER:intron2/11:c.66-36G>T::,CHEK1:NM_001274.5:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:NM_001330427.1:intron_variant:MODIFIER:intron2/12:c.337+738G>T::,CHEK1:NM_001330428.1:intron_variant:MODIFIER:intron2/11:c.7+738G>T::,CHEK1:NR_045204.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/11:n.962+738G>T::,CHEK1:NR_045205.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/12:n.500-36G>T::	regulatory_region_variant:promoter					rs491528	0.3530	0.3143	1570,.	0.3758,0.1920,0.4325,0.2944,0.3297	-0.6630			0.04,0.19	2.21							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STT3A (inh=AR oe_syn=0.85 oe_mis=0.50 oe_lof=0.31), CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125514573	125514573	G	A	het	off-target	QUAL=843;DP=107;AF=0.42;MQM=60;SAP=56;ABP=9	CHEK1	intron	CHEK1:ENST00000278916:intron_variant:MODIFIER:intron9/10:c.1101+410G>A::,CHEK1:ENST00000427383:intron_variant:MODIFIER:intron10/11:c.1281+35G>A::,CHEK1:ENST00000428830:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:ENST00000438015:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000524737:intron_variant:MODIFIER:intron10/12:c.1233+35G>A::,CHEK1:ENST00000534070:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000544373:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::	CHEK1:NM_001114121.2:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:NM_001114122.2:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:NM_001244846.1:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::,CHEK1:NM_001274.5:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:NM_001330427.1:intron_variant:MODIFIER:intron10/12:c.1281+35G>A::,CHEK1:NM_001330428.1:intron_variant:MODIFIER:intron10/11:c.951+35G>A::,CHEK1:NR_045204.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/11:n.1906+35G>A::,CHEK1:NR_045205.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1667+35G>A::						rs521102	0.4361	0.5118	3364,.	0.2771,0.6322,0.3877,0.5184,0.5773	0.5840			0.19,0.20	6.74							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125525195	125525195	A	G	hom		QUAL=1971;DP=59;AF=1.00;MQM=60;SAP=11;ABP=0	CHEK1	missense	CHEK1:ENST00000278916:missense_variant:MODERATE:exon11/11:c.1279A>G:p.Ile427Val:,CHEK1:ENST00000427383:missense_variant:MODERATE:exon12/12:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000428830:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000438015:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000524737:missense_variant:MODERATE:exon12/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000534070:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000544373:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:	CHEK1:NM_001114121.2:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:NM_001114122.2:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:NM_001244846.1:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:NM_001274.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:NM_001330427.1:missense_variant:MODERATE:exon12/13:c.1459A>G:p.Ile487Val:,CHEK1:NM_001330428.1:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:,CHEK1:NR_045204.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2084A>G::,CHEK1:NR_045205.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1845A>G::			496139 [benign DISEASE=not provided];			rs506504		0.9771	14990,.	0.9950,0.9844,0.9996,0.9627,0.9798	1.1800	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.13,0.94	14.52	0.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr12	58144665	58144665	C	T	het	off-target	QUAL=1951;DP=162;AF=0.49;MQM=60;SAP=9;ABP=3	CDK4	intron	CDK4:ENST00000257904:intron_variant:MODIFIER:intron4/7:c.522+41G>A::,CDK4:ENST00000312990:intron_variant:MODIFIER:intron3/6:c.265-211G>A::,CDK4:ENST00000540325:intron_variant:MODIFIER:intron3/6:c.162+41G>A::,CDK4:ENST00000549606:intron_variant:MODIFIER:intron1/3:c.-158+1293G>A::	CDK4:NM_000075.4:intron_variant:MODIFIER:intron4/7:c.522+41G>A::		123829 [GENE=CDK4 PHENOS=Melanoma,cutaneous malignant,3,609048,Autosomal dominant];				rs2069502	0.3367	0.3549	1434,.	0.0762,0.3449,0.6368,0.3213,0.4972	1.7630			0.29,0.21	11.87							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=n/a oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr12	58145156	58145156	C	T	het	off-target	QUAL=5467;DP=416;AF=0.58;MQM=60;SAP=223;ABP=24	CDK4	intron	CDK4:ENST00000257904:intron_variant:MODIFIER:intron2/7:c.219-31G>A::,CDK4:ENST00000312990:intron_variant:MODIFIER:intron2/6:c.219-31G>A::,CDK4:ENST00000540325:intron_variant:MODIFIER:intron2/6:c.-7+127G>A::,CDK4:ENST00000549606:intron_variant:MODIFIER:intron1/3:c.-158+802G>A::	CDK4:NM_000075.4:intron_variant:MODIFIER:intron2/7:c.219-31G>A::	regulatory_region_variant:promoter	123829 [GENE=CDK4 PHENOS=Melanoma,cutaneous malignant,3,609048,Autosomal dominant];				rs2270777	0.2480	0.3412	1934,.	0.1614,0.2341,0.1580,0.4355,0.2380	-0.8270			0.03,0.18	8.00							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=n/a oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr13	32890572	32890572	G	A	het	off-target	QUAL=1359;DP=118;AF=0.45;MQM=60;SAP=6;ABP=6	BRCA2	5'UTR	BRCA2:ENST00000380152:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000544455:5_prime_UTR_variant:MODIFIER:exon2/28:c.-26G>A::	BRCA2:NM_000059.3:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::	regulatory_region_variant:promoter	600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	125965 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified];	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2];		rs1799943	0.2093	0.2455	836,.	0.1012,0.1908,0.3746,0.2581,0.2847	0.4990			0.13,0.34	9.31							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZAR1L (inh=n/a oe_syn=0.79 oe_mis=0.65 oe_lof=0.30), BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32903685	32903685	C	T	het	off-target	QUAL=606;DP=44;AF=0.55;MQM=60;SAP=6;ABP=4	BRCA2	intron	BRCA2:ENST00000380152:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000544455:intron_variant:MODIFIER:intron8/27:c.681+56C>T::	BRCA2:NM_000059.3:intron_variant:MODIFIER:intron8/26:c.681+56C>T::		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	126192 [benign DISEASE=Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified];			rs2126042	0.1859	0.2163	773,.		-0.2330			0.04,0.16	6.56							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32905219	32905219	-	T	het	off-target	QUAL=119;DP=106;AF=0.17;MQM=60;SAP=3;ABP=103	BRCA2	intron	BRCA2:ENST00000380152:intron_variant:MODIFIER:intron9/26:c.793+64dup::,BRCA2:ENST00000544455:intron_variant:MODIFIER:intron9/27:c.793+64dup::	BRCA2:NM_000059.3:intron_variant:MODIFIER:intron9/26:c.793+64dup::		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];			AluSx (SINE/Alu)	rs751977993		0.1177	1,.	0.1093,0.1427,0.1201,0.1052,0.1424					0.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32911888	32911888	A	G	het		QUAL=835;DP=75;AF=0.49;MQM=60;SAP=8;ABP=3	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.3396A>G:p.Lys1132=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	126010 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs1801406	0.2668	0.2976	1426,.	0.2282,0.2127,0.3820,0.3086,0.2989	0.2130			0.49,0.90	7.45				COSV66448451			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32913055	32913055	A	G	hom		QUAL=32017;DP=989;AF=1.00;MQM=60;SAP=9;ABP=0	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat],BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat]	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	132779 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs206075		0.9944	15079,.	0.9257,0.9957,0.9999,0.9996,0.9999	0.0710			0.00,0.27	2.65							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32915005	32915005	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60;SAP=15;ABP=0	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.6513G>C:p.Val2171=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:	regulatory_region_variant:promoter_flanking_region	600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	132780 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs206076		0.9942	15085,.	0.9253,0.9956,0.9999,0.9996,0.9999	-0.8750			0.02,0.13	0.11							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32929232	32929232	A	G	het		QUAL=437;DP=38;AF=0.50;MQM=60;SAP=4;ABP=3	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon14/28:c.7242A>G:p.Ser2414=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	126133 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs1799955	0.2326	0.2289	855,.	0.2155,0.1799,0.3820,0.2162,0.2199	0.0900			0.06,0.30	8.15				COSV66447569			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32929387	32929387	T	C	hom		QUAL=19385;DP=598;AF=1.00;MQM=60;SAP=5;ABP=0	BRCA2	missense	BRCA2:ENST00000380152:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000544455:missense_variant:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon14/27:c.7397T>C:p.Ala2466=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	133738 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Ductal breast carcinoma,Breast-ovarian cancer, familial 2,not specified];			rs169547	0.9758	0.9949	15141,.	0.9326,0.9960,0.9999,0.9997,0.9999	2.3520	T(1.00),T(1.00)	B(0.00),B(0.00)	0.00,0.10	11.56	0.09			COSV66451785			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32936646	32936646	T	C	hom	off-target	QUAL=2098;DP=63;AF=1.00;MQM=60;SAP=9;ABP=0	BRCA2	intron	BRCA2:ENST00000380152:intron_variant:MODIFIER:intron16/26:c.7806-14T>C::,BRCA2:ENST00000544455:intron_variant:MODIFIER:intron16/27:c.7806-14T>C::	BRCA2:NM_000059.3:intron_variant:MODIFIER:intron16/26:c.7806-14T>C::	regulatory_region_variant:promoter_flanking_region	600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Somatic mutation,Autosomal dominant/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Somatic mutation,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Somatic mutation,Autosomal dominant/Prostate cancer,176807,Somatic mutation,Autosomal dominant/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	126158 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified];	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2];		rs9534262	0.5316	0.5468	4695,.	0.5695,0.5137,0.5581,0.5175,0.4892	-0.9840			0.02,0.15	9.85		8.33>7.94					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	79766188	79766188	A	G	het		QUAL=10963;DP=825;AF=0.52;MQM=60;SAP=4;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs2988039	0.5066	0.4061	3257,.	0.7074,0.4284,0.7053,0.2530,0.3501	-0.9470			0.00,0.07	2.93							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr14	45606387	45606387	A	G	het		QUAL=593;DP=53;AF=0.47;MQM=60;SAP=5;ABP=3	FANCM	missense	FANCM:ENST00000267430:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000542564:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000556036:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase]	FANCM:NM_001308133.2:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:,FANCM:NM_001308134.1:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:,FANCM:NM_020937.4:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:	regulatory_region_variant:promoter	609644 [GENE=FANCM PHENOS=Spermatogenic failure 28,618086,Autosomal recessive/Premature ovarian failure 15,618096,Autosomal recessive];	241326 [benign DISEASE=Fanconi anemia,not specified];			rs45547534	0.0054	0.0102	3,.	0.0026,0.0066,0.0000,0.0156,0.0102	0.1240	D(0.00),D(0.00),D(0.00)	D(0.94),D(0.97),P(0.78)	0.70,0.96	23.40	0.12						5	440	1 / 96	2	"[2] Ilnaz Sepahi 12-10-2016 batch import"			FKBP3 (inh=n/a oe_syn=1.05 oe_mis=1.00 oe_lof=0.54), FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	68290372	68290372	T	G	het	off-target	QUAL=6800;DP=523;AF=0.50;MQM=60;SAP=4;ABP=3	RAD51B	intron	RAD51B:ENST00000390683:intron_variant:MODIFIER:intron1/9:c.84+28T>G::,RAD51B:ENST00000471583:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487270:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487861:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000488612:intron_variant:MODIFIER:intron2/11:c.84+28T>G::	RAD51B:NM_001321809.1:intron_variant:MODIFIER:intron2/11:c.84+28T>G::,RAD51B:NM_001321810.1:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron1/9:c.84+28T>G::,RAD51B:NM_001321814.1:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron1/9:c.-31+28T>G::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron2/11:c.-372+28T>G::,RAD51B:NM_001321818.1:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321821.1:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_133509.4:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron2/10:c.84+28T>G::						rs17783124	0.2504	0.3208	1634,.	0.3469,0.1965,0.0743,0.3535,0.2331	0.1790			0.00,0.12	4.74							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68301767	68301767	-	A	het	off-target	QUAL=2995;DP=252;AF=0.49;MQM=60;SAP=3;ABP=3	RAD51B	intron	RAD51B:ENST00000390683:intron_variant:MODIFIER:intron2/9:c.199-22dup::,RAD51B:ENST00000471583:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487270:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487861:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000488612:intron_variant:MODIFIER:intron3/11:c.199-22dup::	RAD51B:NM_001321809.1:intron_variant:MODIFIER:intron3/11:c.199-22dup::,RAD51B:NM_001321810.1:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron2/9:c.199-22dup::,RAD51B:NM_001321814.1:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron2/9:c.85-22dup::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron3/11:c.-257-22dup::,RAD51B:NM_001321818.1:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321821.1:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_133509.4:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron3/10:c.199-22dup::						rs34564590		0.3709	2228,.	0.4928,0.2060,0.1445,0.3497,0.2297					3.28							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68331675	68331675	A	T	hom	off-target	QUAL=13443;DP=507;AF=0.97;MQM=60;SAP=915;ABP=0	RAD51B	intron	RAD51B:ENST00000390683:intron_variant:MODIFIER:intron3/9:c.316-45A>T::,RAD51B:ENST00000471583:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487270:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487861:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000488612:intron_variant:MODIFIER:intron4/11:c.316-45A>T::	RAD51B:NM_001321809.1:intron_variant:MODIFIER:intron4/11:c.316-45A>T::,RAD51B:NM_001321810.1:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron3/9:c.316-45A>T::,RAD51B:NM_001321814.1:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron3/9:c.202-45A>T::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron5/11:c.-42-45A>T::,RAD51B:NM_001321818.1:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321821.1:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_133509.4:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron4/10:c.316-45A>T::	regulatory_region_variant:CTCF_binding_site					rs1474939		0.9748	9295,.	0.9538,0.9450,0.9280,0.9804,0.9786	-0.7150			0.00,0.07	2.22							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68944344	68944344	T	-	het	off-target	QUAL=780;DP=387;AF=0.18;MQM=60;SAP=103;ABP=357	RAD51B	intron	RAD51B:ENST00000390683:intron_variant:MODIFIER:intron9/9:c.1036+9390del::,RAD51B:ENST00000471583:intron_variant:MODIFIER:intron10/10:c.1037-8del::,RAD51B:ENST00000487270:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000487861:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000488612:intron_variant:MODIFIER:intron10/11:c.1036+9390del::	RAD51B:NM_001321809.1:intron_variant:MODIFIER:intron10/11:c.1036+9390del::,RAD51B:NM_001321810.1:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron9/9:c.1036+9390del::,RAD51B:NM_001321814.1:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron9/9:c.922+9390del::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron11/11:c.680-8del::,RAD51B:NM_001321818.1:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_001321821.1:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_133509.4:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron10/10:c.1037-8del::	regulatory_region_variant:promoter_flanking_region				(T)n (Simple_repeat)	rs528099287		0.3362	4,.	0.3351,0.3246,0.3069,0.3405,0.3435	-0.6750				0.13							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	104165753	104165753	G	A	het		QUAL=12821;DP=959;AF=0.52;MQM=60;SAP=3;ABP=5	KLC1,XRCC3	intron,missense	KLC1:ENST00000334553:intron_variant:MODIFIER:intron15/16:c.1849-1239G>A::,KLC1:ENST00000348520:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,XRCC3:ENST00000352127:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000445556:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000452929:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,XRCC3:ENST00000553264:missense_variant:MODERATE:exon6/8:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000554280:intron_variant:MODIFIER:intron14/15:c.1755-1239G>A::,XRCC3:ENST00000554913:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000554974:missense_variant:MODERATE:exon2/4:c.107C>T:p.Thr36Met:PF08423 [Rad51],XRCC3:ENST00000555055:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000555836:intron_variant:MODIFIER:intron15/16:c.1822-1239G>A::,KLC1:ENST00000557450:intron_variant:MODIFIER:intron13/14:c.1624-1239G>A::	XRCC3:NM_001100118.2:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:,XRCC3:NM_001100119.2:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,KLC1:NM_001130107.1:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,XRCC3:NM_001371229.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_001371231.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_001371232.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_005432.4:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,KLC1:NM_182923.3:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::	regulatory_region_variant:promoter_flanking_region	600675 [GENE=XRCC3 PHENOS=Melanoma,cutaneous malignant,6,613972/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	8944 [risk factor DISEASE=Cutaneous malignant melanoma 6];	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3];		rs861539	0.2169	0.2931	1480,.	0.2066,0.1733,0.0546,0.3767,0.2435	0.6410	 , ,T(0.17),T(0.17), ,T(0.17), ,T(0.17),T(0.13),T(0.17), , 	 , ,B(0.19),B(0.19), ,B(0.19), ,B(0.19),B(0.19),B(0.19), , 	0.41,0.16	11.96	0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLC1 (inh=n/a oe_syn=1.01 oe_mis=0.52 oe_lof=0.23), XRCC3 (inh=AD oe_syn=1.06 oe_mis=0.92 oe_lof=1.13)
chr14	105242966	105242966	T	C	het	off-target	QUAL=1967;DP=130;AF=0.61;MQM=60;SAP=13;ABP=16	AKT1	intron	AKT1:ENST00000349310:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000402615:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000407796:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000544168:intron_variant:MODIFIER:intron2/11:c.101+30A>G::,AKT1:ENST00000554581:intron_variant:MODIFIER:intron3/12:c.287+30A>G::,AKT1:ENST00000554848:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000555528:intron_variant:MODIFIER:intron4/13:c.287+30A>G::	AKT1:NM_001014431.2:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:NM_001014432.1:intron_variant:MODIFIER:intron5/14:c.286+30A>G::,AKT1:NM_005163.2:intron_variant:MODIFIER:intron4/13:c.287+30A>G::		164730 [GENE=AKT1 PHENOS=Breast cancer,somatic,114480/Cowden syndrome 6,615109/Proteus syndrome,somatic,176920/Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500];				rs2494735	0.5964	0.4863	4108,.	0.7094,0.5849,0.6464,0.3558,0.5358	-3.9800			0.01,0.08	0.12				COSV62573175			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	105258892	105258892	C	T	hom	off-target	QUAL=3635;DP=111;AF=1.00;MQM=60;SAP=15;ABP=0	AKT1	intron	AKT1:ENST00000349310:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000402615:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000407796:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000554581:intron_variant:MODIFIER:intron1/12:c.46+43G>A::,AKT1:ENST00000554848:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000555528:intron_variant:MODIFIER:intron2/13:c.46+43G>A::	AKT1:NM_001014431.2:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:NM_001014432.1:intron_variant:MODIFIER:intron3/14:c.45+43G>A::,AKT1:NM_005163.2:intron_variant:MODIFIER:intron2/13:c.46+43G>A::		164730 [GENE=AKT1 PHENOS=Breast cancer,somatic,114480/Cowden syndrome 6,615109/Proteus syndrome,somatic,176920/Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500];				rs2494748	0.3562	0.5131	4082,.	0.2491,0.4609,0.1970,0.6140,0.4223	-0.6390			0.02,0.26	5.07							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	105258893	105258893	A	G	hom	off-target	QUAL=3635;DP=111;AF=1.00;MQM=60;SAP=15;ABP=0	AKT1	intron	AKT1:ENST00000349310:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000402615:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000407796:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000554581:intron_variant:MODIFIER:intron1/12:c.46+42T>C::,AKT1:ENST00000554848:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000555528:intron_variant:MODIFIER:intron2/13:c.46+42T>C::	AKT1:NM_001014431.2:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:NM_001014432.1:intron_variant:MODIFIER:intron3/14:c.45+42T>C::,AKT1:NM_005163.2:intron_variant:MODIFIER:intron2/13:c.46+42T>C::		164730 [GENE=AKT1 PHENOS=Breast cancer,somatic,114480/Cowden syndrome 6,615109/Proteus syndrome,somatic,176920/Ovarian cancer,somatic,167000/Colorectal cancer,somatic,114500];				rs2494749		0.8754	12229,.	0.8879,0.7063,0.3346,0.9247,0.6897	-1.9390			0.01,0.06	0.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr15	40998342	40998342	T	G	het	off-target	QUAL=1309;DP=99;AF=0.56;MQM=60;SAP=28;ABP=6	RAD51	intron	RAD51:ENST00000267868:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:ENST00000382643:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000423169:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:ENST00000532743:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000557850:intron_variant:MODIFIER:intron3/7:c.225+4943T>G::	RAD51:NM_001164269.2:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:NM_001164270.2:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:NM_002875.5:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:NM_133487.4:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::	regulatory_region_variant:open_chromatin_region	179617 [GENE=RAD51 PHENOS=Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/Mirror movements 2,614508,Autosomal dominant/Fanconi anemia,complementation group R,617244,Autosomal dominant];				rs45457497	0.3542	0.2722	955,.	0.2457,0.5169,0.6746,0.1655,0.2748	1.7890			0.24,0.39	14.28							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	43701947	43701947	A	-	het		QUAL=548;DP=58;AF=0.43;MQM=60;SAP=5;ABP=5	TP53BP1	splice_region&intron	TP53BP1:ENST00000263801:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000382044:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000450115:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::	TP53BP1:NM_001141979.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TP53BP1:NM_001141980.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TUBGCP4:NM_001286414.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:NM_001355001.2:splice_region_variant&intron_variant:LOW:intron25/28:c.2426-8del::,TP53BP1:NM_005657.4:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TUBGCP4:NM_014444.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::						rs56813954		0.3535	751,.	0.1846,0.3650,0.4202,0.3555,0.3896	0.7510				8.12							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43707808	43707808	A	T	het		QUAL=1611;DP=136;AF=0.46;MQM=60;SAP=15;ABP=5	TP53BP1	synonymous	TP53BP1:ENST00000263801:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:ENST00000382039:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:ENST00000382044:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:ENST00000450115:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:	TP53BP1:NM_001141979.3:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:NM_001141980.3:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:NM_001355001.2:synonymous_variant:LOW:exon24/29:c.2193T>A:p.Ser731=:,TP53BP1:NM_005657.4:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:						rs2230451	0.1286	0.1602	429,.	0.1698,0.1011,0.0024,0.1892,0.2102	0.1810			0.62,0.96	10.94							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43720156	43720156	A	-	het	off-target	QUAL=1011;DP=306;AF=0.17;MQM=60;SAP=3;ABP=293	TP53BP1	intron	TP53BP1:ENST00000263801:intron_variant:MODIFIER:intron18/27:c.3813+58del::,TP53BP1:ENST00000382039:intron_variant:MODIFIER:intron18/26:c.3828+58del::,TP53BP1:ENST00000382044:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:ENST00000450115:intron_variant:MODIFIER:intron18/27:c.3828+58del::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron19/28:c.948+58del::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron18/27:c.3813+58del::					AluJb (SINE/Alu)	rs35437737		0.0194	0,.		1.0870				0.12							39	5127	8 / 584					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43720197	43720197	C	T	het	off-target	QUAL=4219;DP=347;AF=0.55;MQM=60;SAP=12;ABP=12	TP53BP1	intron	TP53BP1:ENST00000263801:intron_variant:MODIFIER:intron18/27:c.3813+17G>A::,TP53BP1:ENST00000382039:intron_variant:MODIFIER:intron18/26:c.3828+17G>A::,TP53BP1:ENST00000382044:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::,TP53BP1:ENST00000450115:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron19/28:c.948+17G>A::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron18/27:c.3813+17G>A::						rs550239	0.3804	0.2725	2032,.	0.6560,0.2112,0.4095,0.1105,0.2170	0.2620			0.19,0.24	14.39							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43724646	43724646	T	G	hom		QUAL=20035;DP=634;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	missense	TP53BP1:ENST00000263801:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:ENST00000382039:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000382044:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000450115:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:NM_001355001.2:missense_variant:MODERATE:exon18/29:c.541A>C:p.Lys181Gln:,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:				CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs2602141	0.5264	0.4413	4130,.	0.8589,0.3182,0.4142,0.3018,0.4497	3.2620	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.01,0.91	18.81	0.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43730486	43730486	A	G	het	off-target	QUAL=11474;DP=893;AF=0.50;MQM=60;SAP=4;ABP=3	TP53BP1	intron	TP53BP1:ENST00000263801:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::,TP53BP1:ENST00000382039:intron_variant:MODIFIER:intron16/26:c.3191+36T>C::,TP53BP1:ENST00000382044:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:ENST00000450115:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron17/28:c.311+36T>C::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::						rs16957730	0.1368	0.1668	464,.	0.1956,0.1017,0.0025,0.1893,0.2105	0.8880			0.09,0.15	4.29							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43739686	43739686	-	A	het		QUAL=27;DP=16;AF=0.31;MQM=60;SAP=7;ABP=8	TP53BP1	splice_region&intron	TP53BP1:ENST00000263801:splice_region_variant&intron_variant:LOW:intron12/27:c.2702-4dup::,TP53BP1:ENST00000382039:splice_region_variant&intron_variant:LOW:intron12/26:c.2717-4dup::,TP53BP1:ENST00000382044:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:ENST00000450115:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::	TP53BP1:NM_001141979.3:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:NM_001141980.3:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:NM_001355001.2:splice_region_variant&intron_variant:LOW:intron12/28:c.-313-4dup::,TP53BP1:NM_005657.4:splice_region_variant&intron_variant:LOW:intron12/27:c.2702-4dup::						rs749575788		0.0744	9,.						14.35				COSV55499673			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43748304	43748304	A	G	hom		QUAL=30192;DP=958;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	synonymous	TP53BP1:ENST00000263801:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:ENST00000382039:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000382044:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000450115:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:	TP53BP1:NM_001141979.3:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:NM_001141980.3:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon12/29:c.-528T>C::,TP53BP1:NM_005657.4:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:						rs690367		0.4454	4244,.	0.8732,0.3186,0.4142,0.3016,0.4349	1.1610			0.02,0.13	1.49				COSV55506600			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43762196	43762196	C	T	het		QUAL=3267;DP=207;AF=0.57;MQM=60;SAP=7;ABP=13	TP53BP1	missense	TP53BP1:ENST00000263801:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:ENST00000382039:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000382044:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000450115:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon11/29:c.-1781G>A::,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:				CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1];		rs689647	0.3824	0.2721	2057,.	0.6566,0.2149,0.4114,0.1121,0.2250	1.1390	T(0.09),T(0.09),T(0.09),T(0.09)	B(0.00),B(0.00),B(0.00),B(0.00)	0.20,0.80	18.38	0.07			COSV55506613			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43767774	43767774	G	C	hom		QUAL=3605;DP=116;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	missense	TP53BP1:ENST00000263801:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:ENST00000382039:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000382044:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000450115:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon9/29:c.-1956C>G::,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:				CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs560191		0.4453	4249,.	0.8730,0.3178,0.4140,0.3015,0.4352	0.2260	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.08,0.92	14.95	0.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43773036	43773036	A	C	het	off-target	QUAL=10489;DP=864;AF=0.48;MQM=60;SAP=3;ABP=6	TP53BP1	intron	TP53BP1:ENST00000263801:intron_variant:MODIFIER:intron5/27:c.484+57T>G::,TP53BP1:ENST00000382039:intron_variant:MODIFIER:intron5/26:c.499+57T>G::,TP53BP1:ENST00000382044:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:ENST00000450115:intron_variant:MODIFIER:intron5/27:c.499+57T>G::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron5/28:c.-2531+57T>G::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron5/27:c.484+57T>G::						rs7173383	0.1368	0.1663	458,.		-0.0660			0.04,0.19	2.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43784000	43784000	C	T	hom	off-target	QUAL=26789;DP=851;AF=1.00;MQM=60;SAP=5;ABP=0	TP53BP1	intron	TP53BP1:ENST00000263801:intron_variant:MODIFIER:intron3/27:c.272-49G>A::,TP53BP1:ENST00000382039:intron_variant:MODIFIER:intron3/26:c.287-49G>A::,TP53BP1:ENST00000382044:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:ENST00000450115:intron_variant:MODIFIER:intron3/27:c.287-49G>A::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron3/28:c.-2743-49G>A::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron3/27:c.272-49G>A::						rs555252		0.9870	14717,.	0.8771,0.9942,0.9993,0.9995,0.9683	0.0460			0.00,0.53	8.72							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	75643615	75643615	-	T	het	off-target	QUAL=571;DP=98;AF=0.12;MQM=60;SAP=55;ABP=58	NEIL1	intron	NEIL1:ENST00000355059:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:ENST00000564784:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:ENST00000569035:intron_variant:MODIFIER:intron2/9:c.435-818dup::	NEIL1:NM_001256552.1:intron_variant:MODIFIER:intron2/9:c.693-818dup::,NEIL1:NM_001352519.1:intron_variant:MODIFIER:intron2/5:c.100-8dup::,NEIL1:NM_001352520.2:intron_variant:MODIFIER:intron3/10:c.129-818dup::,NEIL1:NM_024608.4:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:NR_046311.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/10:n.848-818dup::					AluJr (SINE/Alu)	rs11422837		0.3690	1636,.						7.06							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75643616	75643616	T	-	het	off-target	QUAL=571;DP=98;AF=0.24;MQM=58;SAP=21;ABP=124	NEIL1	intron	NEIL1:ENST00000355059:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:ENST00000564784:intron_variant:MODIFIER:intron3/10:c.435-818del::,NEIL1:ENST00000569035:intron_variant:MODIFIER:intron2/9:c.435-818del::	NEIL1:NM_001256552.1:intron_variant:MODIFIER:intron2/9:c.693-818del::,NEIL1:NM_001352519.1:intron_variant:MODIFIER:intron2/5:c.100-8del::,NEIL1:NM_001352520.2:intron_variant:MODIFIER:intron3/10:c.129-818del::,NEIL1:NM_024608.4:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:NR_046311.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/10:n.848-818del::					AluJr (SINE/Alu)	rs11422837		0.0152	1,.		-0.0610				4.22							187	3521	17 / 625					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr16	3639139	3639139	A	G	het		QUAL=1353;DP=101;AF=0.52;MQM=60;SAP=5;ABP=4	SLX4	synonymous	SLX4:ENST00000294008:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:	SLX4:NM_032444.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:		613278 [GENE=SLX4 PHENOS=Fanconi anemia,complementation group P,613951,Autosomal recessive];	262053 [benign DISEASE=Fanconi anemia,not specified];			rs3810812		0.6325	6710,.	0.8780,0.6691,0.7202,0.5133,0.7614	0.7190			0.00,0.15	1.21							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3639230	3639230	G	A	het		QUAL=1429;DP=111;AF=0.50;MQM=60;SAP=3;ABP=3	SLX4	missense	SLX4:ENST00000294008:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:	SLX4:NM_032444.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278 [GENE=SLX4 PHENOS=Fanconi anemia,complementation group P,613951,Autosomal recessive];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	0.3390	T(0.16)	B(0.06)	0.25,0.84	19.12	0.11			COSV53560456	0.0011	0.0935	0	16	0 / 0					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	23615043	23615043	A	-	het	off-target	QUAL=275;DP=187;AF=0.17;MQM=60;SAP=23;ABP=184	PALB2	intron	PALB2:ENST00000261584:intron_variant:MODIFIER:intron12/12:c.3351-53del::	PALB2:NM_024675.4:intron_variant:MODIFIER:intron12/12:c.3351-53del::		610355 [GENE=PALB2 PHENOS=Pancreatic cancer,susceptibility to,3,613348/Fanconi anemia,complementation group N,610832/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];			(A)n (Simple_repeat)	rs35294437		0.4302	104,.	0.4243,0.4254,0.4533,0.4244,0.4502	-0.6060				0.66				COSV55163224			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23625463	23625463	A	T	hom	off-target	QUAL=1216;DP=38;AF=1.00;MQM=60;SAP=18;ABP=0	PALB2,CTD-2196E14.3	intron,intron&non_coding_transcript	PALB2:ENST00000261584:intron_variant:MODIFIER:intron10/12:c.3114-51T>A::,CTD-2196E14.3:ENST00000561764:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.186-3458A>T::	PALB2:NM_024675.4:intron_variant:MODIFIER:intron10/12:c.3114-51T>A::		610355 [GENE=PALB2 PHENOS=Pancreatic cancer,susceptibility to,3,613348/Fanconi anemia,complementation group N,610832/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	126714 [likely benign DISEASE=Familial cancer of breast];			rs249936	0.9968	1.0000	15704,.	1.0000,1.0000,0.9998,1.0000,0.9861	0.7540			0.00,0.09	8.72							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23640467	23640467	G	A	het	off-target	QUAL=255;DP=23;AF=0.48;MQM=60;SAP=13;ABP=3	PALB2	intron	PALB2:ENST00000261584:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::	PALB2:NM_024675.4:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::		610355 [GENE=PALB2 PHENOS=Pancreatic cancer,susceptibility to,3,613348/Fanconi anemia,complementation group N,610832/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant];	126663 [benign DISEASE=Familial cancer of breast];			rs249954	0.3500	0.3106	1608,.		0.3280			0.00,0.08	5.91							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	68771341	68771343	TCT	-	het		QUAL=577;DP=134;AF=0.33;MQM=60;SAP=99;ABP=37	CDH1	inframe_deletion	CDH1:ENST00000261769:inframe_deletion:MODERATE:exon1/16:c.23_25del:p.Leu8_Ser9delinsPro:,CDH1:ENST00000422392:inframe_deletion:MODERATE:exon1/15:c.23_25del:p.Leu8_Ser9delinsPro:	CDH1:NM_001317184.2:inframe_deletion:MODERATE:exon1/15:c.23_25del:p.Leu8_Ser9delinsPro:,CDH1:NM_001317185.2:5_prime_UTR_variant:MODIFIER:exon1/16:c.-1593_-1591del::,CDH1:NM_001317186.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-1797_-1795del::,CDH1:NM_004360.5:inframe_deletion:MODERATE:exon1/16:c.23_25del:p.Leu8_Ser9delinsPro:	regulatory_region_variant:promoter	192090 [GENE=CDH1 PHENOS=Endometrial carcinoma,somatic,608089/Prostate cancer,susceptibility to,176807,Somatic mutation,Autosomal dominant/Blepharocheilodontic syndrome 1,119580,Autosomal dominant/Gastric cancer,hereditary diffuse,with or without cleft lip and/or palate,137215,Autosomal dominant/Breast cancer,lobular,114480,Somatic mutation,Autosomal dominant/Ovarian cancer,somatic,167000];									0.1880									-0.0347	0.2606	0	45	0 / 0					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68771372	68771372	C	T	hom		QUAL=4018;DP=128;AF=0.99;MQM=60;SAP=3;ABP=0	CDH1	splice_region&intron	CDH1:ENST00000261769:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::,CDH1:ENST00000422392:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::	CDH1:NM_001317184.2:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::,CDH1:NM_001317185.2:splice_region_variant&intron_variant:LOW:intron1/15:c.-1568+6C>T::,CDH1:NM_001317186.2:splice_region_variant&intron_variant:LOW:intron1/14:c.-1772+6C>T::,CDH1:NM_004360.5:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::	regulatory_region_variant:promoter	192090 [GENE=CDH1 PHENOS=Endometrial carcinoma,somatic,608089/Prostate cancer,susceptibility to,176807,Somatic mutation,Autosomal dominant/Blepharocheilodontic syndrome 1,119580,Autosomal dominant/Gastric cancer,hereditary diffuse,with or without cleft lip and/or palate,137215,Autosomal dominant/Breast cancer,lobular,114480,Somatic mutation,Autosomal dominant/Ovarian cancer,somatic,167000];	136692 [benign DISEASE=Hereditary cancer-predisposing syndrome,Hereditary diffuse gastric cancer,not specified];			rs3743674	0.7634	0.8161	10198,.	0.6465,0.7409,0.7648,0.8784,0.7780	-0.1880			0.00,0.15	6.29		8.63>8.16	0.000/0.032				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68771418	68771418	-	GCCCCAGCCCCGT	hom	off-target	QUAL=2378;DP=85;AF=0.99;MQM=60;SAP=3;ABP=0	CDH1	intron	CDH1:ENST00000261769:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:ENST00000422392:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::	CDH1:NM_001317184.2:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:NM_001317185.2:intron_variant:MODIFIER:intron1/15:c.-1568+62_-1568+63insCGTGCCCCAGCCC::,CDH1:NM_001317186.2:intron_variant:MODIFIER:intron1/14:c.-1772+62_-1772+63insCGTGCCCCAGCCC::,CDH1:NM_004360.5:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::	regulatory_region_variant:promoter	192090 [GENE=CDH1 PHENOS=Endometrial carcinoma,somatic,608089/Prostate cancer,susceptibility to,176807,Somatic mutation,Autosomal dominant/Blepharocheilodontic syndrome 1,119580,Autosomal dominant/Gastric cancer,hereditary diffuse,with or without cleft lip and/or palate,137215,Autosomal dominant/Breast cancer,lobular,114480,Somatic mutation,Autosomal dominant/Ovarian cancer,somatic,167000];				rs45625236		0.8107	9714,.	0.6400,0.7363,0.7605,0.8698,0.7752					8.68							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), RNA5SP429 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68857441	68857441	T	C	het		QUAL=14799;DP=1140;AF=0.52;MQM=60;SAP=3;ABP=9	CDH1	synonymous	CDH1:ENST00000261769:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:,CDH1:ENST00000422392:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:	CDH1:NM_001317184.2:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:,CDH1:NM_001317185.2:synonymous_variant:LOW:exon13/16:c.528T>C:p.Ala176=:,CDH1:NM_001317186.2:synonymous_variant:LOW:exon12/15:c.111T>C:p.Ala37=:,CDH1:NM_004360.5:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:	regulatory_region_variant:TF_binding_site,TF_binding_site_variant	192090 [GENE=CDH1 PHENOS=Endometrial carcinoma,somatic,608089/Prostate cancer,susceptibility to,176807,Somatic mutation,Autosomal dominant/Blepharocheilodontic syndrome 1,119580,Autosomal dominant/Gastric cancer,hereditary diffuse,with or without cleft lip and/or palate,137215,Autosomal dominant/Breast cancer,lobular,114480,Somatic mutation,Autosomal dominant/Ovarian cancer,somatic,167000];	142770 [benign DISEASE=Hereditary cancer-predisposing syndrome,Hereditary diffuse gastric cancer,not specified];	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1];		rs1801552	0.7187	0.6957	7780,.	0.8906,0.6658,0.6503,0.6253,0.6535	-0.0840			0.00,0.10	5.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	81816733	81816733	C	T	het		QUAL=4998;DP=430;AF=0.51;MQM=60;SAP=291;ABP=3	PLCG2	intron	PLCG2:ENST00000359376:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::	PLCG2:NM_002661.5:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::		600220 [GENE=PLCG2 PHENOS=Familial cold autoinflammatory syndrome 3,614468,Autosomal dominant/Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878,Autosomal dominant];				rs8045964	0.4241	0.4282	2839,.	0.3924,0.3658,0.2790,0.4221,0.6311	-0.4270			0.00,0.10	1.77							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81816787	81816787	T	A	hom	off-target	QUAL=24059;DP=746;AF=1.00;MQM=60;SAP=3;ABP=0	PLCG2	intron	PLCG2:ENST00000359376:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::	PLCG2:NM_002661.5:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::		600220 [GENE=PLCG2 PHENOS=Familial cold autoinflammatory syndrome 3,614468,Autosomal dominant/Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878,Autosomal dominant];				rs4476171		0.9994	15680,.		-1.8260			0.01,0.14	1.15							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	89805261	89805261	A	G	hom	off-target	QUAL=17997;DP=573;AF=1.00;MQM=60;SAP=3;ABP=0	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:ENST00000389301:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,ZNF276:NM_001113525.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::,ZNF276:NM_152287.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,ZNF276:NR_110122.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2607A>G::,ZNF276:NR_110126.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2490A>G::,ZNF276:NR_110128.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2430A>G::,ZNF276:NR_110129.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2524A>G::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255266 [benign DISEASE=not specified];			rs1800359		0.7253	8640,.	0.9362,0.7857,0.9868,0.5909,0.8015	-3.5420			0.12,0.14	3.17							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89805977	89805977	G	A	het	off-target	QUAL=2213;DP=181;AF=0.48;MQM=60;SAP=10;ABP=4	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:ENST00000389301:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::,ZNF276:NM_001113525.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::,ZNF276:NM_152287.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,ZNF276:NR_110122.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3323G>A::,ZNF276:NR_110126.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3206G>A::,ZNF276:NR_110128.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3146G>A::,ZNF276:NR_110129.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3240G>A::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255264 [benign DISEASE=not specified];			rs1061646	0.5381	0.4245	2844,.	0.5457,0.6134,0.7247,0.2933,0.4714	0.8660			0.27,0.27	7.01		8.17>8.42					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89806347	89806347	A	T	het	off-target	QUAL=879;DP=48;AF=0.71;MQM=60;SAP=3;ABP=21	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:ENST00000389301:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,ZNF276:NM_001113525.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,ZNF276:NM_152287.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,ZNF276:NR_110122.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3693A>T::,ZNF276:NR_110126.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3576A>T::,ZNF276:NR_110129.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3610A>T::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	135541 [not provided DISEASE=not specified];			rs7195906	0.7065	0.5452	5198,.	0.7747,0.6672,0.9831,0.3801,0.5897	-0.5840			0.02,0.13	3.68				COSV57065786			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89815217	89815217	C	T	het	off-target	QUAL=1916;DP=156;AF=0.51;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255254 [benign DISEASE=not specified];	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs1800345	0.5449	0.4279	2870,.	0.5555,0.6309,0.7528,0.2993,0.4786	-0.7250			0.03,0.14	1.40							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89818491	89818491	T	C	het	off-target	QUAL=9384;DP=751;AF=0.49;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];				rs3743860	0.5865	0.4722	3633,.		-0.1670			0.01,0.10	3.73							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89831510	89831510	C	A	het	off-target	QUAL=11999;DP=972;AF=0.48;MQM=60;SAP=4;ABP=6	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::	regulatory_region_variant:promoter	607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255248 [benign DISEASE=not specified];			rs2159116	0.0933	0.1454	288,.	0.0354,0.0997,0.0033,0.1836,0.1863	-3.3830			0.08,0.16	0.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89836323	89836323	C	T	het		QUAL=829;DP=95;AF=0.40;MQM=60;SAP=14;ABP=11	FANCA	missense	FANCA:ENST00000389301:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000568369:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:	FANCA:NM_000135.4:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	134254 [benign DISEASE=Fanconi anemia,not specified];	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA];		rs7195066	0.6667	0.4729	4050,.	0.6757,0.6527,0.9854,0.3093,0.5889	0.3050	T(0.31),T(0.31)	B(0.00),B(0.00)	0.02,0.14	12.82	0.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89838078	89838078	A	G	het		QUAL=12928;DP=1057;AF=0.49;MQM=60;SAP=3;ABP=5	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000568369:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::	FANCA:NM_000135.4:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:NM_001286167.3:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255245 [benign DISEASE=Fanconi anemia,not specified];			rs1800340	0.5599	0.4376	2827,.	0.5199,0.6353,0.7430,0.3035,0.5709	-0.8300			0.02,0.11	0.12			0.000/0.000				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89845194	89845194	A	G	het	off-target	QUAL=6231;DP=616;AF=0.53;MQM=60;SAP=696;ABP=8	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255241 [benign DISEASE=Fanconi anemia,not specified];			rs1800337		0.5203	4625,.	0.6912,0.6621,0.9843,0.3806,0.5917	-1.4990			0.00,0.10	2.64							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89849480	89849480	C	T	hom		QUAL=6739;DP=202;AF=1.00;MQM=60;SAP=83;ABP=0	FANCA	missense	FANCA:ENST00000389301:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:,FANCA:ENST00000568369:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:	FANCA:NM_000135.4:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	134244 [benign DISEASE=Fanconi anemia,not specified];	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs2239359	0.6240	0.5205	4551,.	0.6922,0.6207,0.8561,0.3908,0.4927	-0.0380	T(1.00),T(1.00)	B(0.00),B(0.00)	0.02,0.16	0.03	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89857964	89857964	T	C	het	off-target	QUAL=14549;DP=1042;AF=0.53;MQM=60;SAP=4;ABP=11	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255232 [benign DISEASE=not specified];			rs1800330	0.5719	0.4408	2990,.	0.5601,0.6379,0.7532,0.3041,0.5673	-4.9640			0.00,0.07	0.66		4.71>4.86					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89858505	89858505	T	C	het	off-target	QUAL=4331;DP=304;AF=0.51;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255229 [benign DISEASE=not specified];			rs6500452	0.5317	0.4185	2687,.	0.5151,0.6311,0.7490,0.2939,0.4777	-1.3030			0.02,0.12	1.15							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89858525	89858525	C	G	het	off-target	QUAL=4358;DP=307;AF=0.51;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255230 [benign DISEASE=not specified];			rs1800287		0.5415	5109,.	0.7636,0.6651,0.9842,0.3815,0.5884	-0.2040			0.01,0.14	1.93							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89859008	89859008	G	A	het	off-target	QUAL=948;DP=102;AF=0.41;MQM=60;SAP=24;ABP=10	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];				rs3856	0.5302	0.3997	2588,.		0.5740			0.33,0.28	5.18							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89859016	89859016	T	-	het	off-target	QUAL=876;DP=104;AF=0.39;MQM=60;SAP=22;ABP=13	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron11/42:c.1007-61del::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron11/42:c.1007-61del::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];				rs35617323		0.4849	3908,.		0.7490				1.52							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89866043	89866043	T	C	het		QUAL=9341;DP=729;AF=0.49;MQM=60;SAP=3;ABP=3	FANCA	missense	FANCA:ENST00000389301:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:ENST00000389302:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:ENST00000534992:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:ENST00000543736:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:,FANCA:ENST00000563673:missense_variant:MODERATE:exon9/10:c.796A>G:p.Thr266Ala:,FANCA:ENST00000568369:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:	FANCA:NM_000135.4:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:NM_001018112.3:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:NM_001351830.2:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	134294 [benign DISEASE=Fanconi anemia,not specified];	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs7190823	0.6905	0.5318	4872,.	0.7249,0.6678,0.9844,0.3847,0.5899	0.4020	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.25	5.62	0.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89869761	89869761	T	C	hom	off-target	QUAL=3848;DP=114;AF=1.00;MQM=60;SAP=3;ABP=0	FANCA	intron	FANCA:ENST00000389301:intron_variant:MODIFIER:intron7/42:c.710-12A>G::,FANCA:ENST00000389302:intron_variant:MODIFIER:intron7/10:c.710-12A>G::,FANCA:ENST00000534992:intron_variant:MODIFIER:intron7/10:c.710-12A>G::,FANCA:ENST00000543736:intron_variant:MODIFIER:intron6/9:c.614-12A>G::,FANCA:ENST00000563673:intron_variant:MODIFIER:intron7/9:c.710-12A>G::,FANCA:ENST00000568369:intron_variant:MODIFIER:intron7/42:c.710-12A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron7/42:c.710-12A>G::,FANCA:NM_001018112.3:intron_variant:MODIFIER:intron7/10:c.710-12A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron7/42:c.710-12A>G::,FANCA:NM_001351830.2:intron_variant:MODIFIER:intron6/9:c.614-12A>G::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255269 [benign DISEASE=Fanconi anemia,not specified];			rs1800286		0.7215	8510,.	0.9231,0.7825,0.9887,0.5904,0.7959	-1.9650			0.01,0.11	12.17		9.13>9.77	0.000/0.040				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr17	7572980	7572980	T	G	het		QUAL=154;DP=216;AF=0.35;MQM=60;SAP=168;ABP=44	TP53	missense,intron,3'UTR	TP53:ENST00000269305:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:ENST00000359597:intron_variant:MODIFIER:intron8/8:c.994-3418A>C::,TP53:ENST00000413465:intron_variant:MODIFIER:intron6/6:c.782+4519A>C::,TP53:ENST00000420246:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:ENST00000445888:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:ENST00000455263:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::	TP53:NM_000546.5:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:NM_001126112.2:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:NM_001126113.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:NM_001126114.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:NM_001126115.1:missense_variant:MODERATE:exon7/7:c.733A>C:p.Thr245Pro:,TP53:NM_001126116.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:NM_001126117.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:NM_001126118.1:missense_variant:MODERATE:exon10/10:c.1012A>C:p.Thr338Pro:,TP53:NM_001276695.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:NM_001276696.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:NM_001276697.2:missense_variant:MODERATE:exon7/7:c.652A>C:p.Thr218Pro:,TP53:NM_001276698.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:NM_001276699.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:NM_001276760.2:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:,TP53:NM_001276761.2:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:		191170 [GENE=TP53 PHENOS=Adrenocortical carcinoma,pediatric,202300,Autosomal dominant/Glioma susceptibility 1,137800,Somatic mutation,Autosomal dominant/Basal cell carcinoma 7,614740,Autosomal dominant/Bone marrow failure syndrome 5,618165,Autosomal dominant/Colorectal cancer,114500,Somatic mutation,Autosomal dominant/Nasopharyngeal carcinoma,somatic,607107/Breast cancer,somatic,114480/Osteosarcoma,259500,Somatic mutation/Choroid plexus papilloma,260500,Autosomal dominant/Li-Fraumeni syndrome,151623,Autosomal dominant/Hepatocellular carcinoma,somatic,114550/Pancreatic cancer,somatic,260350];				rs774269719		0.0003	0,.	0.0005,0.0000,0.0001,0.0004,0.0002	0.4640	T(0.29), , , ,T(0.29), 	B(0.01), , , ,B(0.01), 	0.64,0.95	19.24	0.35				-0.1083	0.9312	0	130	0 / 0					TP53 (inh=AR+AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7576477	7576477	G	A	het	off-target	QUAL=21;DP=4;AF=0.75;MQM=60;SAP=10;ABP=5	TP53	intron	TP53:ENST00000269305:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:ENST00000359597:intron_variant:MODIFIER:intron8/8:c.993+376C>T::,TP53:ENST00000413465:intron_variant:MODIFIER:intron6/6:c.782+1022C>T::,TP53:ENST00000420246:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:ENST00000445888:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:ENST00000455263:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::	TP53:NM_000546.5:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:NM_001126112.2:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:NM_001126113.2:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:NM_001126114.2:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:NM_001126115.1:intron_variant:MODIFIER:intron5/6:c.597+376C>T::,TP53:NM_001126116.1:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:NM_001126117.1:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:NM_001126118.1:intron_variant:MODIFIER:intron8/9:c.876+376C>T::,TP53:NM_001276695.2:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:NM_001276696.2:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:NM_001276697.2:intron_variant:MODIFIER:intron5/6:c.516+376C>T::,TP53:NM_001276698.2:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:NM_001276699.2:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:NM_001276760.2:intron_variant:MODIFIER:intron9/10:c.876+376C>T::,TP53:NM_001276761.2:intron_variant:MODIFIER:intron9/10:c.876+376C>T::	regulatory_region_variant:promoter_flanking_region	191170 [GENE=TP53 PHENOS=Adrenocortical carcinoma,pediatric,202300,Autosomal dominant/Glioma susceptibility 1,137800,Somatic mutation,Autosomal dominant/Basal cell carcinoma 7,614740,Autosomal dominant/Bone marrow failure syndrome 5,618165,Autosomal dominant/Colorectal cancer,114500,Somatic mutation,Autosomal dominant/Nasopharyngeal carcinoma,somatic,607107/Breast cancer,somatic,114480/Osteosarcoma,259500,Somatic mutation/Choroid plexus papilloma,260500,Autosomal dominant/Li-Fraumeni syndrome,151623,Autosomal dominant/Hepatocellular carcinoma,somatic,114550/Pancreatic cancer,somatic,260350];			Tigger5b (DNA/TcMar-Tigger)						1.0970			0.28,0.16	6.19					0.0532	0.5803	19	110	0 / 0					TP53 (inh=AR+AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7579472	7579472	G	C	het		QUAL=7653;DP=570;AF=0.54;MQM=60;SAP=4;ABP=10	TP53	missense	TP53:ENST00000269305:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000359597:missense_variant:MODERATE:exon3/9:c.215C>G:p.Pro72Arg:,TP53:ENST00000413465:missense_variant:MODERATE:exon3/7:c.215C>G:p.Pro72Arg:,TP53:ENST00000420246:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000445888:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000455263:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:	TP53:NM_000546.5:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:NM_001126112.2:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:NM_001126113.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:NM_001126114.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:NM_001126118.1:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:NM_001276695.2:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:NM_001276696.2:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:NM_001276760.2:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:NM_001276761.2:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:		191170 [GENE=TP53 PHENOS=Adrenocortical carcinoma,pediatric,202300,Autosomal dominant/Glioma susceptibility 1,137800,Somatic mutation,Autosomal dominant/Basal cell carcinoma 7,614740,Autosomal dominant/Bone marrow failure syndrome 5,618165,Autosomal dominant/Colorectal cancer,114500,Somatic mutation,Autosomal dominant/Nasopharyngeal carcinoma,somatic,607107/Breast cancer,somatic,114480/Osteosarcoma,259500,Somatic mutation/Choroid plexus papilloma,260500,Autosomal dominant/Li-Fraumeni syndrome,151623,Autosomal dominant/Hepatocellular carcinoma,somatic,114550/Pancreatic cancer,somatic,260350];	12351 [drug response DISEASE=CODON 72 POLYMORPHISM,Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not specified,antineoplastic agents response - Efficacy, Toxicity/ADR,cisplatin response - Efficacy, Toxicity/ADR,cyclophosphamide response - Efficacy, Toxicity/ADR,fluorouracil response - Efficacy, Toxicity/ADR,paclitaxel response - Efficacy, Toxicity/ADR,not provided];			rs1042522		0.6682	6369,.	0.3799,0.7145,0.5700,0.7378,0.5002	1.0160	T(0.57),T(0.36),T(0.24),T(0.26),T(0.57),T(0.37)	B(0.05),B(0.35),B(0.37),B(0.13),B(0.05),B(0.15)	0.36,0.50	9.18	0.37			COSV52666208,COSV53098660			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahpohla1 15.04.2019"			TP53 (inh=AR+AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7579644	7579659	CCCCAGCCCTCCAGGT	-	het	off-target	QUAL=134;DP=20;AF=0.50;MQM=60;SAP=17;ABP=3	TP53	intron	TP53:ENST00000269305:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000359597:intron_variant:MODIFIER:intron2/8:c.96+41_97-54del::,TP53:ENST00000413465:intron_variant:MODIFIER:intron2/6:c.96+41_97-54del::,TP53:ENST00000420246:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000445888:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000455263:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::	TP53:NM_000546.5:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:NM_001126112.2:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:NM_001126113.2:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:NM_001126114.2:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:NM_001126118.1:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:NM_001276695.2:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:NM_001276696.2:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:NM_001276760.2:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:NM_001276761.2:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::		191170 [GENE=TP53 PHENOS=Adrenocortical carcinoma,pediatric,202300,Autosomal dominant/Glioma susceptibility 1,137800,Somatic mutation,Autosomal dominant/Basal cell carcinoma 7,614740,Autosomal dominant/Bone marrow failure syndrome 5,618165,Autosomal dominant/Colorectal cancer,114500,Somatic mutation,Autosomal dominant/Nasopharyngeal carcinoma,somatic,607107/Breast cancer,somatic,114480/Osteosarcoma,259500,Somatic mutation/Choroid plexus papilloma,260500,Autosomal dominant/Li-Fraumeni syndrome,151623,Autosomal dominant/Hepatocellular carcinoma,somatic,114550/Pancreatic cancer,somatic,260350];	440349 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs59758982		0.8235	10564,.		1.4060				4.99							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AR+AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	29553485	29553485	G	A	hom		QUAL=2514;DP=83;AF=1.00;MQM=60;SAP=25;ABP=0	NF1	synonymous	NF1:ENST00000356175:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:ENST00000358273:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:	NF1:NM_000267.3:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:NM_001042492.3:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:	regulatory_region_variant:promoter_flanking_region	613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];	183826 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Neurofibromatosis, type 1,Cafe-au-lait macules with pulmonary stenosis,Neurofibromatosis, familial spinal,Neurofibromatosis-Noonan syndrome,not specified,not provided];			rs2285892	0.4968	0.4348	3349,.	0.6830,0.4940,0.5192,0.3012,0.3700	-1.2980			0.04,0.37	5.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	29559061	29559061	-	T	het	off-target	QUAL=512;DP=117;AF=0.22;MQM=60;SAP=15;ABP=81	NF1	intron	NF1:ENST00000356175:intron_variant:MODIFIER:intron24/56:c.3198-4dup::,NF1:ENST00000358273:intron_variant:MODIFIER:intron24/57:c.3198-4dup::	NF1:NM_000267.3:intron_variant:MODIFIER:intron24/56:c.3198-4dup::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron24/57:c.3198-4dup::		613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];	803349 [benign DISEASE=Neurofibromatosis, type 1];		(T)n (Simple_repeat)	rs371047262		0.1950	789,.	0.1409,0.2117,0.2402,0.0924,0.0980					5.65							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	29559932	29559932	C	A	hom	off-target	QUAL=1030;DP=35;AF=1.00;MQM=60;SAP=71;ABP=0	NF1	intron	NF1:ENST00000356175:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:ENST00000358273:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::	NF1:NM_000267.3:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::		613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];	257285 [benign DISEASE=not specified];			rs2066736	0.4581	0.4109	2908,.	0.6156,0.4861,0.4375,0.2999,0.3653	0.1440			0.12,0.18	2.36				COSV62196981			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	29563073	29563073	-	TG	hom	off-target	QUAL=9290;DP=402;AF=0.91;MQM=60;SAP=505;ABP=0	NF1	intron	NF1:ENST00000356175:intron_variant:MODIFIER:intron29/56:c.3974+36_3974+37dup::,NF1:ENST00000358273:intron_variant:MODIFIER:intron29/57:c.3974+36_3974+37dup::	NF1:NM_000267.3:intron_variant:MODIFIER:intron29/56:c.3974+36_3974+37dup::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron29/57:c.3974+36_3974+37dup::		613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];			(T)n (Simple_repeat)	rs1555615581		0.0012	0,.	0.0048,0.0016,0.0008,0.0003,0.0011					0.10					-0.1072	0.4329	572	8128	79 / 1468					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	29563085	29563085	T	G	hom	off-target	QUAL=10229;DP=371;AF=0.99;MQM=60;SAP=508;ABP=0	NF1	intron	NF1:ENST00000356175:intron_variant:MODIFIER:intron29/56:c.3974+46T>G::,NF1:ENST00000358273:intron_variant:MODIFIER:intron29/57:c.3974+46T>G::	NF1:NM_000267.3:intron_variant:MODIFIER:intron29/56:c.3974+46T>G::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron29/57:c.3974+46T>G::		613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];			(T)n (Simple_repeat)	rs72813695		0.0120	1,.	0.0289,0.0160,0.0175,0.0083,0.0099	0.4190			0.03,0.20	0.56							50	810	3 / 75					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	29663625	29663625	-	A	hom	off-target	QUAL=833;DP=40;AF=0.78;MQM=60;SAP=47;ABP=0	NF1	intron	NF1:ENST00000356175:intron_variant:MODIFIER:intron40/56:c.6085-17dup::,NF1:ENST00000358273:intron_variant:MODIFIER:intron41/57:c.6148-17dup::	NF1:NM_000267.3:intron_variant:MODIFIER:intron40/56:c.6085-17dup::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron41/57:c.6148-17dup::		613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];	495785 [benign DISEASE=not provided];			rs33925668		0.3375	1723,.	0.3519,0.3449,0.3132,0.2280,0.2049					0.65				COSV62216701			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	29670190	29670190	C	G	hom	off-target	QUAL=5223;DP=163;AF=1.00;MQM=60;SAP=3;ABP=0	NF1	intron	NF1:ENST00000356175:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:ENST00000358273:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::,NF1:ENST00000417592:intron_variant:MODIFIER:intron3/10:c.328+37C>G::,NF1:ENST00000444181:intron_variant:MODIFIER:intron5/16:c.568+37C>G::	NF1:NM_000267.3:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::		613113 [GENE=NF1 PHENOS=Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Somatic mutation,Autosomal dominant/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Watson syndrome,193520,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant];	257300 [benign DISEASE=not specified,not provided];			rs7405740	0.8738	0.9074	12438,.	0.7987,0.8870,0.8808,0.9149,0.9485	-1.4310			0.00,0.07	3.38							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22), AK4P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	33433487	33433487	C	T	hom		QUAL=2531;DP=85;AF=1.00;MQM=60;SAP=46;ABP=0	RAD51D,RAD51L3-RFFL	missense	RAD51D:ENST00000335858:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:PF08423 [Rad51],RAD51D:ENST00000345365:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000360276:missense_variant:MODERATE:exon5/9:c.359G>A:p.Arg120Gln:,RAD51D:ENST00000394589:missense_variant:MODERATE:exon7/11:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000460118:missense_variant:MODERATE:exon5/9:c.137G>A:p.Arg46Gln:PF08423 [Rad51],RAD51D:ENST00000590016:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:PF13481 [AAA domain],RAD51L3-RFFL:ENST00000593039:missense_variant:MODERATE:exon2/7:c.17G>A:p.Arg6Gln:	RAD51D:NM_001142571.2:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:,RAD51D:NM_002878.3:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:,RAD51D:NM_133629.3:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:,RAD51D:NR_037711.2:non_coding_transcript_exon_variant:MODIFIER:exon5/9:n.520G>A::,RAD51D:NR_037712.2:non_coding_transcript_exon_variant:MODIFIER:exon4/8:n.385G>A::,RAD51L3-RFFL:NR_037714.1:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.246G>A::		602954 [GENE=RAD51D PHENOS=Breast-ovarian cancer,familial,susceptibility to,4,614291];	142159 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 4,not specified,Breast and Ovarian Cancer Susceptibility];	CM172631 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=RAD51D];		rs4796033	0.0951	0.1555	303,.	0.0296,0.2950,0.0455,0.1414,0.1630	1.3250	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.01),B(0.00)	0.04,0.89	15.73	0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 08.05.2018: AF 15% in gnomAD und ExAC"			RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	33445549	33445549	G	A	het		QUAL=1656;DP=131;AF=0.55;MQM=60;SAP=7;ABP=6	RAD51D,RAD51L3-RFFL	intron,synonymous,5'UTR	RAD51D:ENST00000335858:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000345365:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000357906:synonymous_variant:LOW:exon3/4:c.234C>T:p.Ser78=:,RAD51D:ENST00000360276:synonymous_variant:LOW:exon3/9:c.234C>T:p.Ser78=:,RAD51D:ENST00000394589:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000460118:5_prime_UTR_variant:MODIFIER:exon3/9:c.-42C>T::,RAD51D:ENST00000590016:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51L3-RFFL:ENST00000593039:intron_variant:MODIFIER:intron1/6:c.3+2761C>T::	RAD51D:NM_001142571.2:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:NM_002878.3:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:,RAD51D:NM_133629.3:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:NR_037711.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.289+581C>T::,RAD51D:NR_037712.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.289+581C>T::,RAD51L3-RFFL:NR_037714.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.232+2761C>T::	regulatory_region_variant:CTCF_binding_site	602954 [GENE=RAD51D PHENOS=Breast-ovarian cancer,familial,susceptibility to,4,614291];	183785 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 4,not specified,Breast and Ovarian Cancer Susceptibility];			rs9901455	0.1875	0.1616	563,.	0.3055,0.1043,0.2299,0.0821,0.0860	1.6530			0.64,0.92	17.80							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	41223094	41223094	T	C	het		QUAL=4362;DP=432;AF=0.47;MQM=60;SAP=269;ABP=6	BRCA1	missense,intron	BRCA1:ENST00000309486:missense_variant:MODERATE:exon14/22:c.3949A>G:p.Ser1317Gly:,BRCA1:ENST00000346315:intron_variant:MODIFIER:intron12/18:c.4358-7126A>G::,BRCA1:ENST00000351666:missense_variant:MODERATE:exon11/19:c.1288A>G:p.Ser430Gly:,BRCA1:ENST00000352993:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000354071:intron_variant:MODIFIER:intron12/17:c.4358-7704A>G::,BRCA1:ENST00000357654:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000468300:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000471181:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000491747:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000493795:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:NM_007298.3:missense_variant:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007299.4:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007300.4:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon15/23:n.5014A>G::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	41827 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.3558	0.3539	1623,.	0.2404,0.3171,0.3801,0.3259,0.5041	-0.1120	T(0.14), ,T(0.14),T(0.11), ,T(0.11),T(0.12),T(0.12),T(0.10),T(0.11), ,T(0.20), 	B(0.04), ,B(0.01),B(0.01), ,B(0.04),B(0.00),B(0.07),B(0.02),B(0.04), ,B(0.04), 	0.03,0.18	9.51	0.25			COSV58783381			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41234470	41234470	A	G	het		QUAL=343;DP=34;AF=0.50;MQM=60;SAP=25;ABP=3	BRCA1	synonymous,intron	BRCA1:ENST00000309486:synonymous_variant:LOW:exon11/22:c.3420T>C:p.Ser1140=:,BRCA1:ENST00000346315:synonymous_variant:LOW:exon12/19:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000351666:synonymous_variant:LOW:exon8/19:c.759T>C:p.Ser253=:,BRCA1:ENST00000352993:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000354071:synonymous_variant:LOW:exon12/18:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000357654:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000468300:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000471181:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000491747:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000493795:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:NM_007298.3:synonymous_variant:LOW:exon11/22:c.999T>C:p.Ser333=:,BRCA1:NM_007299.4:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:NM_007300.4:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon12/23:n.4485T>C::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	125703 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.3363	0.3485	1511,.	0.1820,0.3116,0.3787,0.3255,0.5038	-0.1190			0.04,0.21	2.72							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	41244000	41244000	T	C	het		QUAL=4694;DP=350;AF=0.49;MQM=60;SAP=4;ABP=3	BRCA1	missense,intron	BRCA1:ENST00000309486:missense_variant:MODERATE:exon9/22:c.2660A>G:p.Lys887Arg:,BRCA1:ENST00000346315:missense_variant:MODERATE:exon10/19:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.548-951A>G::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000354071:missense_variant:MODERATE:exon10/18:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000357654:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000468300:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000471181:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000491747:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000493795:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-951A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3725A>G::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	41818 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.3526	0.3527	1591,.	0.2365,0.3164,0.3795,0.3242,0.5039	-0.3660	T(1.00),T(1.00), , ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	B(0.00),B(0.00), , ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	0.02,0.17	0.11	0.07			COSV58784397			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41244435	41244435	T	C	het		QUAL=10833;DP=980;AF=0.49;MQM=60;SAP=4;ABP=5	BRCA1	missense,intron	BRCA1:ENST00000309486:missense_variant:MODERATE:exon9/22:c.2225A>G:p.Glu742Gly:,BRCA1:ENST00000346315:missense_variant:MODERATE:exon10/19:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.548-1386A>G::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron9/21:c.671-1386A>G::,BRCA1:ENST00000354071:missense_variant:MODERATE:exon10/18:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000357654:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000468300:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:ENST00000471181:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000491747:intron_variant:MODIFIER:intron10/22:c.788-1386A>G::,BRCA1:ENST00000493795:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-28467A>G::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-17897A>G::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+32853A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-1386A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3290A>G::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	41815 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,Pancreatic cancer 4,FANCONI ANEMIA, COMPLEMENTATION GROUP S,not specified,not provided];	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1];		rs16941	0.3357	0.3483	1505,.	0.1818,0.3112,0.3789,0.3252,0.5035	-0.4810	T(0.06),T(0.14), , ,T(0.13),T(0.16), ,T(0.17), ,T(0.15), , , 	P(0.61),B(0.01), , ,B(0.08),P(0.61), ,B(0.00), ,P(0.61), , , 	0.05,0.19	15.07	0.23			COSV58786412			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41244936	41244936	G	A	het		QUAL=2121;DP=130;AF=0.58;MQM=60;SAP=9;ABP=11	BRCA1	missense,intron	BRCA1:ENST00000309486:missense_variant:MODERATE:exon9/22:c.1724C>T:p.Pro575Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315:missense_variant:MODERATE:exon10/19:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.548-1887C>T::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000354071:missense_variant:MODERATE:exon10/18:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000471181:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000493795:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1825C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2789C>T::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	41812 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917		0.4842	4287,.	0.8253,0.3484,0.3789,0.3338,0.5316	4.2470	T(1.00),T(1.00), , ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	B(0.00),B(0.00), , ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	0.02,0.89	18.04	0.14			COSV58784386			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41245237	41245237	A	G	het		QUAL=1538;DP=127;AF=0.46;MQM=60;SAP=3;ABP=5	BRCA1	synonymous,intron	BRCA1:ENST00000309486:synonymous_variant:LOW:exon9/22:c.1423T>C:p.Leu475=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315:synonymous_variant:LOW:exon10/19:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.548-2188T>C::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron9/21:c.671-2188T>C::,BRCA1:ENST00000354071:synonymous_variant:LOW:exon10/18:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:ENST00000471181:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747:intron_variant:MODIFIER:intron10/22:c.787+1524T>C::,BRCA1:ENST00000493795:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-29269T>C::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-18699T>C::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+32051T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1524T>C::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:NM_007300.4:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2488T>C::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	125554 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,Pancreatic cancer 4,FANCONI ANEMIA, COMPLEMENTATION GROUP S,not specified,not provided];	CM1719261 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs16940	0.3353	0.3474	1492,.	0.1815,0.3108,0.3790,0.3237,0.5033	-0.4510			0.06,0.19	5.58				COSV58786443			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41245466	41245466	G	A	het		QUAL=464;DP=62;AF=0.44;MQM=60;SAP=62;ABP=5	BRCA1	synonymous,intron	BRCA1:ENST00000309486:synonymous_variant:LOW:exon9/22:c.1194C>T:p.Ser398=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315:synonymous_variant:LOW:exon10/19:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.548-2417C>T::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron9/21:c.670+2397C>T::,BRCA1:ENST00000354071:synonymous_variant:LOW:exon10/18:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:ENST00000471181:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747:intron_variant:MODIFIER:intron10/22:c.787+1295C>T::,BRCA1:ENST00000493795:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-29498C>T::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-18928C>T::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+31822C>T::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1295C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:NM_007300.4:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2259C>T::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	125536 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM1719085 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799949	0.3365	0.3526	1602,.	0.2372,0.3165,0.3788,0.3242,0.5041	-0.0020			0.00,0.13	3.94				COSV58784419			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41249364	41249364	A	-	het	off-target	QUAL=543;DP=70;AF=0.39;MQM=60;SAP=13;ABP=11	BRCA1	intron	BRCA1:ENST00000309486:intron_variant:MODIFIER:intron6/21:c.-341-58del::,BRCA1:ENST00000346315:intron_variant:MODIFIER:intron7/18:c.548-58del::,BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.547+2428del::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000354071:intron_variant:MODIFIER:intron7/17:c.548-58del::,BRCA1:ENST00000357654:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000468300:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000471181:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:ENST00000491747:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000493795:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.4+27835del::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-22826del::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+27924del::	BRCA1:NM_007294.4:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:NM_007297.4:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron6/21:c.548-58del::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:NM_007300.4:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:NR_027676.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/22:n.725-58del::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	125889 [benign DISEASE=Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified];			rs8176144		0.3006	1497,.		0.9130				16.47							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41256090	41256103	AAAAAAAAGAAAAG	-	het	off-target	QUAL=10;DP=11;AF=0.27;MQM=60;SAP=10;ABP=8	BRCA1	intron	BRCA1:ENST00000309486:intron_variant:MODIFIER:intron5/21:c.-448+36_-448+49del::,BRCA1:ENST00000346315:intron_variant:MODIFIER:intron6/18:c.441+36_441+49del::,BRCA1:ENST00000351666:intron_variant:MODIFIER:intron5/18:c.441+36_441+49del::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000354071:intron_variant:MODIFIER:intron6/17:c.441+36_441+49del::,BRCA1:ENST00000357654:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000468300:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000471181:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:ENST00000491747:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000493795:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.4+21096_4+21109del::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-44+21185_-44+21198del::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+21185_-99+21198del::	BRCA1:NM_007294.4:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:NM_007297.4:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron5/21:c.441+36_441+49del::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:NM_007300.4:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:NR_027676.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/22:n.621+36_621+49del::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	225705 [benign DISEASE=Breast-ovarian cancer, familial 1,not specified];		Alu (SINE/Alu)&(AAG)n (Simple_repeat)	rs373413425		0.2784	1079,.	0.1507,0.2211,0.2941,0.2367,0.4414	1.6730				3.36							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	56769979	56769979	C	T	het	off-target	QUAL=11283;DP=974;AF=0.47;MQM=60;SAP=5;ABP=12	RAD51C	5'UTR	RAD51C:ENST00000337432:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,RAD51C:ENST00000583539:5_prime_UTR_variant:MODIFIER:exon1/8:c.-26C>T::	RAD51C:NM_002876.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-26C>T::,RAD51C:NM_058216.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,RAD51C:NR_103872.2:non_coding_transcript_exon_variant:MODIFIER:exon1/8:n.17C>T::,RAD51C:NR_103873.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.46C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	602774 [GENE=RAD51C PHENOS=Breast-ovarian cancer,familial,susceptibility to,3,613399/Fanconi anemia,complementation group O,613390,Autosomal recessive];	324173 [likely benign DISEASE=Fanconi anemia,Breast and Ovarian Cancer Susceptibility];			rs12946397	0.1583	0.1955	641,.	0.1375,0.1328,0.1701,0.2064,0.1381	-3.0920			0.06,0.35	11.98							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	56798207	56798207	T	C	het	off-target	QUAL=203;DP=27;AF=0.44;MQM=60;SAP=29;ABP=4	RAD51C	intron	RAD51C:ENST00000337432:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:ENST00000583539:intron_variant:MODIFIER:intron6/7:c.904+34T>C::	RAD51C:NM_058216.3:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:NR_103872.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/7:n.779+34T>C::		602774 [GENE=RAD51C PHENOS=Breast-ovarian cancer,familial,susceptibility to,3,613399/Fanconi anemia,complementation group O,613390,Autosomal recessive];				rs28363318	0.2053	0.2905	1401,.	0.2680,0.1858,0.0008,0.3468,0.1934	0.2790			0.05,0.17	1.75							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	59760996	59760996	A	G	hom		QUAL=7636;DP=310;AF=1.00;MQM=60;SAP=676;ABP=0	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:	BRIP1:NM_032043.3:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:		605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Somatic mutation,Autosomal dominant];	183702 [benign/likely benign DISEASE=Neoplasm of the breast,Neoplasm of ovary,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Fanconi anemia, complementation group J,not specified];			rs4986763	0.6208	0.5993	5476,.	0.6543,0.7941,0.7150,0.5867,0.4553	3.1090			0.83,0.98	9.03							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	59763347	59763347	A	G	hom		QUAL=373;DP=12;AF=1.00;MQM=60;SAP=6;ABP=0	BRIP1	missense	BRIP1:ENST00000259008:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000577598:missense_variant:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro:	BRIP1:NM_032043.3:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:		605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Somatic mutation,Autosomal dominant];	133756 [benign/likely benign DISEASE=Neoplasm of the breast,Neoplasm of ovary,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Fanconi anemia, complementation group J,not specified];			rs4986764	0.6278	0.6019	5608,.	0.6744,0.7994,0.7151,0.5875,0.4555	0.1360	T(0.94),T(0.43)	B(0.00),B(0.00)	0.00,0.15	1.50	0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	59763465	59763465	T	C	hom		QUAL=3671;DP=114;AF=1.00;MQM=60;SAP=107;ABP=0	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:ENST00000577598:synonymous_variant:LOW:exon18/18:c.2637A>G:p.Glu879=:	BRIP1:NM_032043.3:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:		605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Somatic mutation,Autosomal dominant];	183703 [benign/likely benign DISEASE=Neoplasm of the breast,Neoplasm of ovary,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Fanconi anemia, complementation group J,not specified];			rs4986765	0.8151	0.7183	8462,.	0.9105,0.8670,0.8908,0.6633,0.6991	-0.0280			0.11,0.93	9.96							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	59857600	59857600	A	-	het	off-target	QUAL=16;DP=26;AF=0.23;MQM=60;SAP=3;ABP=19	BRIP1	intron	BRIP1:ENST00000259008:intron_variant:MODIFIER:intron13/19:c.1935+22del::,BRIP1:ENST00000577598:intron_variant:MODIFIER:intron12/17:c.1935+22del::	BRIP1:NM_032043.3:intron_variant:MODIFIER:intron13/19:c.1935+22del::	regulatory_region_variant:TF_binding_site,TF_binding_site_variant	605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Somatic mutation,Autosomal dominant];				rs74268880		0.0119	0,.	0.0088,0.0130,0.0112,0.0125,0.0124	-0.2540				1.77							0	23	0 / 2					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	59857809	59857809	C	G	het	off-target	QUAL=183;DP=14;AF=0.64;MQM=60;SAP=23;ABP=5	BRIP1	intron	BRIP1:ENST00000259008:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:ENST00000577598:intron_variant:MODIFIER:intron11/17:c.1795-47G>C::	BRIP1:NM_032043.3:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::	regulatory_region_variant:TF_binding_site	605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Somatic mutation,Autosomal dominant];	262005 [benign DISEASE=not specified];		AluJb (SINE/Alu)	rs4988351		0.7905	9866,.	0.8564,0.4960,0.8292,0.7506,0.7925	0.1450			0.02,0.22	8.15							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr18	19995753	19995753	T	C	hom		QUAL=464;DP=19;AF=1.00;MQM=60;SAP=44;ABP=0	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:	CTAGE1:NM_172241.3:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:						rs9946145	0.6855	0.8553	10184,.	0.3488,0.8771,0.8271,0.9161,0.7923	-0.1350			0.02,0.10	0.27							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a)
chr18	19996011	19996011	G	A	het		QUAL=1512;DP=133;AF=0.46;MQM=60;SAP=5;ABP=5	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:	CTAGE1:NM_172241.3:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:						rs7227477	0.4942	0.5056	3822,.	0.4654,0.6070,0.6150,0.4834,0.4305	0.0500			0.00,0.04	0.19							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a)
chr18	20555219	20555219	T	C	hom	off-target	QUAL=2177;DP=70;AF=1.00;MQM=60;SAP=4;ABP=0	RBBP8	intron	RBBP8:ENST00000327155:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000360790:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399722:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399725:intron_variant:MODIFIER:intron6/17:c.428+37T>C::	RBBP8:NM_002894.3:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:NM_203291.1:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:NM_203292.1:intron_variant:MODIFIER:intron6/17:c.428+37T>C::	regulatory_region_variant:promoter_flanking_region	604124 [GENE=RBBP8 PHENOS=Jawad syndrome,251255,Autosomal recessive/Pancreatic carcinoma,somatic/Seckel syndrome 2,606744,Autosomal recessive];	673936 [benign DISEASE=not provided];			rs2336916		0.9650	14076,.	0.8519,0.9811,0.9169,0.9844,0.9366	-1.6630			0.00,0.07	4.56							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	20564801	20564803	TCA	-	het	off-target	QUAL=362;DP=32;AF=0.47;MQM=60;SAP=3;ABP=3	RBBP8	intron	RBBP8:ENST00000327155:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000360790:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399722:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399725:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::	RBBP8:NM_002894.3:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:NM_203291.1:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:NM_203292.1:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::		604124 [GENE=RBBP8 PHENOS=Jawad syndrome,251255,Autosomal recessive/Pancreatic carcinoma,somatic/Seckel syndrome 2,606744,Autosomal recessive];				rs3052770		0.5689	4404,.	0.2077,0.5114,0.4647,0.6430,0.5451	-0.2930				2.52							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	48584855	48584855	-	T	het	off-target	QUAL=2171;DP=215;AF=0.16;MQM=60;SAP=4;ABP=215	SMAD4	intron	SMAD4:ENST00000342988:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000398417:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000588745:intron_variant:MODIFIER:intron4/7:c.667+3508dup::	SMAD4:NM_005359.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::		600993 [GENE=SMAD4 PHENOS=Polyposis,juvenile intestinal,174900,Autosomal dominant/Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050,Autosomal dominant/Myhre syndrome,139210,Autosomal dominant/Pancreatic cancer,somatic,260350];	492739 [benign DISEASE=not specified];			rs386387676		0.1673	19,.	0.1574,0.1563,0.1985,0.1708,0.1496					12.26							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	48584855	48584855	-	TT	het	off-target	QUAL=2171;DP=215;AF=0.38;MQM=60;SAP=11;ABP=31	SMAD4	intron	SMAD4:ENST00000342988:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000398417:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000588745:intron_variant:MODIFIER:intron4/7:c.667+3507_667+3508dup::	SMAD4:NM_005359.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::		600993 [GENE=SMAD4 PHENOS=Polyposis,juvenile intestinal,174900,Autosomal dominant/Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050,Autosomal dominant/Myhre syndrome,139210,Autosomal dominant/Pancreatic cancer,somatic,260350];				rs386387676		0.3060	989,.	0.1110,0.2014,0.2348,0.1888,0.1415					12.23							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr19	17379558	17379558	C	T	het	off-target	QUAL=1316;DP=109;AF=0.48;MQM=60;SAP=6;ABP=4	BABAM1,CTD-2278I10.6	splice_region&intron,intron,intron&NMD_transcript	BABAM1:ENST00000359435:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:ENST00000447614:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000595632:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,CTD-2278I10.6:ENST00000596542:intron_variant&NMD_transcript_variant:MODIFIER:intron1/9:c.-188-45C>T::,BABAM1:ENST00000598188:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000601043:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::	BABAM1:NM_001033549.2:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:NM_001288756.1:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:NM_001288757.1:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::						rs10424178	0.1727	0.2345	960,.	0.3533,0.0925,0.0004,0.1919,0.1115	-0.3270			0.03,0.12	2.54		1.98>3.28	0.000/0.134				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17382505	17382505	A	T	het	off-target	QUAL=331;DP=49;AF=0.37;MQM=60;SAP=3;ABP=10	BABAM1,CTD-2278I10.6	intron,intron&NMD_transcript	BABAM1:ENST00000359435:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000447614:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000595632:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,CTD-2278I10.6:ENST00000596542:intron_variant&NMD_transcript_variant:MODIFIER:intron2/9:c.111-2208A>T::,BABAM1:ENST00000598188:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000601043:intron_variant:MODIFIER:intron3/8:c.344+41A>T::	BABAM1:NM_001033549.2:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:NM_001288756.1:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:NM_001288757.1:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron3/8:c.344+41A>T::						rs10420922	0.4631	0.5057	4195,.	0.6918,0.3280,0.3137,0.4338,0.3806	-0.2920			0.00,0.04	0.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17387254	17387254	G	A	het	off-target	QUAL=1378;DP=101;AF=0.52;MQM=60;SAP=3;ABP=4	BABAM1,CTD-2278I10.6	intron,intron&NMD_transcript	BABAM1:ENST00000359435:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000447614:intron_variant:MODIFIER:intron6/8:c.569+37G>A::,BABAM1:ENST00000595632:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,CTD-2278I10.6:ENST00000596542:intron_variant&NMD_transcript_variant:MODIFIER:intron5/9:c.336-50G>A::,BABAM1:ENST00000598188:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000601043:intron_variant:MODIFIER:intron6/8:c.570-50G>A::	BABAM1:NM_001033549.2:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:NM_001288756.1:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:NM_001288757.1:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron6/8:c.570-50G>A::						rs61634114	0.0990	0.1719	504,.	0.1450,0.0815,0.0007,0.1776,0.1166	0.5630			0.04,0.13	8.16							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17389648	17389648	C	T	het		QUAL=1232;DP=108;AF=0.47;MQM=60;SAP=3;ABP=4	BABAM1,CTD-2278I10.6	splice_region&intron,intron&NMD_transcript	BABAM1:ENST00000359435:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000447614:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000595632:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,CTD-2278I10.6:ENST00000596542:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.552+1930C>T::,BABAM1:ENST00000598188:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::	BABAM1:NM_001033549.2:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288756.1:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288757.1:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:NM_014173.4:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::						rs10406920	0.1118	0.1847	572,.	0.1828,0.0790,0.0006,0.1783,0.1144	0.7670			0.22,0.33	3.11		8.04>7.99	0.000/0.002				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17389704	17389704	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60;SAP=3;ABP=7	BABAM1,CTD-2278I10.6	synonymous,intron&NMD_transcript	BABAM1:ENST00000359435:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000447614:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000595632:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,CTD-2278I10.6:ENST00000596542:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.552+1986G>A::,BABAM1:ENST00000598188:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:	BABAM1:NM_001033549.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288756.1:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288757.1:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:NM_014173.4:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:				CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.1124	0.1865	577,.	0.1918,0.0800,0.0006,0.1795,0.1147	2.9920			0.88,0.94	11.44							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr20	14167283	14167283	A	G	hom		QUAL=905;DP=31;AF=1.00;MQM=60;SAP=4;ABP=0	MACROD2	intron	MACROD2:ENST00000217246:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000310348:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::	MACROD2:NM_001351661.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_001351663.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_080676.6:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.4792	0.5396	4941,.		-0.5350			0.01,0.34	9.25							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=n/a oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	48301146	48301146	G	A	hom		QUAL=39631;DP=1210;AF=1.00;MQM=60;SAP=5;ABP=0	B4GALT5	intron	B4GALT5:ENST00000371711:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::	B4GALT5:NM_004776.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::						rs6512586	0.4681	0.5178	3527,.	0.3755,0.4483,0.3696,0.5460,0.6515	-0.9860			0.00,0.05	0.35							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
